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1. Introduction 
 
1.1 Nucleic Acids Interactions 
 
The genetic information essential for life functions, reproduction and development of 
organisms is stored in base sequences of polynucleotide molecules. Transfer of the genetic 
information is carried out in the processes of deoxyribonucleic acid (DNA) replication and 
transcription into ribonucleic acid (RNA) (Figure 1). Hybridization of complementary 
nucleotide sequences is a crucial step in these processes.  
 
 
Fig. 1 Scheme of gene transfer processes in living cells. 
 
The skeleton of NA strand is formed by a sugar-phosphate backbone and heterocyclic 
bases that are attached to the sugar moiety (ribose and 2'-deoxyribose for RNA and DNA, 
respectively) via an N-glycosidic bond. Four major bases are present in the DNA structure: 
adenine (A), thymine (T), guanine (G) and cytosine (C). In RNA structure, the thymine is 
replaced with uracil (U). The specific base pairing is a key to storage and transfer of genetic 
information. As it was revealed by James Watson and Francis Crick in 1953 [1], adenine 
forms a pair only with thymine (by two hydrogen bonds) while guanine binds by three 
hydrogen bonds cytosine in DNA double-helix (duplex), Figure 2. 
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Fig. 2 Scheme of the adenine (A) - thymine (T) and guanine (G) - cytosine (C) specific Watson-Crick 
base-pairing concept. 
 
Besides the standard Watson-Crick base-pairing found in NA duplexes, other pairing 
schemes can occur in the multi-strand complexes, e.g., Hoogsteen base pairing. Hoogsteen 
pairing is present in NA triple helices (triplexes) that are often considered to regulate the gene 
transcription [2-4]. Triplexes are formed exclusively between homopurine and 
homopyrimidine strands and can have parallel or antiparallel structures according to the 
composition and orientation of the third strand [4]. Potential schemes of DNA or RNA 
triplexes include triplets such as T:A*T, U:A*U or C:G*C
+
 (Figure 3). Formation of triplexes 
depends on temperature, pH, concentrations of particular cations and other factors [5, 6]. For 




require protonation at the N3 
position of cytosine residues and are stabilized by low pH and high ionic strength [7]. 
Fig. 3 Base triplet (U:A*U) occurring in RNA triplex structure; dotted lines represent hydrogen bonds of  
 Watson-Crick base-pairing, dashed lines those of Hoogsteen pairing 
 
Hydrogen bonds occurring in the base pairs play a fundamental role in the 
functionality of nucleic acids (NA), but they are not the main stabilizing factor of the NA 
three-dimensional structure. Their structure is stabilized mainly by the base stacking, and by 
ionic and hydrophobic interactions with the aqueous environment. The geometry of nucleic 
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acids in solution is though not rigid and it is influenced by numerous factors like the base 
sequence, NA concentration, length of the NA strands, temperature, ionic strength, etc [5, 6, 
8]. In general, we distinguish several basic canonical forms of NA duplexes: prevailing is the 




Fig. 4 Basic canonical forms of nucleic acid duplexes: B-DNA (left) and A-RNA (right). 
 
Under particular conditions the organized structure completely disappears and the NA 
complex is denatured. In particular, NA complexes can be destroyed with increasing 
temperature leading to a complete separation of single strands. This process has features of a 
phase transition hence it is referred to as “melting” of NA complexes. Melting temperature 
(Tm) of complexes is defined as the temperature at which half of the complexes are 
disintegrated. Melting temperature is commonly employed as a basic parameter 
characterizing the stability of NA complexes [9]. 
The hybridization reaction is nowadays routinely exploited in numerous molecular 
biology techniques such as polymerase chain reaction (PCR) or blotting techniques [10, 11]. 
These methods rely on highly sensitive and specific detection of hybridization between short 
synthetic oligonucleotide (ON) probe and target nucleic acid sequence. Using common 
instruments applied in such techniques, only the final NA complex is detected and the actual 
process of hybridization cannot be monitored. Moreover for a majority of such assays, a 
radioactive or fluorescent labeling is required within the read-out system. This increases the 
cost and the time of the analyzing procedure. Some labels can also interfere with the 
interaction under study and thus lead to less correct or even false results. Further 
development of NA techniques obligates detailed knowledge of the hybridization reaction. 
There is still a search for sensitive real-time methods that enable monitoring of the 
hybridization process without need of any additive labeling. 
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1.2 Gene targeting therapies 
 
High research interest has recently been focused on the development of strategies for 
gene therapy that basically rely on oligonucleotide hybridization. The standard drugs 
nowadays act at the protein level. The mechanism of their action is based on interrupting the 
target disease-specific protein functionality. As the 3D structure and function of proteins are 
very complex, the mechanism of therapeutic effect of many current drugs is still unclear [12]. 
Current methods for potential drugs development such as combinatorial chemistry or parallel 
synthesis generate tens of thousands of probable protein-target drug molecules per particular 
viral, bacterial or malignant disease. Thus the libraries of compounds must be screened to 
select potential candidates for further development. This process is time consuming and 
prolongs the costs [13]. 
Opposite to that, gene-targeting therapies utilizing short synthetic oligonucleotides 
(ONs) could be more efficient, sensitive, and more universal in combating viral and 
malignant diseases [14]. The principle of such therapies is to block the synthesis of protein 
that is essential for growth of malignant cell or for particular virus reproduction at the early 
stage of this protein synthesis - at the nucleic acids level. The most common concepts of 
gene-targeting therapy include antigene and antisense therapies. Antigene strategies pursue 
the gene targeting by triple-helix-forming oligonucleotides (TFOs) [15]. Anti-messenger 
RNA conceptions comprise the use of artificial ribozymes [16] and so-called antisense 
oligonucleotides [17] with a complementary base sequence to the target mRNA region 
(Figure 5). The aptamers are short DNA or RNA oligomers that can bind to a protein with 
high affinity and specificity and thus can disable the protein function as well [18]. 
 Since the first observations of the antiviral effect of selected oligonucleotides against 
Rous sarcoma virus in the work of Zamecnik et al. two decades ago [19], the antisense 
approach has become the most popular one [17, 20] among these strategies and the research 
has been focused on that. The successful antisense oligonucleotides must meet the 
requirements as follows: (i) the ability to hybridize with the target sequence, (ii) satisfactory 
resistance against nucleases, (iii) the ability to penetrate into the cells through cell membranes 
to the target, and (iv) the ability to elicit RNase H activity [14, 17]. As the natural 
phosphodiester ONs cannot meet the requirement for intracellular stability, the modification 
of ON structure is necessary. The chemists have offered a variety of the ON analogs whereas 
the modifications of internucleotide linkage have been shown to be the most promising [12]. 
The phosphorothioate oligomers as the first generation of antisense oligonucleotides [17, 21, 
22] have reached the clinical trials level and practical use [20, 23]. But the lower specificity 
in comparison with the natural ONs, and some other unwanted side effects of 
phosphorothioate analogs have been reported [24, 25]. Other ON analogs such as the 
compounds consisting of both 2’-O-methyl and phosphorothioate units have reached the 
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clinical trials level as the antisense oligonucleotides of the second or the third generation [20, 
26, 27]. However, there is still a continuous search for another antisense oligonucleotide with 









1.3 Surface Plasmon Resonance Method 
 
 Oligonucleotide (ON) hybridization can be in principle studied in solution or using 
solid-phase based methods. The common approaches investigating ON hybridization in 
solution such as optical spectroscopy (ultra-violet UV [28, 29], circular dichroism CD [30], 
fluorescence [31, 32] and Raman spectroscopy [8]), or other methods, e.g., calorimetry [30] 
or molecular modeling [28, 33] can either provide an useful information on the structural 
features of formed complexes [8] or enable to predict the complex stability. Nevertheless it is 
not possible to monitor the actual process of the hybridization and thus to determine kinetic 
parameters of the reactions by using standard devices. 
 The hybridization has been studied in solid phase using different matrices such as 
polyacrylamide gel [34], nylon membranes [10] or glass [35]. The interest in a solid-phase 
detection of ONs, particularly in reaction between the single-stranded oligonucleotide probe 
immobilized on the surface and the complementary target strand in solution has significantly 
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increased since the development of the first DNA chip [36]. This technology enables 
simultaneous detection of hundreds to thousands hybridization reactions in an array format. 
Nowadays, the advances in photolithographic, spotting and other array techniques allow for 
parallel monitoring of up to thousands of DNA hybridization reactions with the lowest 
concentration limit of ON detection (LOD) at femtomolar level [37]. However, such sensitive 
DNA or RNA microarrays still require fluorescent or radioactive labeling [31, 32].  
 Biosensor technology can meet the requirements for sensitive specific real-time and 
label-free monitoring of biomolecular interactions involving hybridization reaction and thus it 
is of a huge interest of current research. In past years, many examples of use of biosensor 
technology for detection of biological or chemical analytes and for studying various 
biomolecular interactions can be found [38-41]. Among other sensor technologies, e.g., those 
based on electrochemical [42] or piezoelectric principle of action [43], the optical biosensors 
are advantageous because of their high sensitivity. Next advantage of optical sensor 
measurements is that they do not require any electrical signal in a sensing area and cannot be 
perturbed by electric or magnetic fields [44-46]. Optical biosensors offer a universal platform 
for study of various biological or chemical molecules and their interactions. 
 Surface plasmon resonance (SPR) biosensors have been significantly improved within 
the family of label-free optical biosensors in many aspects including the detection limit, 
microfluidics, immobilization methods, sample handling, and data analysis. Nowadays, SPR 
biosensors represent the most widely used label-free optical biosensors; numerous 
commercial SPR instruments have been extensively produced and sold. Various platforms of 
SPR biosensors such as array-format based SPR imaging for parallel monitoring of many 
reactions or portable SPR sensors for the field use have been developed and optimized for 
particular applications [47, 48]. Overwhelming amount of research papers prove that modern 
SPR biosensors enable highly sensitive, rapid, and label-free detection of various 
biomolecules [49-51]. Moreover, the kinetics of interaction can be monitored due to real-time 
regime of the measurement [52, 53]. These advantages make SPR biosensors excellent 
candidates for investigating NA interactions such as oligonucleotide hybridization processes 
or NA-enzyme interactions. 
 The surface plasmon resonance biosensors are based on measuring changes in 
properties of an optical wave excited at a metal-dielectric interface. This wave represents a 
special mode of electromagnetic field - surface plasmon polariton (SPP) – that propagates 
along the surface of a thin metal film. The commonly used metal is gold due to its chemical 
stability. Intensity of the SPP electromagnetic field decays exponentially from the metal 
surface to an adjacent medium. A change of the refractive index due to the binding of analyte 
molecules to biomolecular recognition elements immobilized on the metal surface influence 
the SPP propagation constant [54]. SPR biosensor measures the changes in the propagation 
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constant of the SPP and thus it determines the relative amount of bound analyte on the 
biosensor surface. 
The SPR biosensor utilizes measurement of one of the characteristics of SPP-exciting 
light wave that is modified by the changes in the SPP propagation constant. Depending on the 
particular measured parameter, the SPR sensors are classified as sensors with angular, 
wavelength, intensity, phase, or polarization modulation [54]. 
One of the successful strategies of SP excitation is based on attenuated total reflection 
(ATR) in a prism coupler, Figure 6 [54]. In SPR sensors with wavelength modulation, a beam 
of polychromatic light incidents on the metal film under a fixed angle of incidence and 
excites an SPP (Figure 6). The propagation constant of the SPP is characterized by measuring 
the intensity of reflected light at various wavelengths and determining the wavelength at 





Fig. 6 Left: Excitation of the surface plasmons via prism coupler. Right: Intensity of reflected light as a function 
of wavelength for a fixed angle of incidence (curves for two different refractive indices of the sample). 
 
 
The shift in resonant wavelength is proportional to the refractive index change at the 
sensor surface. An SPR-sensorgram of the analyte binding to receptor immobilized on the 
sensor surface is shown in Figure 7 as a typical plot of the shift in sensor response 
nanometers versus time. Three phases of the single measurement can be distinguished: (1) 
washing the sensor surface with buffer till the stable baseline is achieved (Fig. 7, phase I.), 
(2) flowing with solution of analyte over the sensor surface - complex formation with 
immobilized biomolecular partner is monitored (Fig. 7, phase II.), (3) washing the sensor 
surface with the same buffer as before the analyte injection – dissociation of complexes can 
be measured (Fig 7, phase III.). The amount of bound analyte at the sensor surface is 
determined as the difference in the sensor response nanometers between the equilibrium level 
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obtained when the same buffer was flowed before the injection of the analyte solution (at the 
end of phase I.). 
 
 



















































Fig. 7 Typical SPR sensorgram corresponding to real-time measurement of analyte binding to functionalized 
sensor surface. In the first phase, the functionalized sensor surface is washed with buffer (I.), then the 
solution of analyte is injected and the biomolecular complex formation is monitored (II.), washing the 
solution with the same buffer as it was used in the phase I. to measure potential dissociation of 
complexes and to determine the level of tightly bound analyte. 
 
 
The sensor response can be calibrated to provide the surface concentration of bound 
molecules. The calibration coefficient is proportional to their molar weight [55] and depends 
on the resonant wavelength. 
For the majority of experiments mentioned in this dissertation, four-channel or eight-
channel SPR sensors based on wavelength modulation [56] and wavelength division 
multiplexing (WDM) [57, 58], were used. These sensors were developed at the Department 
of Optical Sensors of the Institute of Radio Engineering and Electronics of the Academy of 
Sciences of the Czech Republic. The eight-channel SPR sensor combined wavelength 
division multiplexing of two serially ordered sensing channels in a special sensing element 
with four parallel light beams (Figure 8) to yield the total of eight sensing channels. 
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Fig. 8 Scheme of an eight-channel SPR sensor with four parallel light beams and the wavelength division 
multiplexing (WDM) of sensing channels (lower graph); Spectrum of transmitted light with two SPR 
dips before (dashed line) and after the binding (solid line) (upper graph). 
 
Broadband light from a halogen lamp was collimated, polarized and then introduced 
into the WDM-SPR sensing element interfaced with a chip made of a glass coated by an 
adhesion-promoting titanium film (thickness - 2 nm) and a gold film (thickness - 55 nm). 
Upon the first incidence on a thin gold film, each light beam excited a surface plasmon at a 
certain wavelength (~ 650 nm and ~ 750 for eight-channel and four-channel system, 
respectively). In the eight-channel system, the reflected light was redirected towards the gold 
film at a different angle of incidence and excited a surface plasmon at another wavelength 
(~800 nm). The sequential excitation of the surface plasmons generated two narrow dips in 
the spectrum of light leaving the sensing element (Figure 8). Finally the reflected light was 
collected into a four optical fibers and coupled to a four-channel spectrograph. Acquired 
spectra were analyzed in real time by an home-made software package that allowed 
determination of the resonant wavelength for each sensing channel [59]. A flow-cell with 
four or eight separate flow chambers facing each sensing spot was interfaced with the chip to 
confine the sample during the experiment. The flow chambers were precisely aligned with the 
zones where the surface plasmons were excited in each sensing channel. The depth of each 
flow cell was about 50 µm and the volume of each flow-cell chamber was 1-3 µl with respect 
to the particular flow cell design. A peristaltic pump was used to flow liquid samples over the 
sensing spots. The overall scheme of the eight-channel SPR instrument is shown in Figure 9. 
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Fig. 9 The eight-channel SPR sensor combining parallel architecture with the wavelength division multiplexing 
of serially arranged channels. 
 
Within the four-channel SPR biosensor instrument, it was possible to control the 
temperature at which we monitored the molecular interactions. The temperature was 
stabilized by a Peltier’s thermoelectric element installed into a thermally stabilized body and 
a precision temperature controller (ILX Lightwave, USA). Liquid samples in thin-walled 
Peek tubing were flowed across the thermally stabilized body. The optical prism and the 
sensor chip were also in contact with the stabilized body (Figure 10). The accuracy of the 
temperature setting was 0.2°C (limited by the accuracy of the thermistor calibration); the 













Fig. 10 Scheme of the temperature stabilization set-up used in four-channel SPR sensor 
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1.4 Art of Immobilization 
 
Besides the optical transducer, a biomolecular recognition element that is attached to 
the sensor surface makes a heart of the SPR biosensor. Various biomolecules such as 
antibodies [60], peptides [61], oligonucleotides [62, 63], or molecularly imprinted polymers 
[64] have been used as the biomolecular recognition elements (receptors). The 
immobilization of receptors on the sensor surface is a fundamental step of the particular 
biosensor development because it influences significantly the resulting sensor sensitivity and 
specificity of the target analyte detection. The important requirements that the immobilization 
procedures have to fulfill are the defined and sufficiently high density of immobilized 
receptors with preservation of their biological activity and non-fouling background of the 
sensor chip surface. 
In general, methods of immobilization of biomolecular recognition elements on gold 
films exploit physico-chemical interactions such as chemisorptions [65], covalent binding 
[66, 67], hydrophobic and electrostatic interactions [68], and high-affinity biomolecular 
linker systems (e.g., streptavidin–biotin [69, 70], proteins A or G [71], and complementary 
oligonucleotides [72]). 
The first reports on using SPR technology for (bio) analytical applications were based 
on simple physical adsorption of protein ligands to the SPR metal surfaces [73]. However, it 
was soon realized that a more sophisticated approach was needed in order to meet the 
challenges demanded by the range of sensing applications. Commonly used gold substrate for 
SPR shows a high tendency for spontaneous adsorption of proteins and other molecules. This 
passive binding to the metal substrate can result in a loss of the sensor bioactivity. Studies on 
antibody binding activities in ELISA-type assays after their adsorption on plastic surfaces 
have shown bioactive levels as low as 2-10 % of the adsorbed amount [74]. These effects can 
be explained by a reorganization of the ligand to reach the most favorable thermodynamic 
state. For example, adsorption to hydrophobic surfaces is driven by rearrangement in the 
ligand conformation that optimizes contact of hydrophobic segments with the substrate. 
Passive binding to the surface substrate also opens the possibilities for uncontrolled exchange 
of the ligands during the measurement. 
One of the most remarkable techniques in surface chemistry is the spontaneous self-
organization of n-alkylthiols or disulfides on gold substrate enabling formation of well-
ordered arrays. Self-assembled monolayers (SAMs) have been employed in many 
immobilization methods for spatially controlled attachment of biomolecular recognition 
elements to surfaces of sensors [50], Figure 11. To achieve a desired surface density of 
receptors, SAMs mixed of long-chained (n=12 and higher) n-alkylthiols terminated with 
functional group for further attachment of receptors and of short-chained alkylthiols for a 
non-fouling background have been utilized [75]. 
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Fig. 11 Scheme of n-dodecanethiolate self-assembled on gold substrate. The assembly is held together by bonds 
between the sulfur head groups and the gold surface as well as by van der Waals and hydrophobic 
interactions between neighboring hydrocarbon chains (from [76]). 
 
 Several approaches for oligonucleotide immobilization onto gold sensor surface have 
been suggested. Two most common strategies are as follows: (1) assembly of thiol-
terminated oligonucleotide probes directly on the gold surface [63, 77, 78], and (2) coupling 
of biotinylated probes to the streptavidin assemblies via a non-covalent highly affinitive 
streptavidin-biotin interaction [50, 79, 80]. Disadvantage of the first type of the 
immobilization is a need of expensive chemical modification of the immobilized 
oligonucleotides and a limited length of immobilized probes [63]. Further comparison of 
immobilization procedures on gold surfaces is available for instance in [70]. 
An immobilization approach employing the streptavidin – biotin system reaches a 
good stability due to an extremely high binding affinity (Kd ~ 10
-15
 M) between streptavidin 
and biotin [81]; each streptavidin molecule contains four equivalent binding pockets for 
biotin [82], Figure 12. 
 
Fig. 12 Scheme of streptavidin tetramer with four biotin molecules (yellow-colored) bound in its four binding 
pockets. 
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In the most widespread commercial SPR biosensors (BIAcore™), streptavidin coating 
is prepared using “amine coupling chemistry” based on covalent attachment of streptavidin 
by primary amines to activated carboxylate groups of a carboxymethyl group-terminated 
hydrogel (dextran) matrix [67, 83]. This method (if it starts from the bare gold substrate) is 
rather laborious and problems with stability [84], non-specific binding [85] and 
reproducibility [86] were reported. This method is also less suitable for kinetic studies due to 
undesired additive effect of analyte penetration through the hydrogel matrix that influences 
the resulting binding kinetics [87-89]. 
 
 
1.5 Kinetic Aspects of SPR Method 
 
The interaction of biomolecules makes a heart of biology. Much research effort has 
been focused on biomolecular interactions analysis in the areas such as antibody engineering, 
drug development research or functional protein analysis; these interactions are also vital in 
industrial applications where manufacture and purification of biomolecules is performed. One 
of fundamental characteristics of these interactions relies on the kinetics of association and 









where AR is the product of their association and ka, kd are association and dissociation kinetic 
rate constants. In this chapter it is assumed that A and R are homogeneous species that 
interact each other in a monovalent manner. If A and R are mixed, only the association 
(forward) reaction initially occurs. The AR complex is formed and concentrations of A and R 
decrease. As a time proceeds and the concentration of AR increases, the reverse reaction 
(dissociation) becomes significant. After some time (this can take as little as a few seconds or 
as long as overnight depending on the kinetics and the biological system under study) the 
rates of the two reactions (forward and reverse) come into equilibrium when overall 
concentrations of A, R, and AR become stable. These equilibrium concentrations ([A], [R], 
and [AR]) are related by the Law of Mass Action: 
 
 [AR]=Ka[A][R] (2) 
 
Ka is termed as an association equilibrium constant. The reciprocal form of Ka is referred to 
as a dissociation equilibrium constant Kd. The relationship between the equilibrium and the 
rate constants is given by 
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 Kd=1/Ka=kd/ka (3) 
 
The equilibrium constant Kd or Ka can in most cases be readily determined. On the opposite, 
the majority of methods that are today used to determine the kinetic rate constants kd and ka 
are too laborious, too specialized or too inaccurate for a common use. This situation has 
changed since the advent of new biosensor technologies; the potential for kinetic rate 
constants determination has thus become one of the greatest advantages of the SPR biosensor 
technique.  
 Current kinetic analysis of biosensor data is based on the concept that interaction 
between monovalent analyte A in solution and immobilized receptor binding site R can be 
described by the Eq. 1. We further assume that reaction scheme of the interaction between the 
A and R may be described by pseudo-first-order kinetics in situations where constancy of the 
analyte concentration is maintained as the result of either continual replenishment by flowing 
analyte solution along the sensor surface or by the use of a sufficiently high analyte 
concentration [90]. 
SPR biosensors measure in time the relative changes in the molecular mass in the 
close proximity of the sensor surface. The sensor response  is directly proportional to the 
concentration of the bound analyte. To analyze quantitatively the sensor response to 
interactions between the studied biomolecular analyte and the surface bound receptors, it is 
necessary to employ a relevant mathematical model [Appendix XII]. Kinetic equation that 
describes how the amounts of formed/dissociated complexes depend on the local 
concentrations of the free analyte and the free binding sites of the receptors is for the binding 







       (4) 
 
where γ is the amount of the complexes formed per unit time, 0 is the injected concentration 
of the analyte [A], and  is the concentration of the receptors on the sensor surface. Thus  -  
is the concentration of free unbound receptors. Both quantities  and  are expressed in the 
same way in terms of local density. Equation (4) was originally derived by Langmuir for 
interactions at a surface in contact with reactants in solution. In real molecular systems, the 
processes in the active sensor layer may be more complicated and the sensor response is a 
superposition of several parallel or consecutive reactions. In these cases it is necessary to 
employ relevant (and more difficult) kinetic models to achieve a desired accuracy of kinetic 
rate constants determination. 
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Although in ideal cases an appropriate kinetic model of molecular interaction is able 
to completely describe the SPR biosensor response, in reality the effect of hydrodynamic 
conditions need to be taken into account [91]. In flow cell-based biosensor experiments, the 
free analyte transport from bulk to the sensor surface is always limited by diffusion. The 
extent of effect of mass transport limitations on the reactions at the sensor surface is given by 
comparing the transport throughput to the kinetic rates. Slow analyte transport causes a 
decrease in its concentration when it is consumed during the association phase and an 
increase when it is produced during the dissociation phase. As a result, both reactions are 
slowed down. Rigorous approach to modeling the reaction kinetics at the sensor surface, 
including the mass transport effects, requires solving of the fundamental partial differential 
equation (PDE) coupled with the relevant kinetic equations (full model) [93]. This equation 
can be solved only numerically. The enormously time-consuming computation of full model 
hampers the use of this approach for routine fits of experimental data. It has been more 
employed to verify simpler models and/or to confirm the reasonability of rate constants by 
comparison with experimental data. To enable more convenient and routine analysis of 
measured sensorgrams, simpler models of mass transport effects have been proposed and 
implemented into commercial SPR data analyzing software [94, 95]. 
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2. Objectives 
 
The hybridization reaction analysis that is nowadays routinely exploited in molecular 
biology techniques relies on highly sensitive and specific detection of hybridization between 
short synthetic oligonucleotide probes and target nucleic acid sequences. Commonly used 
instruments detect, however, only the final NA complex but cannot monitor the actual 
process of the hybridization. In addition to that, great majority of current hybridization-based 
assays require radioactive or fluorescent labeling to visualize the hybridization reaction. 
Missing detailed information about hybridization reaction of short oligonucleotides still 
hampers development of NA techniques. For example, the general rules accounting for the 
NA duplex stability based solely on the relative occurrence of guanine-cytosine base pairs 
and buffer conditions are not sufficient for short NA chains since the local sequence 
dependences are not averaged out as in longer sequences [9]. An approach based on nearest 
neighbor model has been proposed as a promising idea to predict stability of various types of 
short oligonucleotide complexes [96-98]. The complex stability prediction is though still 
complicated for systems of hybrid (RNA-DNA) complexes as well as for complexes formed 
by oligonucleotide analogs with modified chemical structure [8, 28, 99, 100]. Therefore, 
further development of experimental techniques is desirable with the aim to obtain detailed 
knowledge of the hybridization reaction. Detailed knowledge of hybridization could benefit 
many areas such as medical diagnostics, environmental monitoring, food safety or biological 
warfare detection [101]. Real-time label-free surface plasmon resonance biosensors bring a 
new insight into these issues and are of growing research interest. 
The objective of my PhD work in general was to improve and optimize methodology 
of SPR bioexperiments for various sensor platforms to set up routine SPR measurements. The 
goal was to develop robust methods for SPR sensors to be capable of highly sensitive, 
specific and reproducible detection of biomolecules from pure and complex samples as well 
as precise analysis of various biomolecular interactions. The experimental work has mainly 
been carried out at the Department of Optical Sensors of the Institute of Radio Engineering 
and Electronics of the Academy of Sciences of the Czech Republic, where advanced 
platforms of SPR sensors have been designed (see part 1.3). In this research, I have also 
utilized previous experience with investigation of oligonucleotide interactions by methods of 
optical spectroscopy, performed at the Division of Biomolecular Physics (Institute of Physics, 
Charles University). 
The primary aim of my dissertation work was to design surfaces of receptors 
including oligonucleotides, antibodies, antigens or other proteins with further potential of 
sensitive detection of target analytes and kinetic analysis performance. During the first two 
years of the doctoral study, a systematic work was carried out to improve and optimize 
procedures of SPR biosensor functionalization. The goal was to immobilize various receptors 
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on a gold sensor surface with optimal density and reproducibility with preservation of their 
specific affinity to biomolecular targets. Sensor biomolecular surfaces should also resist the 
possible non-specific binding of other molecules from analyte solutions. 
Next goal of this work was using the developed biomolecular sensor surfaces to detect 
target analytes with the sensitivity, specificity and reproducibility as high as possible and then 
to study various biomolecular interactions, mainly those of the NA-NA and NA-enzyme 
types. The optimized procedure of DNA/RNA chips preparation was employed for study of 
hybridization properties of synthetic modified oligonucleotides with potential application in 
antisense therapy. By means of the optimized SPR biosensor chip and 
 in situ monitoring of the enzyme activity (in particular HIV-1 integrase strand 
transfer activity) has also been performed. 
Due to the comprehensive description of both the methodology research and the 
obtained results of interaction studies in publications attached to this work, the following 
section is composed mainly of short comments to the publications with emphasized the novel 
improvements to previously reported results. The contribution of the own author's work to 
individual publications is specified. 
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3. Results 
 
3.1 Immobilization of Proteins on the Surface of SPR Sensor 
 
As mentioned in the Introduction Section, biomolecules can be attached to the gold 
sensor surface by using different physico-chemical principles. Various immobilization 
methods of immobilization of biomolecular ligands has been proposed, tested and described 
in literature [66-68, 74, 83, 102, 103]. While DNA chip technology has been nowadays 
routinely exploited at the research level as well as in the clinical laboratories, protein chip 
technology is in the beginning of common laboratory use. The major reason for that is a high 
complexity of protein molecule (e.g., antibody, antigen, enzyme) that makes requirements for 
stability, biological activity and orientation of protein receptor layer difficult to meet. 
Recent trends in the field of protein immobilization techniques are as follows: (1) full 
resistance to non-specific binding of other molecules from analyzed solution and thus a 
formation of non-fouling background on the sensor chip, (2) increasing of the affinity and 
stability of protein receptors, (3) higher robustness and reproducibility of biomolecular 
recognition element purification or synthesis, (4) higher robustness and reproducibility of 
immobilization procedure with respect to its potential application in robot microarrays. 
 During the course of this doctoral work, a set of functionalization procedures have 
been investigated for immobilization of various protein ligands such as antibodies, antigens 
or peptide-albumin conjugates. They included dextran-based “amine coupling chemistry” that 
is nowadays mostly utilized in commercial SPR sensors (BIAcore™), methods utilized self-
assembled monolayers (SAM) of varied composition, method based on electrostatic coupling, 
protein A or protein G-based immobilization, and others. The method based on formation of 
mixed self-assembled monolayer (SAM) followed with covalent attachment of ligands via 
amide bond formation was found to be the most suitable for majority of tested biomolecular 
systems. Schematic description of the procedure is shown in Figure 13. 
Each step of this alkanethiol attachment chemistry was optimized for individual 
biomolecules. For antibody (IgG typed) immobilization, this method was optimized as 
follows: The sensor chip slides were first cleaned in UV ozone cleaner for 15 minutes, then 
washed with milliQ water and dried with nitrogen stream. A molar 7:3 mixture of C11-
chained and C16-chained alkanethiols was dissolved in degassed absolute ethanol with a total 
thiol concentration of 1 mM. These alkanethiols formed a self-assembled monolayer (SAM) 
on clean gold surface. The C16 alkanethiols terminated with a carboxylic group were used to 
anchor antibody by amide bond formation; C11 alkanethiols terminated with a di(ethylene 
glycol) group were used to form a stable non-fouling background. Sensor chips were 
immersed in the solution of alkanethiols at temperature of 40°C and then stored in a dark 
place at room temperature for up to 2 days.  
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After, the chips were rinsed with ethanol, dried under nitrogen stream, rinsed with 
water and dried with nitrogen again. The carboxylic terminal groups on the sensor surface 
were transformed into reactive N-hydroxysuccinimidyl esters with N,N,N',N'-Tetramethyl-O-
(N-succinimidyl)uronium tetrafluoroborate (TSTU) as follows. A sensor chip was immersed 
in solution of TSTU in argon degassed DMF (2 mg/ml), then it was sonicated for 5 minutes 
and shaken for 1 h. The sensor chip was rinsed with water, dried with nitrogen and 
immediately mounted into the SPR instrument. Antibody attachment was performed in situ 
by flowing sodium acetate buffer (SA) of pH 5.0, which was about one point lower than 
typical isoelectric point of an antibody molecule. When the baseline was achieved, the SA 
buffer solution with 10-50 µg/ml of antibody was brought into contact with the sensor surface 











Fig. 13 Immobilization of antibodies to the sensor surface based on mixed SAM and covalent coupling: Clean 
gold surface was first covered with mixture of carboxylic group and oligo(ethyleneglycol) terminated 
alkanethiols to form a tight SAM. After activating the carboxylic group by hydroxysuccindiimide, 
antibody molecules were attached to the SAM by amide bond formation. 
 
This optimized alkanethiol attachment chemistry was employed for immobilization of 
antibody against human immunoglobulin E on the sensor chip of special design (Appendix 
II, Measurement Science and Technology 2006) exploiting simultaneous excitation of two 
different surface plasmons in a single sensing spot. Four different antibodies (antibody 
against Immunoglobulin E, antibody against Immunoglobulin G, antibody against 
horseradish peroxidase, and antibody against human choriogonadotropin) were immobilized 
using this method with the aim of multianalyte detection (Appendix III, Sensors and 
Actuators 2004 and Appendix IV, Methods 2005).  
This immobilization method was also employed to validate applicability of a new 
high-throughput surface plasmon resonance (SPR) sensor based on combination of SPR 
imaging with polarization contrast and of a spatially patterned multilayer SPR structure, for 
detection of bioanalyte, especially for  detection of human choriogonadotropin (hCG) with 
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antibody against hCG immobilized on the sensor surface (Appendix V, Biosensors & 
Bioelectronics 2005).  
An effort in immobilization methods improvements for protein attachment to the 
sensor surface came to a head with the work concerning immobilization of peptides for 
highly sensitive detection of antibody against Epstein-Barr virus (anti-EBNA) in human 
serum (Appendix VII, Biosensors & Bioelectronics 2006). Three different immobilization 
methods were investigated for the attachment of EBNA-1 conjugated with bovine serum 
albumin (BSA) to obtain high ligand density and minimal loss of peptide immunoactivity: 
alkanethiol attachment chemistry with covalent coupling of BSA-EBNA conjugates (CHEM 
I), electrostatic and hydrophobic interactions-based methods (CHEM II and CHEM III, 
respectively). For purpose of this work, the eight-channel SPR sensor was used. It was found 
that non-polar amino acids composition of EBNA peptide influenced significantly level of 
immobilized BSA-EBNA receptors. Optimized alkanethiol attachment chemistry resulting in 
slightly hydrophilic layer showed the lowest ligand density in contrast with attachment of 
BSA-EBNA on clean gold via mostly hydrophobic interactions. Although the highest amount 
of immobilized receptors was obtained using the electrostatic coupling-based immobilization 
method (CHEM II), the highest immune-activity of EBNA-1 was achieved when 
immobilized by using chemistry based on physical adsorption of BSA-EBNA conjugates on 
clean gold surface in physiological conditions (CHEM III). Thus, the hydrophobic 
interactions-based coupling was the most compatible with the non-polar EBNA structure and 
preserved the EBNA biological activity. A reference-compensated sensor response to 
anti-EBNA binding for the series of different antibody concentrations for different 
immobilization methods is shown in Figure 14. 




























Fig. 14 Sensor response to anti-EBNA binding to EBNA-1 surface in dependence on anti-EBNA concentration   
 that was obtained from spots functionalized with BSA-EBNA conjugates using CHEM I, II and III, 
respectively. 
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3.2  Detection of Protein Target Analytes 
 
   The sensor chips functionalized with protein receptors using optimized methods of 
immobilization were used for detection of respective analytes using different platforms of 
SPR sensors that were developed in the Institute of Radio Engineering and Electronics. 
The eight-channel SPR sensor based on spectroscopy of surface plasmons and 
wavelength division multiplexing was mainly used for the purpose of this doctoral work. This 
sensor was described in details in the Introduction Section. A model experiment 
demonstrating potential of this multi-channel sensor for multi-analyte detection was carried 
out (Appendix III, Sensors and Actuators 2004). Four different antibodies (antibody against 
Immunoglobulin E, antibody against Immunoglobulin G, antibody against horseradish 
peroxidase, and antibody against human choriogonadotropin) with respective antigens were 
used as a model system. Each type of antibody was immobilized into two sensing spots. It 
was shown, that sensor responses to the target analyte when it was present alone in the 
injected solution were fully comparable with those obtained from a complex solution 
containing also the other three antigens. Our results showed a great potential of the developed 
eight-channel sensor for simultaneous detection of a series of analytes from complex 
samples. Figure 15 shows sensor response to different concentrations of analytes when they 
were detected from pure buffer and from the mixture of all antigens. The binding data for 
selected antibody-antigen (IgE) system are shown in Figure 16. Results of these experiments 
are discussed in more details in Appendix IV, Methods 2005. My contribution to this 
publication, dealing with description of the currency and future of multi-channel SPR 
platforms, was in writing the review of immobilization methods as well as in performance of 
the above mentioned model bioexperiments. 
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Fig. 15 Sensor response as a function of analyte concentration for Px, IgE, hCG and IgG measured in pure 
buffer and mixture of all antigens. 
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Fig. 16 Sensorgrams corresponding to IgE binding for solutions containing either only IgE or mixture of all four 
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Sensor for highly sensitive detection of antibody against Epstein-Barr virus (anti-
EBNA) in diluted human serum was developed (Appendix VII, Biosensors & Bioelectronics 
2006). Short synthetic peptide (EBNA-1) conjugated with bovine serum albumin (BSA) was 
used as a biomolecular recognition element and immobilized on the sensor surface via 
previously optimized method based on hydrophobic interactions. Resulting sensor calibration 
curve performed high chip-to-chip reproducibility (standard deviation less than 18%). The 
detection limit for the direct detection of anti-EBNA was found to be 0.2 ng/ml. This 
detection limit was lower by a factor of five when compared to detection limit obtained using 
widely used indirect ELISA assay. The procedure for the regeneration of sensor chip was 
developed and no significant loss in sensor sensitivity was observed after more than 10 
regeneration/measurement cycles. It was demonstrated as well that the reported peptide-
modified chips could be stored for at least 30 days with no loss in the sensor sensitivity 
(Figure 17).  


























































































































































Fig. 17 Sensor responses to anti-EBNA binding on EBNA surface obtained using one sensor chip immediately 
after functionalization and the same sensor chip after 30 days of storage at 4°C. Before injection of 
each anti-EBNA solution at concentration of 200 ng/ml, sensor surface was regenerated with  NaOH 
(30 mM). 
 
 The demonstrated detection limit was reproduced in a diluted human blood serum. 
Sensor responses to analyte in human serum and in buffer are compared in Figure 18. Only 
very low non-specific binding was observed for measurements in 1% human serum. Typical 
sensorgram obtained during anti-EBNA binding from human serum in measuring 
(BSA-EBNA) and reference channel, respectively is displayed in Figure 18. The detected 
concentrations of anti-EBNA corresponded well to clinically relevant values. These results 
demonstrate the potential of this developed SPR biosensor with synthetic peptide receptor for 
its use in medical diagnostics. 
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Fig. 18 Detection of anti-EBNA of increasing concentration measured by SPR sensor in buffer and in 
 diluted human serum (upper figure); Lower picture shows sensorgrams corresponding to binding of 
anti-EBNA at a concentration of 2µg/ml in human serum: specific binding to BSA-EBNA surface 
(black line) and non-specific binding to reference surface (gray line). 
 
In the Appendix II (Measurement Science and Technology 2006), a novel sensor 
design that exploits simultaneous excitation of two different (symmetric and anti-symmetric) 
surface plasmons in a single sensing spot was presented. Besides the sensor sensitivity and 
noise, we considered also the cross-sensitivity to background refractive index in the 
optimization process, which allowed us to evaluate the true sensor resolution. The derived 
formulae for cross-sensitivity can be directly used for evaluation and optimization of other 
SPR cross-sensitivity compensating techniques. We have compared the performance of the 
proposed structure with the two-channel compensated SPR detecting IgE analyte. It was 
found that the noise of the retrieved surface refractive index change was 11 times worse in 
the proposed configuration. However, the cross-sensitivity to background refractive index 
changes was nearly twice as low, which favors the proposed configuration for measurements 
with relative high background refractive index changes. 
 
A laboratory prototype of the high-throughput SPR sensor based on combination of 
SPR imaging with polarization contrast and of a spatially patterned multilayer SPR structure 
with 108 sensing channels was used for detection of human choriogonadotropin (hCG) with 
antibody against hCG immobilized on the sensor surface. Results showed that this novel SPR 
sensor was capable of detecting hCG at concentrations lower than 0.5 µg/ml (Appendix V, 
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Biosensors & Bioelectronics 2005). My contribution to the last two publications was in 
optimization of immobilization procedure for particular biological system and sensor design 
under study and in the performance of all bioexperiments. 
 
 A review of the state of the art of SPR biosensors applications in medical diagnostics, 
especially a review of the use of SPR biosensors for detection of disease biomarkers 
(antigens, antibodies or other proteins that are related to diseases such as cancer or heart 
attack) was reported in the Appendix IX, chapter in Surface Plasmon Resonance Based 
Sensors, 2006. It was summarized in this chapter that although majority of the SPR detection 
experiments have been still performed in pure buffer solutions with minimum or no matrix 
interferences, clinical samples have also been tackled. It is further expected that advances in 
SPR sensor instrumentation (reducing size, improving sensitivity, increasing throughput), 
receptors and methods for their immobilization (increasing sensitivity and specificity) will 
lead to new systems for rapid detection and identification of disease biomarkers that will 
extend applicability of SPR biosensor technology in medical diagnostics. 
 
 
3.3 UV Absorption Study of Oligonucleotide Hybridization 
 
A subject of my diploma thesis was to study hybridization of short synthetic 
oligonucleotides potentially applicable in antisense therapy by UV absorption spectroscopy. 
Under supervision of Prof. Josef Štěpánek we developed methodology based on precise 
measurements of temperature-dependence of whole UV absorption spectra of oligonucleotide 
mixed solutions. Modified system of temperature monitoring and prepared software for 
automatic computer control enabled simultaneous measurements of up to six samples. 
Obtained sets of absorption spectra were analyzed by using statistical data treatment (factor 
analysis) to determine thermodynamic parameters of oligonucleotide complexes formation 
[104]. 
This method, in certain sense complementary to the biosensor approach, was 
employed in the beginning of my doctoral work to study effect of mismatched base pairs in 
four nonamer hybrid duplexes formed between the 5’-d(GTGATATGC)-3’ complement and 
its 50-r(GCAUNUCAC)-30 (N=A, C, G, U) counterparts (Appendix I, Biopolymers 2004). 
This oligonucleotide set was considered as a molecular model system for future systematic 
studies of various modifications of internucleotide linkages with respect to their impact on 
the binding specificity to complementary base sequence. In the paper, UV absorption 
spectroscopy was used as an additional method to Raman spectroscopy. Determined duplex 
thermodynamic stabilities obtained from UV absorption analysis showed that the dT•rG 
mismatch decreased the hybrid duplex stability very weakly while the effect of both 
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pyrimidine–pyrimidine mismatches was much higher. Results from Raman spectroscopy 
measurements revealed that the A-like family of torsion angles of the sugar–phosphate 
backbone of single-stranded RNA oligonucleotides persists in the hybrid duplexes. Since no 
important increase of B-markers was observed, the A-like local conformation was likely 
forced to part of the DNA strand as well. The influence of the mismatches on the structure of 
the hybrid duplexes was significantly weaker than their influence on the structure of 
analogous DNA-DNA duplexes. In particular it was found, the dT•rG mismatch pair was 
relatively well incorporated into the double helix structure. 
This obtained experience in the field of oligonucleotide hybridization properties was 
utilized in development and optimization of surface plasmon resonance (SPR) method for 
monitoring of the oligonucleotide hybridization. Further effort within my doctoral work was 
concentrated to the surface plasmon resonance biosensor measurements, including 
methodological development of immobilization chemistries for various analytes and 




3.4 Immobilization of Oligonucleotides on the Surface of SPR 
Sensor 
 
 A major part of my doctoral work was focused on oligonucleotide (DNA/RNA) chip 
development that would be able to direct sensitive detection of oligonucleotide analytes. 
Recent trend in development of SPR DNA- or RNA-sensors is to lower the detection 
limits in order to make the resulting sensor sensitivity comparable with the widely used 
fluorescent or radioactive-based DNA (micro) arrays. The lowest concentrations of short ON 
targets that were detected directly and without any additional (enzymatic, electrochemical, 
fluorescent) amplification by current SPR biosensors, were at a nanomolar level [11, 105, 
106]. Nevertheless, a micromolar levels were used in a majority of SPR-based studies of ON 
hybridization [4, 7, 38, 47, 107]. 
Another requirement for oligonucleotide chip development is a potential for precise 
kinetic analysis of oligonucleotide interactions. Because of that, the functionalization method 
based on “3D” dextran hydrogel matrix that is mostly produced within commercial chips is 
not suitable since the analyte transport through the gel matrix can influence the resulting 
kinetics. The immobilization method, which was chosen and optimized for sensitive 
monitoring of oligonucleotide interactions was based on formation of a “2D” self-assembled 
monolayer (SAM) followed with covalent attachment of streptavidin and non-covalent 
binding of biotinylated oligonucleotides (MHA method). 
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 Optimization of this method is in detail described in Appendix IX. A streptavidin was 
covalently attached to NHS-ester-terminated alkanethiolates [83, 85] followed with a 
coupling of biotinylated oligonucleotide probes. Systematic optimization of parameters 
influencing the resulting ligand density and activity such as buffers salt composition, pH, 
reagent concentrations or spacer length was carried out to develop a robust, effective and 
reproducible DNA chip functionalization method. The final optimized procedure of ON 
immobilization that is described in the Appendix IX was shown to be highly reproducible 
(≥91% and ≥95% for chip-to-chip and on-chip reproducibility, respectively) with a small ON 
probe consumption (50nM probe concentration was found to reach the saturation level). 
Typical sensorgram corresponding to streptavidin and biotinylated ON probe binding is 
shown in Figure 19. 
 


















































































Fig. 19 A typical sensorgram corresponding to DNA chip functionalization with MHA method. The resulting 
amounts (in sensor response units) of bound streptavidin and ON probe are indicated. Arrows indicate 
when injections of particular solutions have started. 
 
The MHA method-based sensor characteristics were compared to previously 
optimized and well established method of streptavidin immobilization to biotin-terminated 
alkanethiols (BAT method) [72]. By using the approach optimized herein, a significant 
increase of hybridization efficiency was achieved (86% for MHA method vs. 63% for BAT 
method in case of maximal available sensor coverage with streptavidin of biotinylated 
probes). Furthermore, a highly efficient streptavidin immobilization was demonstrated by 
detected more than three binding sites available for biotinylated probe binding per one 
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3.5 Detection of Oligonucleotide Hybridization 
 
Optimized procedure of DNA / RNA chips preparation was employed for detection of 
oligonucleotide (ON) analytes. It was shown that SPR sensor with optimized MHA method 
enables a rapid direct detection of short oligonucleotides with high specificity, reproducibility 
and regenerability over three orders of target concentration (100 pM – 200 nM) (Figures 20-
21). The resulting sensor detection limit of 100pM for 23-mer oligonucleotides was one 
hundred times lower than the typically reported detection limits of SPR-based direct 
oligonucleotide detections. Detailed characteristics of developed DNA sensor were described 
in Appendix VIII (Biopolymers 2006) and IX. 
 
Fig. 20 Detection of oligonucleotide (23-mer) hybridization on sensor chip functionalized with 23-mer 
biotinylated oligonulucleotide probe (BdO23) using the optimized MHA method. Sensor response to 
increasing concentration of fully complementary strand CdO23 (8 min. incubation time, regeneration 
performed after injected concentrations higher than 2nM (upper left) with a detail of the concentration 
range 0.2 nM- 2nM (upper right). 
 






























Fig. 21 Calibration curve of ON sensor with optimized MHA method; the calibration curve was derived from 
association rates for each measured concentration (averaged from four independent sensing channels). 
 
The eight-channel sensor was employed for primary screening of hybridization 
properties of a set of synthetic modified oligonucleotides with the aim to select potential 
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candidates for antisense therapy (Appendix VIII, Biopolymers 2006). The 23-mer 
ribooligonucleotides (rA23) were immobilized on the sensor surface into all sensing spots via 
optimized MHA chemistry. Solutions of homothymidine 15-mer deoxyribooligonucleotides 
(natural and seven synthetic compounds with different internucleotide linkage modification) 
were injected separately into the functionalized sensing channels. Concentration of each ON 
was 50 nM and incubation time employed for these experiments was 20 minutes. Real-time 
observation of hybridization of ON analytes with immobilized RNA complement using the 
eight-channel SPR system is shown in Figure 22; a scheme of the structural modification is 
attached to each sensorgram. Different binding kinetics for different modification suggested 
that the insertion of internucleotide linkage modification caused different interaction 
mechanisms. It was shown that this rapid screening with very low sample consumption 
enables primary choice of perspective candidates for antisense therapy. Moreover, if we 
compared the modified ON sensor response amplitudes to these obtained from ligand (rA23) 
immobilization and calibrated the values to unified molecular weight, we could conclude that 
a stoichiometry of formed complexes was in some cases higher than 1:1. This indicated that 
triplexes were also formed in addition to duplexes for selected modified ONs. Detailed 



















































































































































Fig. 22 Screening of synthetic modified oligonucleotide interactions with immobilized natural rA23 counterpart 
in comparison with natural dT15 binding; X means occurrence of depicted internucleotide linkage 
modification in 15-mer homothymidine sequence. 
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Another multi-channel biosensor combining an optical platform based on SPR 
imaging on special multilayers and polarization contrast with a spatially resolved optimized 
functionalization was used for detection of oligonucleotides (Appendix VI). It was 
demonstrated that this optical platform offered a considerably higher sensitivity and 
resolution than the conventional SPR imaging. This sensor could perform 64 independent 
measurements simultaneously. The spatially resolved functionalization based on 
microspotting applied to immobilization of short oligonucleotides was shown to provide a 
surface concentration of oligonucleotide probes higher by 80 percent than the flow-through 
functionalization method. Sensor response to different concentrations of short 
oligonucleotides (23-mers) is shown in Figure 23. In these experiments, sensor chips 
functionalized with dO23 probes (sensing channels) and dT23 probes (reference channels) 
were used and samples containing different concentrations of CdO23 in PBM buffer were 
flowed across different flow-chambers of the flow-cell.  
 





























Fig. 23 Detection of oligonucleotides using the multichannel SPR sensor functionalized by the microspotting 
technique; Temporal sensor response measured for three different concentrations of CdO23 
oligonucleotide. Response from a reference channel corresponding to CdO23 concentration of 50 nM is 
shown for comparison. 
 
 
3.6 Kinetics of NA Triplex Formation 
 
A review of molecular interaction models that are mostly used for kinetic analysis of 
SPR data as well as of hydrodynamic effects discussions is reported in Appendix XII 
(chapter in Surface Plasmon Resonance Based Sensors 2006). In this chapter, an interaction 
model concerning consecutive binding of two analytes (“consecutive binding model”) to the 
receptor binding sites, which was proposed within this doctoral work, is also described. The 
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advantage of this model is that it can be applied for kinetic analysis of oligonucleotide triplex 
formation in the case when duplex formation is followed with binding of the third strand to 
create final triplex. This situation can occur, when an homopurine oligonucleotide is fixed at 
the sensor surface as a receptor and complementary oligonucleotides consecutively form a 
triplex. This involves two successive reactions, each occurring at a unique binding site. The 
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where 1 is a concentration of the first complex (it can be for instance a duplex in case of 
describing oligonucleotide triplex kinetics) and 2 means the concentration of the consecutive 
complex (triplex); S is a standard sensor response (in RU) corresponding to all receptor sites 
bound to analyte in a 1:1 ratio. Fitting parameters ka1, kd1 and ka2, kd2 are the investigating 
kinetic rate constants of the first complex (duplex) formation and consecutive second 
complex (triplex) formation, respectively. 
Figure 24 shows time-dependences of individual participating compound 
concentrations (free analyte, formed duplex, formed triplex) and a total sensor response for 
the consecutive binding model. A fit of this model (with incorporated modeled effects of 
hydrodynamic conditions) to respective SPR data is a subject of our recent work. Based on 
the fit of the model we would like to determine amounts of the biomolecular complexes with 
different stoichiometry and the kinetic parameters of each single process with high accuracy. 
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Fig. 24 Kinetics and sensorgram according to the model of two consecutive binding reactions in case of bivalent 
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3.7 Monitoring of HIV-1 Integrase Activity 
 
The eight-channel SPR sensor with optimized MHA chemistry was employed to study 
of DNA-enzyme interactions, especially for real-time monitoring of the activity of human 
immunodeficiency virus (HIV) integrase. HIV-1 integrase (IN) is an enzyme catalyzing 
integration of a double-stranded DNA copy of the HIV genome into the host genome. It is a 
crucial step of HIV replication and thus it has become an attractive target for drug design 
[108]. The catalysis proceeds in two distinct reactions: the 3'-processing reaction, where 5' 
phosphorylated dimer (pGT) is specifically cleaved from both viral long terminal repeats 
(LTR) yielding a processed DNA and the strand transfer reaction, in which the exposed 3'-
hydroxyl groups of the processed ends are joined to 5’ phosphates in the host DNA [109]. 
The catalytic activity of IN has been demonstrated in vitro using oligonucleotide (ON) 





) [110, 111].  
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It has been demonstrated in Appendix X that SPR method can be used for a direct 
label-free monitoring of the HIV-1 Integrase strand transfer activity. An effect of four 








) on IN binding to DNA was 
investigated using model deoxyribooligonucleotides representing viral LTR ends and model 
triple-helical ONs. Four measuring spots were functionalized with the 23-mer double-
stranded ON (SS’)23 representing viral ends with terminal CA/GT bases. Additional four 
spots were functionalized with model triple-stranded complexes (TAT)23. Model triplexes 
were used as the reference surfaces with respect to the previously proposed triplex-mediated 
inhibition of HIV IN activity [108]. 
Solutions of IN with particular metal cofactor were injected into (SS’)23 and (TAT)23 
channels (each type of metal cofactor per one pair of measuring and reference spots was 
used), Figure 25. It was found that integrase forms stable complexes both with viral DNA 
substrate (SS’)23 and with (TAT)23 triplexes in the presence of all tested ions. The amount of 
enzyme that remained bound to ONs after washing the sensor surface with buffer was in 
average 1.5-times higher for (TAT)23 than for (SS’)23 for all ions. 
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Fig. 25 Sensorgrams corresponding to HIV-1 Integrase binding to (SS’)23 and (TAT)23 arrays in the presence of 
different divalent metal cofactors. Concentration of each divalent ion in buffer was 8mM; the arrows 













HIV-1 Integrase strand transfer activity and thus integration of viral DNA to target 
DNA was directly monitored using developed SPR assay. The target DNA was represented 
by 5´-phosphorylated double-stranded 9-mer ON (pTS)12 that was injected into the sensor 
covered with IN-oligonucleotide complexes. A scheme of this reaction is depicted in Figure 
26. 
 
- 34 - 
 
Fig. 26 A scheme of SPR assay for direct monitoring of the HIV-1 integrase strand transfer activity.. The 
solution of 5’-phophorylated double-stranded 12-mer ON (100nM) representing target DNA is injected 
into the sensing channel functionalized with ON terminated with viral LTR ends and the strand transfer 
reaction proceeds resulting in integration of processed target DNA to the simulated viral DNA. 
 
Sensorgram corresponding to the IN-catalyzed strand transfer reaction is shown in 
Figure 27. It was observed, that the reaction proceeded preferentially in the presence of Mn
2+
. 
This is in accordance with the previous reports where in vitro reaction was mostly detected in 
the presence of Mn
2+
. However, the same reaction in vivo proceeds in the presence of Mg
2+
 
ions. Using our method, IN reaction in the presence of Mg
2+ 
was detected as well; 
nevertheless the response was relatively weak compared to Mn
2+
. These results were obtained 
from two independent experiments using de novo functionalized sensor chips. 



















































Fig. 27 SPR-sensor based monitoring of IN strand transfer activity: Sensor response to pTS12 binding to IN-
(SS’)23 complex (A) and IN-(TAT)23 (B) complex in the presence of different divalent metal cofactors; 
concentration of pTS12 was 100nM, incubation time was 25 min. 
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Our results showed that SPR technique can be used for direct label-free real-time 
monitoring of DNA-enzyme interactions. Investigation of NA interaction with other enzymes 
such as ribonuclease H, ribonuclease L is a subject of our future work. 
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4. Conclusions 
 
Within this doctoral work, a methodology of surface plasmon resonance biosensor 
measurements was developed and optimized for various biomolecular systems. The 
methodology was applied for several different platforms of SPR sensors.  
The most promising approach to DNA/RNA/protein chips preparation was selected, 
optimized and set up as a routine procedure. It was shown that the prepared SPR biosensors 
were capable of detecting oligonucleotides with high sensitivity, specificity and 
reproducibility compared to previously published results. This demonstrates that it is worth to 
invest time and effort to optimization of immobilization method because a substantial 
increase in sensor sensitivity, specificity, and reproducibility can be achieved. 
SPR biosensor-based detection of various biomolecules with the sensor chips 
functionalized with receptors using optimized immobilization chemistries both in pure 
samples and complex solutions (serum) has been carried out. Results revealed high potential 
of SPR technique applications in further biomolecular interaction studies as well as in the 
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Several molecular biological techniques require accu-
rate predictions of matched v. mismatched hybridiza-
tion thermodynamics (e.g., polymerase chain reaction
(PCR), sequencing by hybridization, gene diagnos-
tics, antisense strategy). Therefore, thermodynamics and
molecular structures of Watson–Crick and mismatch
base pairs have been extensively studied by methods of
ultraviolet (UV) melting,1,2 nuclear magnetic resonance
(NMR) distance geometry,3–6 and X-ray diffraction.7–9
Single rG  rU or dG  dU mismatches can form sta-
ble wobble base pairs10,11 that are almost as stable as
rA : rU or dA : dT Watson–Crick base pairs.4 dG  dT
and dT  dT mismatch base pairs likely form wobble
base pairs as well, whereas dC  dT mismatch is rather
stabilized by stacking interactions with adjacent purine
rings. Structural studies indicate that hydrogen bonds
are formed between mismatched nucleotides and that
water molecules can be involved in base pairing too.
Stability of hybrid duplexes with a single mis-
match is affected by the nature of the mismatch and
the adjacent base pairs.1 It is also different for dN 
rN0 and dN0  rN mismatches. The rG  dT mismatches
are the most stable ones, whereas the stability of rU 
dT and rC  dT mismatches was found to be weak.1
Study of mismatch structures is also important for
the development of new synthetic drugs based on a pre-
cise recognition of target molecules (i.e., proteins or
nucleic acids). They are nowadays intensively searched
and investigated in order to improve drug efficiency
and to suppress side effects. ‘‘Antisense’’ strategy is a
concept of novel gene therapy in which the translation
of a pathogen gene is inhibited by a short oligonucleo-
tide complementary to the mRNA target sequence. It
forms a local double-helical complex that prevents the
mRNA to serve as a matrix for deleterious protein syn-
thesis.12 If the ‘‘antisense’’ oligonucleotide is the
deoxy type, the effectiveness of the antisense drug can
be substantially enhanced by the RNase H enzyme that
excises the mRNA strand of the hybrid duplex while
the ‘‘antisense’’ deoxy strand is left unperturbed. Natu-
ral oligonucleotides are unfortunately unsuitable for in
vivo applications owing to their lack of resistance
against cell nucleases. An intense search is therefore
underway to find novel synthetic oligonucleotide ana-
logues that would possess suitable properties, i.e.,
resistance in a cellular environment, high binding affin-
ity, specificity to the target nucleic acid sequence, and
finally elicitation of RNase H activity.
We have investigated thermodynamic properties of
new types of internucleotide linkage modifications by
Raman spectroscopy, in developing a method that
would allow the determination of the stoichiometry,
stability, and structure of the complexes formed
between a modified oligonucleotide chain and its natural
complementary counterpart. This approach, based on
precise Raman titration, Raman temperature profile
measurements, and special data treatment procedures,
has been applied to characterize two families of various
isopolar, nonisosteric modifications of internucleotide
linkages.13,14
Investigation of the binding specificity, i.e., whether
the particular internucleotide linkage modification
does or not favor ‘‘fake’’ base pairing, is a natural con-
tinuation of our studies. The first Raman results were
obtained for a model system of DNA duplexes15 based
on 50-d(GTGATATGC)-30 and 50-d(GCATNTCAC)-30
strands, the latter with alternated central nucleobase
N ¼ A, C, G, T. We confirmed the sensitivity of
Raman spectra to structural deviations of mismatch
duplexes and we obtained reference spectral signatures
on a complete set of natural deoxyoligonucleotides.
As a next step, this work presents a study of mis-
match hybrid duplexes based on the analogous model
system of 50-d(GTGATATGC)-30 and 50-r(GCAU-
NUCAC)-30 strands, N ¼ A, C, G, U. The emphasis
of the study was to determine structural changes in
hybrid duplexes due to a mismatched base pair and to
obtain their Raman spectral signatures. The structural
characteristics were compared with the duplex stabil-
ities determined by UV absorption measurements.
MATERIAL AND METHODS
The deoxyoligonucleotide complement was synthesized in
LMFR of Masaryk University in Brno, then high perform-
ance liquid chromatography (HPLC) purified and lyophi-
lized. RNA oligonucleotides were purchased from Dharma-
con, Inc., in the stable 20-acetoxyethoxy protected form (for
oligonucleotide sequences, see Table I). They were depro-
tected with enclosed buffer and lyophilized. Stock solutions
of the single-stranded oligonucleotides (40 L) were pre-
pared by dissolution in a Millipore-filtered solution of
4 mM Na2SO4 and 100 mM NaCl. The concentration was
20 mM in nucleotides (UV determination). DNA–RNA
mixed solutions of 1:1 molar ratio were prepared from the
single-strand solutions by weighting. After Raman meas-
Table I Composition of the Studied Oligonucleotides
Oligonucleotide Sequence
DNA complement 50-d(GTG ATA TGC)-30
RNA1 50-r(GCA UAU CAC)-30
RNA2 50-r(GCA UCU CAC)-30
RNA3 50-r(GCA UGU CAC)-30
RNA4 50-r(GCA UUU CAC)-30
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urements, the mixed solutions were lyophilized and then
dissolved in 50 mM Tris buffer (pH ¼ 7.6) with 100 mM
NaCl and 1 mM EDTA to obtain solutions of 4 and 80 M
total oligonucleotide concentrations for UV measurements.
Before both Raman and UV measurement, the 1:1 mixtures
were annealed by heating up to 908C and slow cooling
down to the starting temperature.
Raman spectra excited with the 488-nm line of an argon
ion laser (power at the sample 350 mW) were recorded in
a 908 scattering geometry on a Jobin Yvon T64000 CCD
Raman spectrometer with a 1200 grooves/mm holographic
grating. Samples were placed into a 12-L temperature-sta-
bilized microcell. All measurements were carried out at
158C; the total exposure time for each spectrum was
180 min. Particular spectrum acquisition was divided into 9
separate accumulations (of 20 min). Before each accumula-
tion, a neon glow lamp spectrum was recorded for precise
recalibration of the wavenumber scale. The spectrum of
Na2SO4 solution was subtracted from the set of Raman
spectra by using a homemade code ‘‘Pomlazka.’’ Simulta-
neously, a background adjustment was made by subtraction
of trace contributions from the microcell walls. The water
signal was used as an internal intensity standard.
UV absorption spectra were recorded with VARIAN
Cary 100 Bio spectrophotometer in the 3–588C temperature
range. Sample temperature was measured directly in the
absorption cell by using a miniature thermoprobe. Individ-
ual acquisitions of UV spectra were performed after 7 min
of temperature stabilization at desired temperature.
The melting curves obtained as temperature dependence
of the absorbance value at 260 nm (corrected for the
experimental offset by subtraction of the absorbance value
at 320 nm) were fitted according to the following equation:
AmixT ¼ cDuT ðADu0 þ T  ADu1 Þ þ ðcssDNAT þ cssRNAT Þ




ssRNA are concentrations of the
duplex, DNA, and RNA single strands at temperature T,
mutually related via equilibrium constant of the helix to coil
transition given by the van’t Hoff equation:









ss represent fitted coefficients (normal-
ized to unit concentration) of a linear temperature depend-
ence for both duplex and single strands extinctions.16,17
Values of enthalpy DH0 and entropy DS0 changes were
determined in a least-square sense accordingly to Eqs. (1)
and (2), taking into account relations for the total DNA and
RNA nonamer concentrations (CTotDNA, CTotRNA). Change
of Gibbs energy and the melting temperature were calcu-
lated according to
G0T ¼H0  TS0;
Tm ¼ H
0
S0 þ Rln CTotDNAþCTotRNA
4
  ð3Þ
Monte Carlo simulations of individual temperature profiles
within estimated levels of the absorbance value error
(60.001) were performed to determine confidence limits18
of 99% probability of the thermodynamic parameters. In
other words, each absorbance value inside a particular tem-
perature profile was shifted to a random value (within the
estimated error interval) and the obtained modified temper-
ature profile was fitted. This procedure was repeated 20
times and the resulting set of thermodynamic parameters
(DH0, DS0, DGT
0, and Tm) statistically treated and
the confidence intervals of 99% probability were deter-
mined.
RESULTS AND DISCUSSION
Thermodynamic parameters determined by fitting UV
temperature profiles of 1:1 mixtures of DNA and
RNA nonamers are listed in Table II. The confidence
intervals of DS0 and DH0 values are substantially
Table II Thermodynamic Parameters of Nonamer Hybrid Duplexes with Matched or Mismatched










Ctot ¼ 80 M Ctot ¼ 4 M
dT  rAb 210 6 10 726 3 7.08 6 0.06 38.76 0.2 30.9 6 0.2
dT  rCc 193 6 19 626 6 2.68 6 0.28 18.36 0.6 < 5
dT  rGb 187 6 9 646 3 6.15 6 0.05 34.46 0.2 25.9 6 0.2
dT  rUc 187 6 16 616 5 3.50 6 0.17 21.66 0.6 < 5
a Confidence limit of 99% probability.
b Results of a simultaneous fit on data from 1:1 DNA : RNA mixtures of 4 and 80 M total nonamer concentrations.
c Results obtained just from 80 M mixtures, because of only part of the melting profile was obtained for 4 M mixtures (Tm < 58C).
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larger than those of DG310 K
0 and Tm owing to known
highly correlated effect of the DS0 and DH0 values on
the sum of squared deviations in the fit of the van’t
Hoff equation.19 The duplex stability is obviously
dependent on the mismatched base-pair composition.
While the stability decrease caused by dT  rG mis-
match is very weak, dT  rC and dT  rU mismatches
reduce the stability considerably. This is in agreement
with a previous study of DNA : RNA mismatch
duplexes by UV spectroscopy1 as well as with predic-
tions by SantaLucia and Peyret’s database HyTherTM
(available at http://ozone2.chem.wayne.edu/), even
though the predicted thermodynamic parameters are
systematically lower than our results.
FIGURE 2 Raman spectra of hybrid duplexes with or without a central mismatch: duplex with
dT  rU central mismatch (a), with dT  rC central mismatch (b), with dT  rG central mismatch (c),
and fully complementary duplex with dT : rA central base pair (d).
FIGURE 1 Raman spectra of single-strand oligonucleotides: (a) RNA4, (b) RNA2, (c) RNA3,
(d) RNA1, and (e) DNA complement.
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Spectra of the single-strand oligonucleotides are
shown in Figure 1. Different nucleotide compositions
cause the main spectral differences between the DNA
complement and the various RNA match or mismatch
strands. Differences between the RNA strands are
due to variation of only one nucleobase among 9 and
therefore they are detectable mainly for intense
bands, such as 784 (C, U),20,21 1230 (U),22 1245
(C),23 1337 (A),24,25 1481 (G),26 and 1575 cm1 (A,
G).26 Furthermore, there are also remarkable strong
markers of A-like conformation of sugar–phosphate
backbone (810 cm1).24,27 It means that the single-
strand RNA oligonucleotides are partly organized
into the conformation they adopt in duplexes. On
the other hand, the DNA complement spectrum con-
tains only a very weak marker of B-like conformation
(838 cm1).26,27
Spectra of hybrid duplexes (shown in Figure 2) are
more similar to each other than the single-strand
spectra. It confirms that a mismatch does not drasti-
cally disturb the overall conformation of the dupl-
exes. Still, the intense bands with major contributions
from base vibrations are different from each other,
owing to the varied mismatch base. The backbone
conformation is reflected by markers of the A-like
conformation of the sugar–phosphate backbone,
which exceed those of the B-like conformation. The
band at about 1094 cm1 assigned to the PO2
 sym-
metric vibration is composed of two bands, i.e., 1092
and 1101 cm1. The former position corresponds to
the B-family of backbone torsion angles, the latter to
the A-family.26,27 Nevertheless, difference spectra
obtained by subtraction of the relevant single-strand
spectra from a given duplex spectrum (not shown)
exhibit increased intensities at 1101 cm1 only. On
the other hand, the duplex spectra also feature bands
assigned to coupled vibrations of bases and sugar
moieties in the C20-endo/anti puckering, i.e., 669
(dT), 683 (dG), and 728 cm1 (dA).21,24,26 Hence, the
DNA strand bound to its RNA counterpart likely
adopts a specific backbone local geometry showing
certain structural features of both A-type and B-type
double helices.
Structural changes within the mismatch sites in the
hybrid duplexes were analyzed at the level of Raman
difference spectra between the match and the mis-
match duplexes (Figure 3). In the same way as in our
previous study of DNA duplexes with a mismatch,15
FIGURE 3 Difference Raman spectra between mismatch and match hybrid duplexes.
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the duplex spectra were normalized to unit intensity
and the differences obtained with a subtraction factor
set to one. These spectra show only the spectral fea-
tures caused by the substitution of the dT : rA Wat-
son–Crick base pair by the dT  rN mismatch one.
Many bands simply represent the substitution of the
mismatch nucleobase N. Missing rA is featured by
1257, 1299, 1339, 1510, and 1572 cm1 negative
bands, while replacement by rC, rG, or rU gives rise
to 782, 1243, 1286, and 1525 cm1; 668, 1318, and
1478 cm1; or 781 and 1227 cm1 positive bands,
respectively. The backbone conformation of all mis-
match duplexes is weakly altered from the A-like
geometry according to the negative peaks at positions
of its marker bands,26,27 i.e., 815 and 1100 cm1.
Nevertheless, the structure of hybrid duplexes is
much less disturbed by the mismatched pair occur-
rence than that of the DNA duplexes.15 In particular,
the difference spectrum of the dT  rG mismatch
duplex shows almost no spectral change except the
bands of adenosine and guanosine due to the dA ?
rG substitution.
An interesting spectral feature is the negative band
at 1376 cm1, which is present only in the difference
spectra of pyrimidine–pyrimidine mismatches. This
band is assigned to a vibration of dT. Intensity
decrease of this band was interpreted26 in terms of a
more hydrophilic environment around the thymidine
C5—CH3 methylene group. Because there is no spec-
tral change in the difference spectra of the dT  rG
mismatch, it leads to the conclusion that the substitu-
tion of adenine with a pyrimidine nucleobase changes
stacking of the opposite thymine, whereas the substi-
tution with guanine does not.
Another important finding is very weak or no spec-
tral change in the region of carbonyl vibrations
(1600–1700 cm1). The positive bands at 1670 and
1697 cm1 in the difference spectrum of the dT  rU
mismatch only reflect additive carbonyl groups of the
substituted uracil. In the case of DNA duplexes with
analogous mismatches,15 this region yielded impor-
tant spectral differences. Moreover, they were found
different for the dT  dC mismatch in comparison to
the dT  dG and dT  dT mismatches.
Unique spectral characteristics of the DNA
duplexes with respect to the hybrid ones and vice
versa are revealed in their difference spectra (Figure 4).
Spectrum of the hybrid duplex was subtracted from
the DNA duplex spectrum with the corresponding
(mis)match base pair by using a subtraction co-
efficient equal to one, owing to the same normaliza-
tion of both spectra. Different positions of base
pairs within the different double helixes are featured
by intensity changes of conformation-sensitive
bands24,25,27 with important contributions from base
vibrations such as 1206 (T), 1230 (U), 1265 (C),
1339 (A), 1476 (A), and 1617 cm1 (U) as well as by
the spectral shift 1582 ? 1571 cm1 (A).
FIGURE 4 Difference spectra between hybrid and DNA duplexes with (a) dT  rU and dT  dT
mismatches, (b) dT  rG and dT  dG mismatches, (c) dT  rC and dT  dC mismatches, and (d) with
all Watson–Crick base pairs. Positive bands are characteristic for the hybrid duplexes, while the
negative ones belong to the DNA duplexes.
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Other spectral changes are similar in all difference
spectra. Some bands shift by several wavenumbers
(795 ? 784 cm1, 836 ? 813, 1092 ? 1102 cm1)
showing a change of the backbone geometry from the
B-family of backbone torsion angles in the DNA
duplexes close to A-family in the hybrid duplexes. A
positive band at 867 cm1 is characteristic for RNA
oligonucleotides and it is assigned to the base moiety
of guanosine.23 Negative bands at 680 and 743 cm1
reflect C20-endo/anti sugar puckering of guanosine
and thymidine residues in the DNA duplexes, while a
strong band at about 1663 cm1 indicates different
interactions of carbonyl groups within the different
double helixes.
Comparison of hybrid and DNA duplexes spectra
shows significant differences not only in the structure
of the duplexes, but also in structural deviations
caused by the mismatch. This finding agrees with
thermodynamic characteristics of duplexes with a sin-
gle mismatch.1,5,28,29 Consequently, only the hybrid
and not DNA : DNA duplexes represent a relevant
molecular system to study the structural effect of the
internucleotide linkage modification on mispaired
duplexes possibly formed in ‘‘antisense’’ action. The
proposed molecular model will consist of four RNA
nanomers, 50-r(GCAUNUCAC)-30 (N ¼ A, C, G, U),
and analogs of the DNA complement, 50-d(GTGA-
TATGC)-30, with modified internucleotide linkage in
the neighborhood of the central base.
CONCLUSIONS
Like in our previous study,15 the results obtained
for hybrid duplexes with or without a central mis-
match proved the suitability of Raman spectroscopy
to monitor conformational variations within mis-
match sites of nucleic acid duplexes. We have
found that single-stranded RNA oligonucleotides
adopt an A-like family of torsion angles of the
sugar–phosphate backbone. This backbone confor-
mation persists in the hybrid duplexes, and since no
important increase of B-markers was observed, the
A-like local conformation was likely forced to part
of the DNA strand as well. The influence of the
mismatches on the structure of the hybrid duplexes
is significantly weaker than their influence on the
structure of analogous DNA duplexes. In particular,
the dT  rG mismatch pair is very well incorporated
into the double helix structure. The substitution of
adenine in the dT : rA pair by pyrimidine causes
change of the thymine position that alters the sur-
rounding of its methyl group but does not, in con-
trast to DNA duplexes, influence interactions of car-
bonyl oxygens. Overall, magnitudes of obtained
changes in Raman structural features correlate well
with the duplex stabilities.
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15. Nĕmec̆ek, D.; S̆tĕpánek, J.; Turpin, P.-Y.; Rosenberg, I.
Biopolymers 2004, 74, 115–119.
16. Petersheim, M.; Turner, D. H. Biochemistry 1983, 22,
256–263.
17. SantaLucia, J., Jr. In Spectrophotometry & Spectro-
fluorimetry; Gore, M. G., Ed.; Oxford University Press:
Oxford, UK, 2000; pp 329–356.
18. Press, W. H.; Teukolsky, S. A.; Vetterling, W. T.;
Flannery, B. P. Numerical Recipes in Fortran, 2nd ed.;
Cambridge University Press: Cambridge, UK, 1992; pp
684–694.
19. Wu, P.; Nakano, S.; Sugimoto, N. Eur J Biochem 2002,
269, 2821–2830.
20. Thomas, G. J., Jr.; Tsuboi, M. In Advances in Biophysi-
cal Chemistry; Bush, C. A., Ed.; JAI Press: Greenwich,
CT, 1993; Vol 3, pp 1–70.
21. Benevides, J. M.; Wang, A. H.-J.; van der Marel, G. A.;
van Boom, J. H.; Thomas, G. J., Jr. Biochemistry 1989,
28, 304–310.
Mismatch in Oligonucleotide Hybrid Duplexes 7
22. O’Connor, T.; Bina, M. J Biomol Struct Dyn 1984,
2(3), 615–625.
23. Nishimura, Y.; Tsuboi, M. J Mol Struct 1986, 146,
123–153.
24. Thomas, G. J., Jr.; Wang, A. H.-J. In Nucleic Acids and
Molecular Biology; Eckstein, F., Lilley, D. M. J., Eds.;
Springer-Verlag: Berlin, Heidelberg, Germany, 1988;
Vol 2, pp 1–30.
25. Nishimura, Y.; Tsuboi, M. In Advances in Spectro-
scopy; Clark, R. J. H., Hester, R. E., Eds.; John Wiley
& Sons: Chichester, UK, 1986; Vol 13, Chap 4, pp
177–232.
26. Deng, H.; Bloomfield, V. A.; Benevides, J. M.;
Thomas, G. J., Jr. Biopolymers 1999, 50, 656–666.
27. Benevides, J. M.; Thomas, G. J., Jr. Biochemistry
1988, 27, 3868–3873.
28. Allawi, H. T.; SantaLucia, J., Jr. Nucleic Acid Res
1998, 26(21), 4925–4934.
29. Peyret, N.; Seneviratne, P. A.; Allawi, H. T.; Santa-
Lucia, J., Jr. Biochemistry 1999, 38, 3468–3477.
Reviewing Editor: Kenneth J. Breslauer


















Advanced biosensing using simultaneous excitation of 





Measurement Science and Technology, 17 (2006), 932 – 938 
 
INSTITUTE OF PHYSICS PUBLISHING MEASUREMENT SCIENCE AND TECHNOLOGY
Meas. Sci. Technol. 17 (2006) 932–938 doi:10.1088/0957-0233/17/4/045
Advanced biosensing using simultaneous
excitation of short and long range surface
plasmons
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Abstract
We present a novel optical biosensor which exploits simultaneous excitation
of two different surface plasmons in a single sensing spot. It allows
compensation of cross-sensitivity to background refractive index change, as
a typical surface plasmon resonance sensor is sensitive to both the
absorption of a thin film on the surface (sensing event) and the refractive
index change of the background (an interfering effect). The structure
parameters are optimized to yield low noise and minimum cross-sensitivity.
In the performed model experiment, IgE biomolecules at a concentration of
250 ng ml−1 are detected during a change in the background refractive index
of 10−3.
Keywords: surface plasmon resonance, optical sensor, reference-
compensated sensing, biosensor
1. Introduction
The interest in surface plasmon resonance (SPR) for optical
biosensing is continuously increasing. Next-generation SPR
biosensors, however, require further miniaturization (e.g.,
using optical waveguides [1, 2]), increase in the resolution
(e.g., using advanced detection schemes [3] or advanced data
analysis [4]), high throughput (e.g., using SPR imaging [5])
and suppression of cross-sensitivity to background refractive
index (e.g., by temperature stabilization [6], using two
channels with receptors with different analyte affinity [7], and
two-plasmon spectroscopy [8, 9]).
The SPR biosensor cross-sensitivity originates in the
fact that the surface plasmon (SP) field penetrates into
the background through a thin layer of analyte adsorbed
at the sensor surface from a solution (background). Thus,
both surface-adsorbed analyte (causing surface refractive
index change) and the background (causing bulk refractive
index change) are within the SPR sensitive region. The
background changes usually have their origin in variations
of temperature or composition.
There are several reports on schemes for suppression
of the background refractive index cross-sensitivity [6–9].
The temperature stabilization is typically limited to ±0.1 ◦C
[6] and cannot compensate for changes in the background
composition. Two-plasmon spectroscopy uses, e.g. [8], a
special lightpipe, where light excites two SPs with different
penetration depths at two different spots of the sensor surface.
Putting a medium under study in contact with both spots and
using data analysis, information on surface and background
changes are retrieved. Though this method [8, 9] is powerful
in its compensation ability, it collects data from two different
parts of the sensor surface, at which identical conditions
cannot be guaranteed (e.g., temperature and coverage with
receptors). Moreover, there is a time delay between the two
SPR responses. Using two separate sensor channels covered
by receptors with and without affinity to the analyte is another
technique (two-channel-compensated SPR [7]). Its advantage
is compensation ability for both the background and non-
specific adsorption. The disadvantages are the need for a
higher number of sensing channels and, as for the special
lightpipe, the fact that the two signals come from two different
sensing spots.
Recently, we suggested another approach to two-plasmon
spectroscopy [10]. We demonstrated that in the SPR
sensors based on identification of SPR feature spectral
position in attenuated total reflection (ATR) configuration
(spectral configuration [11]), it is possible to excite
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Figure 1. Sensor element configuration for excitation of S/A-SPR.
simultaneously symmetric and anti-symmetric SPs at two
different wavelengths at the same (sensing) spot.
In this paper, we expand this idea [10] to develop a
new self-referenced biosensor. We optimize the structure
in terms of resolution and cross-sensitivity to background
refractive index changes. The sensing structures are realized
and employed in a model IgE biosensing experiment, where
antibodies against human immunoglobulin E (aIgE) are
immobilized on the sensor surface. Results are compared
with the two-channel-compensated SPR performed on a
conventional two-channel SPR instrument.
2. Sensor element structure and principle of
operation
Polychromatic light incident from a high-refractive index
material (optical prism) can excite two SPs bound to a metal
layer, symmetric bound mode (symmetric surface plasmon,
S-SP) and anti-symmetric bound mode (anti-symmetric
surface plasmon, A-SP) [10], figure 1. However, this is
possible only when the metal is surrounded by two dielectric
materials of similar refractive indices (background and buffer
layer). For a rather thick metal layer, the propagation constant
of the S-SP is close to that of the A-SP. Consequently,
a polychromatic wave of finite bandwidth can excite both
SPs simultaneously. Similarly to two-plasmon spectroscopy
[8], the two SPs have different field profiles (and thus also
different penetration depths into the medium under study),
which enables separation of surface and bulk refractive index
changes.
We demonstrated [10] that efficient simultaneous coupling
into S/A-SPs, when more than 95% of incident light is coupled
into both SPs at the two SPR wavelengths, is possible when
Teflon AF is used as the buffer layer in combination with gold
as the metal layer. Due to a poor adhesion of gold to Teflon
AF, a thin adhesive titanium layer (not shown in figure 1) has
to be introduced.
3. Theoretical analysis
In order to compare different sensor designs, we define surface
and bulk refractive index sensitivity as a change in the SPR
wavelength due to a unit change in the thickness of a thin film
with refractive index of 1.48 (proteins) adsorbed at the sensor
surface and due to a unit change in the background refractive
index (RIU), respectively. Further, we define sensor resolution
as the smallest change of the parameter of interest resolvable
by the sensor. The resolution is influenced by the sensitivity,
the accuracy with which SPR spectral position is found, and
the cross-sensitivity (sensitivity to other than the measured
parameter).
As follows from [4], the accuracy with which SPR position
is found is linearly proportional to SPR depth and square-root
to its width. As there are, to our knowledge, no data for cross-
sensitivity analysis for SPR biosensing in the literature, we
derive the necessary formulae in the following part, where
we adopt the fibre Bragg grating sensors cross-sensitivity
analysis published in [12]. There is an important difference
between an SPR biosensor and fibre Bragg grating sensor,
which allows us to simplify the cross-sensitivity analysis. In an
SPR biosensor, a very small change in the parameter of interest
(analyte thickness) has to be measured (first simplification—
the measured changes are small) and, consequently, the
change in the interfering parameter has to be kept reasonably
low (e.g., by temperature stabilization), as all compensation
techniques are limited in their compensation ability (second
simplification—relatively small changes in both the measured
and interfering quantities allow for linear analysis).
3.1. Cross-sensitivity analysis
3.1.1. Ideal case. Generally, both SPR spectral positions are
sensitive to both bulk and surface refractive index changes.
The surface S and bulk B changes are given as follows:


















where K is the characteristic matrix of the sensor. Provided
the determinant of K, det(K) = K1SK2B − K1BK2S , is not
equal to zero, the values of interest are found as [12]
 = K−1 = K ′ 
det(K)






Subscripts B and S denote bulk and surface and λ1,2 are
SPR resonance wavelength shifts caused by the sensing event
for S-SPR and A-SPR, respectively. K is given by two
calibrations (considering the linear regime, as follows from the
second simplification), where purely surface (first calibration)




































where we considered S/A-SPR sensitivity ratios for surface
(sS) and bulk (sB):
λB=02 = sSλB=01 , λS=02 = sBλS=01 . (6)
From (3) and (5), S and B are then
S = SB=0 λ1s
B − λ2
λB=01 (sB − sS)
, B = BS=0 −λ1s
S + λ2
λS=01 (sB − sS)
. (7)
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3.1.2. Noise and cross-sensitivity. Considering the linear
regime (the second simplification), it can be shown [12]
that the sensor output noise is predominantly determined by
error (noise) in  and the sensor cross-sensitivity by error in
coefficients of the matrix K. Error in  is given by uncertainty
of the resonant wavelengths and error in K by inaccuracy of
the sensor calibration. For errors in  and K we write [12]












where δ1,2,S,B represents the fractional error in each element
of K and λ1,2 are absolute errors of λ1,2. In practice, often
only the maximum errors |δ| and |λ| are known. Supposing
the error is cumulative, one can get an estimation of the worst
case. Considering that the errors of elements of K are much
smaller than the value of these elements, we can approximate
the worst case cross-sensitivity (superscript K) [12]:
|S|K = {|S|(|K1SK2Bδ1S | + |K1BK2Sδ2S |)
+ |B||K1BK2B |(|δ1B | + |δ2B |)}/{|det(K)|}, (10)
|B|K = {|B|(|K1BK2Sδ1B | + |K1SK2Bδ2B |)
+ |S||K1SK2S |(|δ1S | + |δ2S |)}/{|det(K)|}. (11)
The worst case level of noise caused by  (superscript ) is
[12]
S = |K2Bλ1| + |K1Bλ2||det(K)| ,
B = |K2Sλ1| + |K1Sλ2||det(K)| .
(12)




























where we considered that the calibration errors are caused
only by an inaccuracy in determining the resonant wavelengths
λ1,2 during the calibration:∣∣λS,B=0i ∣∣ = 2|λi |, i = 1, 2. (14)
The expressions for noise (|S| and |B|) are obtained by
substituting K elements given by (5) into (12)
|S| =
∣∣∣∣SB=0λB=01
∣∣∣∣ |sBλ1| + |λ2||sB − sS | ,
|B| =
∣∣∣∣BS−0λS=01
∣∣∣∣ |sSλ1| + |λ2||sB − sS | .
(15)
The expressions for cross-sensitivity are obtained by
substituting K elements given by (5) and δ elements given








∣∣∣∣ |sBλ1| + |λ2|∣∣λB=01 ∣∣|sB − sS |
)
, (16)
Table 1. Parameters of the sensor.
Gold Titanium |B|
thickness thickness |S| (10−6 × |S|K,S0/|B|
(nm) (nm) |sS − sB | (pm) RIU) (RIU nm−1)
45 1 1.46 9.0 6.9 3.6
3 0.85 9.6 8.2 3.8
5 0.59 10.1 9.4 4.0
55 1 0.89 14.3 10.9 5.7
3 0.42 17.1 14.1 6.8
5 0.24 19.9 17.4 7.9
65 1 1.05 23.1 17.1 9.2
3 0.71 16.1 13.6 6.4








∣∣∣∣ |sBλ1| + |λ2|∣∣λS=01 ∣∣|sB − sS |
)
. (17)
From (15)–(17) we conclude that all the errors are inversely
proportional to |sB − sS |. This term approaches zero when the
two SPs have similar ratios of bulk and surface refractive index
sensitivities. The calibration error ((16) and (17)) of B and S









, respectively. Thus, to suppress
the cross-sensitivity of B in S, high calibration change in B is
desirable (however, we need to stay within the linear regime).
Although the cross-sensitivity is a function of both S and B
((16) and (17)), in the following analysis we concentrate on a
usual situation in biosensing, where an extremely small change
in the surface refractive index is of interest (S → 0) and the
bulk change needs to be eliminated (the first simplification).
Approximating S = 0 in (16) we get
|S|K,Sneglect = |B|
(∣∣∣∣ 2(BS=0)2
∣∣∣∣ |sBλ1| + |λ2|∣∣λB=01 ∣∣|sB − sS |
)
, (18)
where the superscript Sneglect means that the surface refractive
index change is neglected.
It is worth noting that for a small change in the bulk
refractive index B, the noise will dominate over the cross-
sensitivity, which is linearly dependent on B and vice versa.
For a certain value of B (B = Bcrit), these two errors are equal
(|S|K,S0 = |S|). Using (15) and (18) we get
Bcrit = BS=0/2. (19)
Thus, the relative level of cross-sensitivity is predominantly
given by the calibration accuracy and does not depend on the
design. However, its absolute value, as well as the noise, is
strongly design dependent, as will be shown later (table 1).
We can conclude that for B < Bcrit = BS=0/2, the resolution
is given predominantly by the noise |S|, while for B >
Bcrit = BS=0/2 by the cross-sensitivity |S|K,Sneglect .
3.2. Design
Here, we look for optimum parameters of the proposed
structure. We consider optical constants shown in figure 2. To
analyse propagation of light through the sensor element
structure (figure 1), we used a transfer matrix method,
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Figure 2. Dispersion relations of the involved materials. On the left is the real part of the refractive index of gold (a), Ti (b), BK7 glass (c),
water (d) and Teflon AF (e). On the right is the imaginary part of the refractive index of gold (a) and Ti (b), while it is zero for the rest of
materials.




















Figure 3. Spectral reflectivity for gold layer thicknesses of 45, 55,
and 65 nm; Ti is 3 nm thick. Corresponding Teflon AF thicknesses
are 350, 390 and 400 nm.
Fresnel’s formulae and multiple-reflection theory, as
described, e.g., in [13]. The calibration values λS=0,B=01 and
sS,B are obtained by modifying surface and bulk refractive
index and observing shifts in S/A-SPR positions. For the
design, we considered realistic calibration changes in S and
B of 10 nm and 5 × 10−3, respectively. For errors λ1,2,
we considered that they are given as the square-root of SPR
resonance widths, as suggested in [4]. Our experimental
results showed that λ1,2 ≈ 3 pm for SPR minimum of
100 nm FWHM. Thus, we considered that





where FWHM1,2 are calculated FWHMs for S-SPR and A-
SPR, respectively. Further, we varied the thickness of the gold
and titanium layers and adjusted the angle of incidence and
Teflon AF thickness. The angle of incidence was adjusted
to get the two SPRs symmetrically around 730 nm. The
Teflon AF thickness was adjusted to get optimum coupling
into both SPs. For all considered thicknesses (Ti of 1, 3 and
5 nm, Au of 45, 55 and 65 nm), reflectivity dropped at both
SPR wavelengths below 10%. Examples of resulting SPR
responses for different gold layer thicknesses are shown in
figure 3. The parameters of |S| and |B| (given by (15)),
and |B|K,S0 (given by (18)) are summarized in table 1.
In table 1 we see that the term |sS − sB | is closer to
zero for thicker gold layers. As was already pointed out,
this influences also the noise (given by |S| and |B|)
and cross-sensitivity (|S|K,S0/|B|), which are all higher for
thicker gold layers. For a gold layer of 45–55 nm thickness,
an increase in the titanium layer results in poorer performance
in terms of both noise and cross-sensitivity.
On the basis of the results presented in table 1, we
designed the structure in terms of |S|K,Sneglect and |S| to
have the following parameters: gold layer thickness of 45 nm,
titanium layer thickness of 1 nm. For this design, the optimum
Teflon AF thickness is 355 nm.
4. Experimental details
The set-up is, except for the sensor chip, identical to the single-
SPR-based spectral configuration [11]. A 20 W halogen bulb
(Avantes Inc., The Netherlands) is TM polarized by a polarizer
and delivered to a collimator with 30 mm focal length with
nearly diffraction-limited performance (Zeiss Inc., Germany)
via a step-index optical fibre of 200 µm core diameter. The
transmitted light is captured into two output fibres (400 µm
core diameter, step-index) using a pair of 2 mm diameter
Selfoc collimating lenses. The dual-channel spectrograph
is a 2048-element CCD-based, covering a spectral range of
550–1100 nm (Ocean Optics Inc., USA). To account for
spectral characteristics of the used source and the detector,
the measured spectra are normalized to system response to
TE polarized light. For two-channel-compensated SPR, the
sensor chip consists of a glass slide made of glass identical to
the prism (BK7, Schott Inc.), a thin titanium adhesion layer
and a gold layer. The S/A-SPR sensor chip is similar, but
between the glass and the adhesion layer is placed a buffer
layer made of Teflon AF 1600 (Dupont Inc.) [10]. The
Teflon AF has a refractive index close to that of water and
is environmentally stable. The sensor chip is attached to the
coupling prism via an index matching liquid. Each of the used
materials was first deposited on a bare BK7 glass slide and was
characterized using ellipsometry (Sentech Inc., Germany) in
the spectral range of 450–1200 nm, figure 2. It is worth noting
that the ultra-thin adhesion layer of Ti strongly oxidized during
deposition and thus its optical constants are close to those of
TiO2.
935
R Slavı́k et al




















Figure 4. Spectral response of a realized structure together with a
theoretical fit, which gave Teflon AF, titanium and gold layers of
360 nm, 2 nm and 49 nm.
The Teflon AF was spin-coated and its thickness was
measured to be 350 ± 10 nm using the ellipsometry. The
titanium was e-beam vacuum evaporated and the gold was
deposited using thermal vacuum evaporation. The temperature
of all the vacuum depositions was 150 ◦C. The layer
thicknesses given by a crystal oscillator placed in the vacuum
chamber were as follows: Ti: (1–2) nm and Au: (47 ± 2) nm.
Subsequently, we characterized the sensor chip, figure 4.
The best agreement with the theoretical predictions we got
for 360 nm of Teflon AF, 2 nm of titanium and 49 nm of gold
(figure 4), which is very close to the expected values.
4.1. Biosensing
The biosensing technique used was described in detail, e.g., in
[14]. The reagents used were as follows. The C11-chained and
C16-chained alkanethiols (C11-mercapto-1-undecanol and C16-
mercaptohexadecanoic acid) and the N, N, N′, N′-tetramethyl-
O-(N-succinimidyl)uranium tetrafluoroborate (TSTU), which
was used for activation of carboxylic terminal groups on
C16 alkanethiol were from Sigma-Aldrich, USA. Monoclonal
affinity-purified antibodies against human immunoglobulin E
(aIgE) and M (aIgM) were from Seva Immuno, CZ and human
immunoglobulin E (IgE) from Biodesign, USA. Immune
reaction activity of all immune partners was confirmed by the
ELISA method. Antibody solutions were prepared in a 10 mM
phosphate buffer, pH 7.6 at 20 ◦C. Antigen solutions were
prepared in PBS (10 mM phosphate buffer, 137 mM NaCl,
2.7 mM KCl, pH 7.4 at 20 ◦C) containing bovine serum
albumin (BSA) (Sigma-Aldrich, USA) at a concentration of
100 µg ml−1.
Two sensor chips (with and without a Teflon AF layer,
respectively) were UV ozone cleaned for 10 min (UV cleaner
42–220, Jelight Company Inc.), washed with deionized
water, and dried with nitrogen stream. A 7:3 mixture of
C11-chained and C16-chained alkanethiols was dissolved in
degassed absolute ethanol with a total thiol concentration of
1 mM. The C16 alkanethiols terminated with a carboxylic
head group were used to anchor an antibody; C11 alkanethiol
chain terminated with a hydroxyl head group was used to
form a stable non-fouling background. Sensor chips were
immersed in thiol solution and stored in a dark place at room
temperature for 24 h. Then, the chips were rinsed with ethanol,
dried with nitrogen, rinsed with water and dried with nitrogen
again. The carboxylic terminal groups on the sensor surface
were activated by TSTU dissolved in dimethylformamide at




























Figure 5. Immobilization of antibodies for the aIgE-covered
channel of the two-channel compensated SPR (conventional SPR)
and for S/A-SPRs.










































Figure 6. SPR wavelength shifts for two-channel compensated SPR
for the sensing (dashed) and reference (dotted) channels. The
surface refractive index change S is shown as a solid line.
a concentration of 1 mg ml−1 for 4 h. After activation, the
chips were rinsed with deionized water, dried with nitrogen
and immediately mounted into the SPR instrument. The
immobilization of antibodies was performed in situ, figure 5.
First, a phosphate buffer was introduced and flowed through
the flow cell until the baseline was achieved. Subsequently,
a phosphate buffer solution with 50 µg ml−1 of aIgE was
injected. For two-channel compensated SPR, 50 µg ml−1 of
aIgM (receptors not interacting with IgE) was injected into
the second sensing channel (not shown in figure 5). It was
allowed to flow for 15 min at a flow rate of 20 µl min−1.
After the sensor surfaces incubation with a phosphate buffer
(PB), the phosphate buffer containing sodium chloride at a
concentration of 0.75 M (PBS∗) flowed for 15 min to remove
all non-covalently bound antibody. The phosphate buffer
(PB) was injected again and after a short incubation it was
replaced with PBS. Finally, PBS-solution containing BSA at
a concentration of 0.5 mg ml−1 flowed until a stable baseline
was reached.
The SPR wavelength evolution during the sensing events
for two-channel compensated SPR and A/S-SPR are shown
in figures 6 and 7, respectively. First, buffer solution (marked
as BSA1) flowed through both sensing channels until a stable
baseline was achieved (flow rate—20 µl min−1). Antigen
solutions were prepared in the BSA/PBS solution of a slightly
different refractive index with respect to the BSA1 (marked
as BSA2). The BSA2 was prepared from the BSA1 by
adding a small amount of NaCl to the buffer solution. The
difference in the refractive indices of BSA2 and BSA1 was
different for the two experiments being about twice as high for
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Figure 7. S-SPR (solid) and A-SPR (dashed) wavelengths recorded
during the sensing event, when the solution containing increasing
concentrations of IgE was introduced.
S/A-SPR. After the incubation of the IgE solution for 15 min,
it was replaced with BSA1. IgE was injected sequentially in
concentrations of 250, 500 and 1000 ng ml−1.
4.2. Sensor output
In order to calculate the sensor output using (7), we would
need to know the absolute values of surface/bulk refractive
index changes during the calibration process, SB=0 and BS=0.
As we do not have these data available, we used the predicted
values of the sensor sensitivities: cB and cS are surface and
bulk refractive index sensitivities of S-SPR and cconventionalB ,
cconventionalS are surface and bulk refractive index sensitivities of
conventional SPR, respectively. For 360 nm of Teflon AF, 2
nm of titanium and 49 nm of gold (figure 4) we calculated:
cB = 1160 nm RIU−1, cS = 1.16 nm nm−1,
cconventionalS = 4.6 nm nm−1, cconventionalB = 4500 nm RIU−1.
(21)
Using these values and data obtained from measurement shown





















The rest of the parameters were retrieved from data shown in
figure 5 considering the a-IgE sorption as purely surface
change and the PB–PBS difference (around 50 min) as a pure
bulk refractive index change:
λS=01 = 1.41 nm, λB=01 = 4.69 nm, λS=0conventional = 6.46,
sB = 3.47, sS = 2.42, λ1 = 2.5 pm,
λ2 = 3.7 pm, λconventional = 3.5 pm,
(23)
where λ1,2,conventional are given as standard deviations of
baselines, figure 5.
The sensor responses B and S shown in figure 8 are derived
using (7), (22) and (23). For two-channel compensated SPR,
where λconventional is given as the difference between the SPR
wavelengths of the two channels, the response Sconventional (22)
is shown in figure 6.






































Figure 8. Surface (solid) and bulk (dashed) refractive index change
retrieved using (7) from the S/A-SPR wavelengths that are shown in
figure 7.
4.3. Noise and cross-sensitivity analysis
For comparison, we calculated the estimation of the worst case
for the realized structure from (15) and (18), where we used
the calibrations (23):
|S| = 10 pm, |S|K,S0 = 25 pm,
|S|K,S0/B = 16.7 RIU nm−1. (24)
The noise (standard deviation) and cross-sensitivity (nearly-
instantaneous change detected in S near S = 0 caused
by a nearly-instantaneous change in B) retrieved from the
experimental data (figures 7 and 8) are
S = 9 pm, SK = 20 pm,
|S|K,S0/B = 13.3 RIU nm−1, (25)
which are in very good agreement. For two-channel
compensated SPR, figure 6, we get∣∣Sconventional∣∣ = 0.8 pm, ∣∣SKconventional∣∣ = 15 pm,∣∣SKconventional/B∣∣ = 21 RIU nm−1. (26)
5. Discussion
The presented theory provides a good prediction in terms
of noise and cross-sensitivity, as shown in (24) and (25).
Compared with two-channel compensated SPR, the noise-
limited resolution in surface refractive index is about 11 times
worse ((25) and (26)), however, the cross-sensitivity given
by |S|K,S0/B and |S|Kconventional
/
B, respectively, is nearly
twice as good in the proposed configuration.
Thus, for lower levels of background refractive index
change, where the measurement is limited by the noise,
the two-channel compensated SPR has better performance
compared to S/A-SPR and vice versa for a measurement
limited by the cross-sensitivity. At a certain value of
the background refractive index change, Blim, the two
configurations are comparable, while above/below this limit
S/A-SPR has superior/inferior performance. This limit
corresponds to a situation when the noise of S/A-SPR
approaches the cross-sensitivity of two-channel compensated
SPR:
SK,S0/B lim = Sconventional, (27)
which, for our experiment ((25) and (26)), gives a value of
B lim = 4.3 × 10−4. It is worth noting that this value is about
four times lower than that realized experimentally for S/A-
SPR, figure 8.
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6. Conclusions
We designed a layered structure for two-plasmon-based
biosensing using simultaneous excitation of symmetric and
anti-symmetric bound surface plasmons. Besides the sensor
sensitivity and noise, we considered also the cross-sensitivity
to background refractive index in the optimization process,
which allowed us to evaluate the true sensor resolution. The
derived formulae for cross-sensitivity can be directly used for
evaluation and optimization of other SPR cross-sensitivity-
compensating techniques.
We have compared the performance of the proposed
structure and the two-channel compensated SPR detecting IgE
analyte. It was found that the noise of the retrieved surface
refractive index change was 11 times worse in the proposed
configuration. However, the cross-sensitivity to background
refractive index changes was nearly twice as low, which
favours the proposed configuration for measurements with
relative high background refractive index changes. Besides
that, there are other advantages of the proposed method, as
only single receptors are used and the number of channels is
halved, requiring also half the analyte.
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Abstract
A novel multichannel surface plasmon resonance (SPR) biosensor with spectral interrogation and wavelength division multiplexing of sens-
ing channels is presented. A special design of SPR prism element is used to enable wavelength division multiplexing of serial sensing channels.
In addition to increasing the number of sensing channels, this approach allows discrimination of the sensor response due to analyte–receptor
binding from interfering background refractive index fluctuations. A novel eight-channel SPR sensor combining the wavelength division
multiplexing of serial sensing channels with the conventional parallel channel architecture is described. Application of this multichannel SPR
sensor for simultaneous detection of multiple analytes is described.
© 2005 Elsevier B.V. All rights reserved.
Keywords:Surface plasmon resonance; Optical sensor; Biosensor; Multichannel sensor; Wavelength division multiplexing
1. Introduction
Since the end of the last century, surface plasmon res-
onance (SPR) has been increasingly exploited for develop-
ment of optical biosensors. SPR biosensors have been ap-
plied for analysis of biomolecular interactions (BIA) and de-
tection of chemical and biological analytes[1], where they
provide benefits of real-time, sensitive and label-free technol-
ogy. SPR biosensors have been used for detection of various
chemical and biological compounds related to significant ar-
eas such as environmental protection (e.g. herbicides[2]),
food safety (e.g. protein toxins[3], bacteria[4]) and medical
diagnostics (e.g. DNA[5] and hormones[6]). Recent years
have witnessed intensive research effort towards increasing
the number of sensing channels to introduce benefits of SPR
biosensor technology to multianalyte detection and highly
parallelized biomolecular interaction analysis. Numerous ap-
proaches in multichannel SPR sensor development have been
demonstrated to date[7–14]. In these sensors, changes in SPR
∗ Corresponding author. Tel.: +422 688 1804; fax: +422 688 0222.
E-mail address:homola@ure.cas.cz (J. Homola).
condition were determined by measuring variations in light
intensity (SPR sensors with intensity modulation) or spec-
trum (SPR sensors based on surface plasmon spectroscopy).
The intensity modulation-based SPR imaging devices allow
parallel measurements in up to hundreds of sensing chan-
nels[9,10] with a typical accuracy in discrimination of SPR
changes of 10−5 refractive index (RI) units. Sensors based
on spectroscopy of surface plasmons are capable of more ac-
curate measurements of SPR changes (up to 3× 10−7 RIU),
however, the number of independent sensing channels usu-
ally does not exceed ten[11,12].
Most sensors with surface plasmon spectroscopy rely on
the parallel architecture and spatial multiplexing of sens-
ing channels[12]. In this approach, light beams exciting
surface plasmons in a row of sensing channels are interro-
gated independently to determine SPR changes in each chan-
nel. In SPR biosensors with wavelength modulation, spec-
tral analysis of multiple light beams is performed by mul-
tiple spectrographs[3] or by using an optical switch rout-
ing light from multiple channels at single spectrograph[13]
(time multiplexing). Alternative approach to multiplexing of
parallel sensing channels is the wavelength division mul-
0925-4005/$ – see front matter © 2005 Elsevier B.V. All rights reserved.
doi:10.1016/j.snb.2004.12.096
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tiplexing (WDM) by means of a thin dielectric overlayer
[14].
In this work we report a novel configuration of multi-
channel surface plasmon resonance biosensor withserial
architecture and wavelength division multiplexing (WDM)
of sensing channels. We show that this approach makes it
possible to discriminate binding of analyte from the inter-
fering effects such as background refractive index fluctua-
tions and thus provide more robust SPR measurements. We
present a new eight-channel SPR sensor based on combi-
nation of this method with the parallel architecture and de-
scribe its application for simultaneous detection of multiple
analytes.
2. Theory
2.1. Wavelength division multiplexing of serial SPR
sensing channels
Surface plasma wave (SPW) is an electromagnetic wave
guided along a metal–dielectric interface. SPW may be op-
tically excited in the Kretschmann geometry of the attenu-
ated total reflection (ATR) method[16]. In this geometry,
an optical wave is introduced into a prism, where it under-
goes total reflection on the prism base with a thin metal
film. The generated evanescent field in the metal film cou-
ples to a SPW at outer metal film boundary if their propa-
gation constant components parallel to the metal surface are
equal:






wherek0 is the wave number of light in vacuum,np the prism
refractive index,θ the angle of incidence of the optical wave,
ε1 the metal film permittivity andε2 the permittivity of the
dielectric at the outer interface of the metal film.
In order to achieve the wavelength division multiplexing
of serial SPR sensing channels, we use a special design of
the ATR prism coupler[15] depicted inFig. 1a. A colli-
mated polychromatic optical wave launched into this element
is made incident on a thin metal film in two distinct regions
denoted as A and B. In the first region (region A), it hits the
metal film under the angle of incidenceα and couples to a
SPW at the outer metal surface at the wavelengthλA. The ex-
citation of SPW produces a sharp absorption dip in the spec-
trum of the optical wave centered atλA. The reflected light is
redirected inside the element and made incident on the metal
film in the second region (region B) under a different angle
of incidenceβ (β <α). At this angle of incidence, the optical
wave couples to a SPW at a longer wavelengthλB (λB >λA)
generating a dip in the spectrum of the optical wave centered
at λB. Consequently, the wavelength spectrum of the trans-
mitted light exhibits two SPR dips corresponding to SPRs
in two distinct regions of the metal film,Fig. 1b. Based on
the carried out theoretical analysis, materials and parameters
of the structure were selected as follows: special prism ele-
ment, SF14 glass; SPR-active layer, gold; thickness, 55 nm;
dielectric, aqueous medium; refractive index, 1.33. For this
structure, the angles of incidenceα = 54.6◦ andβ = 52.5◦ cor-
respond to SPW excitation atλA = 640 nm andλB = 790 nm,
respectively.
2.2. Sensitivity of SPR biosensor with WDM of sensing
channels
When the refractive index of the dielectric adjacent to the
metal surface is changed, a shift in the SPR wavelength oc-
curs. In principle, there are two types of refractive changes
involved in SPR biosensing: (a) bulk refractive index changes
within the whole dielectric adjacent to the metal surface and
(b) refractive index changes within a thin layer with the
thickness much smaller then the SPW penetration depth into
the dielectric (typically > 100 nm in the wavelength region
600–1000 nm for the interface between gold and dielectric
with RI 1.33). In the approximation of small responses, SPR
wavelength shift can be assumed to be a linear function of
the bulk refractive index changenB, and surface refractive
index changenS:
λA = SB(λA)nB + SS(λA)nS,
λB = SB(λB)nB + SS(λB)nS, (2)
Fig. 1. (a) Special prism coupler for sequential excitation of SPW and wavelength division multiplexing of sensing channels and (b) resulting spectrum of
transmitted light.
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Fig. 2. Transmitted spectrum calculated for (a) bare gold surface with back-
ground dielectric medium with a refractive indexnB = 1.33, (—) (b) bare gold
and a higher refractive index of background dielectric mediumnB = 1.335, (–
– – – ) and (c)gold with a thin dielectric layer (thicknessd= 5 nm,nF = 1.43)
and background dielectric medium with a refractive indexnB = 1.33, (. . .).
whereλi is the SPR wavelength change (i = A, B), and
SB andSS are the bulk and surface RI sensitivities, respec-
tively.
As the penetration depth of SPW increases with the wave-
length, SPWs at the wavelengthsλA andλB are unequally
sensitive to changes in the refractive index at the surface and
in the bulk dielectric. This is illustrated inFig. 2which shows
a model situation, in which changes in the coupling wave-
lengths due to the presence of a thin film and the change in
bulk refractive index are identical in the short-wavelength
channel, while the change due to the bulk refractive index
change is more pronounced in the long-wavelength channel.
Therefore the Eq.(2)may be inverted and the coupling wave-
length shifts can be decomposed into the contributions due
to the changes in the refractive index at the surface and in the
bulk dielectric:
nS = λAkB − λB
(kB − kS)SS(λA) , nB =
λB − kSλA
(kB − kS)SB(λA) ,
(3)
where kB =SB(λB)/SB(λA) and kS =SS(λB)/SS(λA) are the
bulk and surface RI change calibration constants. By us-
ing Fresnel reflectivity model, the sensitivities and cal-
ibration constants were calculated to beSB(640 nm) =
2710 nm RIU−1, SB(790 nm) = 8500 nm RIU−1, SS(640 nm)




The special prism element was made of SF14 glass. An
SPR chip was attached to the base of the element and opti-
cal contact was established using a refractive index match-
ing fluid (from Cargille). The sensor chip consisted of an
SF14 glass slide coated by an adhesion promoting chromium
layer (thickness, 2 nm) and SPR-active gold layer (thick-
ness, 55 nm) by means of thermal evaporation in vacuum.
The optical setup of the eight-channel biosensor instrument
is depicted inFig. 3. Polychromatic light from a halogen
lamp (Avalight-Hal from Avantes) was coupled into an op-
tical fiber (FT-400-EMT from Thorlabs) and collimated us-
ing two cylindrical lenses. The collimated light beam was
polarized by a dichroic polarizer (Polarcor) and coupled in
the special SPR prism element, where it was made incident
on the SPR-active surface in eight areas denoted as A1–A4
and B1–B4,Fig. 3. Light beams reflected at areas A1–A4
and B1–B4 were collected by four miniature GRIN lenses
(NSG America) and coupled in four optical fibers (FT-400-
EMT from Thorlabs) connected to four-channel spectrograph
(S2000, Ocean Optics). The SPR spectra were measured in
TM polarization and normalized with spectra obtained in TE
polarization. Measured SPR spectra were averaged in time
Fig. 3. Scheme of the optical system of eight-channel SPR sensor combining parallel architecture with the wavelength division multiplexing of serially ordered
channels.
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Fig. 4. Transmitted spectra measured from bare gold surface with back-
ground dielectric medium refractive indexnB = 1.33 in sensing channels
A1–A4 and B1–B4.
and polynomial fitting method was applied for determina-
tion and tracking of the SPR dip minimum in each sensing
channel. Examples of SPR normalized spectra are given in
Fig. 4. In comparison with theory (Fig. 2), experimental SPR
dips are broader by 30% and observed SPR dips are shifted to
longer wavelength by about 13 and 5 nm for short-wavelength
and long-wavelength SPW, respectively. This discrepancy is
mostly due to an error in the angle of incidence and difference
between gold permittivity used in simulations and that of the
real layer.
An eight-channel flow-cell was clamped against the SPR
chip in order to contain liquid samples during experiments.
The flow-cell was made of an acrylic substrate with input and
ports interfacing flow-cell chambers for each sensing chan-
nel. The flow-cell chambers were cut into a gasket made into
a 50m thick polyurethane sheet using a CO2 laser beam
(custom made by Micronics, Inc.). The volume of each flow-
cell chamber was 2l. Input flow-cell ports were connected
via tubing (from Upchurch Scientific) with two four-channel
peristaltic pumps (Reglo Digital, from Ismatec) to control the
flow of liquid samples across the sensor surface. The flow-
rate of 50l/min was used in the experiments.
3.2. Materials
Bovine serum albumin (BSA), C11-mercapto-1-
undecanol acid (C11-chain alkanethiol), C16-mercapto-
hexadecanoic acid (C16-chain alkanethiol) andN,N,N′,N′-
tetramethyl-O-(N-succinimidyl)uronium tetrafluoroborate
(TSTU) were purchased from Sigma–Aldrich, USA.
Monoclonal affinity-purified antibodies against human
immunoglobulin E (aIgE), human immunoglobulin G
(aIgG), human choriogonadotropin (ahCG) and horseradish
peroxidase (aPx) were obtained from Seva Immuno, Czech
Republic. Human immunoglobulin E (IgE) was purchased
from Biodesign, USA, human immunoglobulin G (IgG)
was obtained from Laboratory of Anthropology and Human
Genetics at Faculty of Sciences, Charles University, Czech
Republic, human choriogonadotropin (hCG) was from
Calbiochem, USA, and horseradish peroxidase (Px) was
from Kem-En-Tec, Denmark. Antibody solutions were pre-
pared in 10 mM phosphate buffer, pH 7.6 at 20◦C. Antigen
solutions were prepared in PBS (10 mM phosphate buffer,
137 mM NaCl, 2.7 mM KCl, pH 7.4 at 20◦C) containing
bovine serum albumin at the concentration of 100g/ml. For
the cleaning of the gold surface of the sensor chip we used
1:3 mixture of 30% hydrogen peroxide and 96% sulfuric
acid (Piranha solution).
3.3. Sensor chip preparation
The surface of gold was cleaned in Piranha solution for
3 min, rinsed with deionized water and dried in nitrogen
stream. Then, the sensor chip surface was immersed in the 7:3
mixture of C11-chain and C16-chain alkanethiols dissolved in
degassed ethanol (total thiol concentration, 1 mM) and stored
in a dark place at room temperature for 2 days to allow the
thiols to form a self-assembled monolayer. Subsequently, the
chip was rinsed with ethanol and water and dried in nitrogen
stream. C16 alkanethiol terminated with a carboxylic head
group was used to anchor antibodies, while C11 alkanethiol
chain terminated with a hydroxyl head group formed a sta-
ble non-fouling background. The carboxylic terminal groups
on the sensor surface were activated with TSTU dissolved in
dimethylformamide at the concentration of 1 mg/ml for 4 h
[17]. After the activation, the sensor chip was rinsed with
water, dried in nitrogen stream and loaded into the SPR in-
strument, where in situ immobilization of antibody was per-
formed. Antibodies dissolved in PBS at the concentration of
50g/ml were flowed across the sensor surface for 15 min.
Different sensing channels were functionalized with differ-
ent antibodies; specifically, aPx antibody was immobilized
in sensing channels A1 and B1, aIgE in A2 and B2, ahCG in
A3 and B3, and aIgG in A4 and B4.
3.4. Calibration of the sensor instrument
In order to establish bulk and surface refractive index
calibrations of the sensor, the response of sensing channels
A1–A4 and B1–B5 to known background medium and sur-
face refractive index changes was measured.Fig. 5a shows
SPR wavelength shifts obtained while liquids with different
refractive indices were flowed over the sensor surface (the re-
fractive index values are given at the wavelength of 650 nm).
These data imply that the average bulk RI sensitivities are
SB (λA) = 2650 nm RIU−1 and SB (λB) = 8800 nm RIU−1.
The position of SPR wavelengths in channels A1–A4 and
B1–B4 were determined with the standard deviation of
0.0035 and 0.006 nm, respectively. These noise levels cor-
respond to bulk RI changes resolutions of 1.3× 10−6 RIU in
sensing channels A1–A4 and 7× 10−7 RIU in sensing chan-
nels B1–B4. The bulk RI change calibration constant was
calculated to lie within the rangekB = 3.25–3.32. Within the
operating range 3× 10−3 RIU, no cross sensitivity between
sensing channels with SPR encoded in the same wavelength
spectrum due to the overlap in their SPR dips was observed.
The surface RI change calibration constant was determined
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Fig. 5. (a) SPR wavelength shifts due to changes in the refractive index of
background dielectric medium, (b) SPR wavelength shifts due to changes
in the refractive index at the sensor surface. SPR wavelengths in channels
A1–A4 and B1–B4 are offset by 653 and 795 nm, respectively.
from SPR sensor response to formation of BSA layer from
PBS (BSA concentration, 100g/ml), Fig. 5b. From this ex-
periment, the surface RI calibration constant was determined
to lie withinkS = 1.78–1.92. We believe that the observed vari-
ations in the calibration constants for different sensing chan-
nel pairs are mainly due to inconsistencies in the alignment of
the optical beams in the middle of the flow chamber, inhomo-
geneity of the sensor surface and variations in the sample flow
conditions in different sensing channels. Experimental sensor
responses shown in this work were calibrated to effective bulk
refractive index change at the wavelengthλB = 795 nm – in
channels A1–A4 the SPR wavelength shifts were divided by
the factorSB(λB)/kS and in channels B1–B4 the SPR wave-
length shifts were divided by the bulk sensitivitySB(λB).
4. Results and discussion
4.1. Discrimination of background and surface
refractive index changes by WDM SPR
When the same effects occur in complementary sensor
chip areas A and B, these effects may be simultaneously mon-
itored at two different wavelengthsλA andλB. As discussed in
Section2.2, by means of measuring SPR dip shift at two dif-
ferent wavelengths, the sensor responses to surface and bulk
refractive index changes can be discriminated. This feature
is illustrated in the model experiment, in which a thin protein
monolayer was grown on a bare gold surface from a liquid
the refractive index of which was changing. Initially, liquids
with different RI were sequentially injected to the flow-cell
of the sensor in the following order – PBS buffer, PBS buffer
dissolved in water at the ratio 2:3 (PBS+) and PBS. Then, a
protein layer was grown on a bare gold surface by means of
physical sorption from the PBS buffer with BSA at the con-
centration of 10g/ml. While the protein layer was grown,
the background dielectric refractive index was continuously
changed by means of mixing this solution with a solution
containing the same amount of BSA dissolved in PBS+. Fi-
nally, the sensor surface was flushed with the pure PBS buffer
until the sensor response became stable. The sensorgram pre-
sented inFig. 6shows measured SPR wavelength shifts at the
wavelengthλA andλB together with the deconvoluted sensor
responses associated with the background refractive index
change and the growth of the BSA monolayer. The data sug-
gest that the deconvolution was performed with the accuracy
better than 97%. The noise in deconvoluted sensor response,
however, increased by a factor of 2.5–3.5 compared to that of
the individual sensing channels A1–A4, B1–B4. This noise
increase can be reduced by increasing the difference between
calibration constants for bulk and surface RI changeskB and
kS, for example, by employing SPWs at more different wave-
lengths.
4.2. Multianalyte detection by means of WDM SPR
biosensor
The antibody-coated SPR biosensor chip was used for
multianalyte detection in mixtures comprising proteins Px,
IgE, hCG and IgG. Buffer solution was flowed through all
the channels until stable baseline in the sensor response was
achieved. Then, the solution containing a mixture of anti-
gens Px, IgE, hCG and IgG at concentrations of 0.5, 0.1,
2 and 0.5g/ml, respectively, was flowed through sensing
channels B1–B4. Simultaneously, four solutions containing
only one of the antigens (at an identical concentration) were
injected into channels A1–A4 coated with a respective anti-
body. After the incubation of samples for 15 min, the samples
were replaced with pure buffer. The obtained sensorgram pre-
sented inFig. 7shows the comparison of sensor response to
each analyte in pure buffer and mixture of other antigens. The
observed higher response to mixture of antigens is probably
mainly due to the non-specific binding of other proteins in
mixture to antibodies on the sensor surface. After washing the
sensor surface with buffer, the sensor response at channels in
contact with pure protein and with protein mixture reached al-
most identical levels suggesting that the non-specific binding
was mostly reversible and there were no significant compet-
itive and hindrance effects.
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Fig. 6. (a) SPR wavelength change measured at two different wavelengths when BSA monolayer was grown on bare gold surface from the solution refractive
index of which was changing, (b) decomposition of the sensor response into the surface and background medium refractive index change contributions.
Fig. 7. Sensor response to antigens Px, IgE, hCG and IgG contained in pure buffer and in the mixture of antigens.
5. Conclusions
We have demonstrated a new approach to multichannel
SPR sensing based on serial sensing channel architecture and
wavelength division multiplexing of sensing channels. This
approach was combined with the parallel channel architec-
ture and implemented in a new eight-channel SPR sensor.
This multichannel SPR sensor technology offers two modes
of operation: (i) all the sensing channels can be functionalized
and used for detection of different analytes or (ii) the sens-
ing channels at different wavelengths can be paired for dis-
crimination of specific binding events from interfering back-
ground refractive index fluctuations and thus allows more
robust biosensing. This feature is expected to be particularly
useful for biosensing in complex realistic samples, in which
interfering effects pose a major challenge for conventional
SPR biosensors.
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Abstract
Surface plasmon resonance (SPR) biosensors are aYnity sensing devices exploiting a special mode of electromagnetic Weld—sur-
face plasmon-polariton—to detect the binding of analyte molecules from a liquid sample to biomolecular recognition elements
immobilized on the surface of the sensor. In this paper, we review advances of SPR biosensor technology towards detection systems
for the simultaneous detection of multiple analytes (multi-analyte detection). In addition, we report application of a recently devel-
oped multichannel SPR sensor based on spectroscopy of surface plasmons and wavelength division multiplexing of sensing channels
to multi-analyte detection.
  2005 Elsevier Inc. All rights reserved.
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1. Introduction
In the last two decades, we have witnessed remarkable
progress in the development of biosensors and their
applications in the areas such as environmental monitor-
ing, biotechnology, medical diagnostics, drug screening,
food safety, and security. Various sensor technologies
have been developed (e.g., electrochemical sensors [1],
piezoelectric sensors [2], electrical impedance sensors [3],
and optical sensors [4]) and applied to detection of
chemical and biological analytes [5]. Optical sensors
oVer several important features—they exhibit high sensi-
tivity, their performance is insensitive to electromagnetic
interference, and they do not require electrical signal in a
sensing area. Optical methods exploited in aYnity bio-
sensors include Xuorescence spectroscopy [6], label-free
methods such as interferometry [7], spectroscopy of
guide modes of dielectric waveguides (grating coupler
[8], resonant mirror [9]), and metallic waveguides (sur-
face plasmon resonance [10,11]).
This paper focuses on surface plasmon resonance (SPR)
biosensors technology, reviews fundamentals of SPR sens-
ing, and discusses advances of this technology towards
multi-analyte detection. A special attention is given to a
recently developed multichannel SPR sensor combining the
wavelength division multiplexing of serially ordered sensing
channels with the conventional parallel channel architec-
ture. Application of this multichannel SPR sensor for simul-
taneous detection of multiple analytes is described.
2. Principle of operation of SPR biosensors
An aYnity optical biosensor consists of an optical
transducer and a biological recognition element (BRE)
which interacts with an analyte. The SPR transducer
incorporates a thin metal Wlm which supports a special
mode of electromagnetic Weld—a surface plasmon-
polariton (SPP)—sometimes referred as to a surface
plasma wave. The SPP propagates along the surface of
the metal Wlm and the intensity of its electromagnetic
* Corresponding author.
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Weld exponentially decays from the metal surface into
the adjacent medium. The most commonly used metal is
gold due to its chemical stability. A change in the refrac-
tive index due to the binding of analyte molecules to bio-
molecular recognition elements immobilized on the
metal surface results in a change in the propagation con-
stant of the SPP [11]. Surface plasmon resonance biosen-
sors take advantage of this phenomenon and measure
changes in the propagation constant of the SPP to deter-
mine changes in the amount of bound analyte and subse-
quently the concentration of analyte in a sample.
Changes in the propagation constant of the SPP are
determined by measuring one of the characteristics of
the light wave that excites the SPP. On the basis of the
characteristic of the light wave which is measured, SPR
sensors are classiWed as sensors with angular, wave-
length, intensity, phase, and polarization modulations
[11].
The operating principle of the three modulation
approaches (angular, wavelength, and intensity) used
most frequently in SPR sensors is illustrated in Fig. 1, in
which the excitation of surface plasmons is performed by
the attenuated total reXection (ATR) in a prism coupler,
Fig. 1A [11]. In SPR sensors with angular modulation, a
beam of monochromatic light is used to excite an SPP
(Fig. 1B). The propagation constant of the SPP and its
changes are determined by measuring the intensity of
reXected light at multiple angles of incidence and deter-
mining the angle of incidence yielding the strongest cou-
pling with an SPP [12,13]. In SPR sensors with
wavelength modulation, a beam of polychromatic light
incident on the metal Wlm under a Wxed angle of inci-
dence is used to excite an SPP (Fig. 1C). The propaga-
tion constant of the SPP and its changes are determined
by measuring the intensity of reXected light at multiple
wavelengths and determining the wavelength at which
the strongest coupling with an SPP occurs [14]. In SPR
sensors with intensity modulation, a beam of monochro-
matic light is made incident on the metal Wlm under a
Wxed angle of incidence near the resonant angle of inci-
dence (Fig. 1C) and changes in the intensity of reXected
light are measured [15,16].
3. Advances in development of multi-analyte SPR sensors
3.1. Multichannel SPR sensor platforms
The most straightforward approach to multichannel
SPR sensing is SPR imaging. SPR imaging is intensity
modulation-based technique in which a collimated beam
of monochromatic light passes through a prism coupler
and excites SPPs on a thin metal layer. Intensity of the
reXected light depends on the strength of the coupling
between the light and SPPs which depends on the
refractive index at the metal surface. Therefore, spatial
distribution of the refractive index at the metal surface
can be determined by measuring the distribution of light
intensity across the reXected beam by means of a two-
dimensional detector array (Fig. 2). This approach to
spatially resolved SPR sensing has been applied to char-
acterization of ultrathin Wlms [17] and lipid layers
[18,19].
When the metal surface is divided into multiple
sensing spots, the SPR imaging device can be used as a
multichannel SPR sensor. A multi-analyte biosensor
based on SPR imaging was reported by Berger et al.,
[20], who demonstrated detection of four diVerent ana-
lytes in a 16-channel matrix imaging format. SPR
imaging was also applied to the observation of DNA
hybridization [21], antibody–antigen binding, and
Fig. 1. (A) Excitation of surface plasmons via prism coupler. (B) Inten-
sity of reXected light as a function of angle of incidence for a Wxed
wavelength and two refractive indices of sample. (C) Intensity of
reXected light as a function of wavelength for a Wxed angle of incidence
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DNA–protein interaction [22], and detection of the
sequence-speciWc binding of transcription regulatory
proteins [23]. SPR imaging has also been exploited to
study DNA-binding proteins to double-stranded DNA
(dsDNA) array immobilized in a 10 £ 12 array proving
applicability of this method for monitoring the kinetics
of binding of proteins to 120 diVerent dsDNA
sequences [24]. The major challenge for application of
SPR imaging approach for biosensing is its rather lim-
ited resolution. Existing SPR imaging systems are
capable of resolving bulk refractive index changes of
about »10¡5 RIU (refractive index units) [25]. To
improve resolution of SPR imaging, this method was
combined with polarization contrast and a spatially
patterned multilayer SPR structure [26]. This approach
generates high-contrast SPR images suitable for auto-
mated computer analysis, minimizes crosstalk between
neighboring sensing channels, and provides compensa-
tion for light Xuctuations improving the refractive
index resolution to 3 £ 10¡6 RIU. This system was
demonstrated to allow simultaneous monitoring of
over 100 immunoreactions [26].
In contrast with SPR imaging systems, SPR sensors
based on spectroscopy of surface plasmons take advan-
tage of information contained in the whole wavelength
or angular spectrum of light and therefore oVer a con-
siderably better resolution (up to 3 £ 10¡7 RIU) [27].
For multiplexing of sensing channels, most SPP spec-
troscopy-based sensors rely on parallel arrangement of
sensing channels in which multiple light beams excite
SPPs in diVerent sensing channels and their reXectivity
spectra are interrogated independently to determine
SPR changes in each channel. Recently, SPR sensors
based on serial channel architecture have also been
reported. In these sensors, SPR spectra from multiple
channels are encoded into a single optical wave [28,29].
Multichannel SPR sensors based on spectroscopy of
SPP rely on ATR prism couplers [28–35] and diVrac-
tion gratings [36–38]. In ATR-based SPR biosensors
with angular modulation and parallel architecture,
series of convergent monochromatic beams are focused
on a row of sensing channels where they excite SPPs.
Light beams reXected from a row of sensing channels
are projected on a two-dimensional detector array,
Fig. 3. The Wrst multi-channel SPR biosensors with
angular modulation of SPR allowed simultaneous
measurements in up to four sensing channels [30];
recently, the number of channels was extended to 6
[31], and 10 [32].
Lately, an interesting multichannel SPR sensor with
angular interrogation and parallel sensing channels
using a special planar sensor chip with diVractive optic
coupling elements has been proposed. These elements
project monochromatic light on an array of sensing
channels and image the angular reXectivity spectra
from each sensing channel on a CCD detector array
[33]. In ATR-based SPR sensors with wavelength mod-
ulation and parallel architecture, series of collimated
polychromatic beams are made incident on a row of
sensing channels. SPR spectra encoded into the
reXected light beams are analyzed by a spectrograph.
The spectral analysis of multiple light beams is per-
formed by multiple spectrographs [34] or by using an
optical switch routing light from multiple channels to a
spectrograph [35]. An alternative approach to multi-
channel SPR sensing with wavelength modulation is
the wavelength division multiplexing (WDM). In the
WDMSPR sensors, SPR spectra from multiple chan-
nels are encoded in diVerent wavelength regions of a
single polychromatic light beam. This is accomplished
by changing the angle of incidence of the incident light
beam (Fig. 4A) or by a dielectric overlayer deposited
over a part of the SPR-active surface (Fig. 4B).
Multichannel sensors based on SPP spectroscopy
have been also realized using diVraction grating cou-
plers. These include an SPR compact disk platform
employing a rotating sensor chip [36] and an HTS Bio-
systems SPR sensor in which SPR signal for each chan-
nel is determined from an angular reXectivity spectrum
acquired by sequential angular scanning of SPR images
















Fig. 3. SPR sensor with four parallel sensing channels (provided by
S. Löfås, Biacore AB).
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[37]. Another approach to multichannel SPR sensing is
based on SPP spectroscopy on a two-dimensional array
of diVraction gratings, where SPR angular spectra are
sequentially scanned from rows of diVraction grating
[38]. Mass production of diVraction grating-based SPR
chips from plastics by technologies such as hot emboss-
ing or injection molding [39] oVers potentially low-cost
sensing elements [40] Fig. 5.
3.2. Spatially controlled immobilization for multichannel 
SPR sensors
Various types of biomolecular recognition elements
(antibodies [41], aptamers [42], peptides [43], and molec-
ularly imprinted polymers [44], etc.) have been used in
aYnity biosensors. To enable multi-analyte detection,
multiple biomolecular elements targeted to diVerent ana-
lytes need to be immobilized in diVerent sensing chan-
nels. This task requires the development of spatially
controlled procedures for reproducible attachment of
deWned concentrations of biomolecular recognition ele-
ments on the surface of a sensor chip, Fig. 6. Other
important requirements that these immobilization pro-
cedures have to fulWll are the conservation of biological
activity of immobilized biomolecular recognition ele-
ments, non-fouling background of the sensor chip sur-
face and the possibility to regenerate the biomolecular
recognition elements (i.e., break their complex with the
analyte molecules and make them available for another
use).
In general, methods for immobilization of biomolecu-
lar recognition elements on gold Wlms exploit physico-
chemical interactions such as chemisorptions [45],
covalent binding [46,47], electrostatic coupling [48], and
high-aYnity molecular linkers in multilayer systems (e.g.,
streptavidin–biotin [49,50], proteins A or G [51], and
complementary oligonucleotides [52]) and photo-immo-
bilization (e.g., albumin derivatized with aryldiaziridines
as a photo-linker [53]). One of the most remarkable
techniques in surface chemistry is the spontaneous self-
organization of n-alkylthiols or disulWdes on gold into
well-ordered arrays. Self-assembled monolayers (SAMs)
have been employed in many immobilization methods
for spatially controlled attachment of biomolecular rec-
ognition elements to surfaces of sensors [54]. To provide
a desired surface concentration of biomolecular recogni-
tion elements on gold, mixed SAMs of long-chained
(n D 12 and higher) n-alkylthiols terminated with func-
tional group for further attachment of biomolecular rec-
ognition elements and short-chained alkylthiols for a
non-fouling background have been developed [55,56].
To deliver molecular recognition elements to diVerent
areas of the SPR sensor surface, the immobilization
chemistry needs to be spatially controlled. Most of the
Fig. 4. SPR dual-channel sensors based on wavelength division multi-
plexing (WDM) of sensing channels. (A) WDM of sensing channels by
means of altered angles of incidence [28]. (B) WDM of sensing chan-
nels by means of a high refractive index overlayer [29].
Polychromatic
radiation Prism coupler

























Fig. 5. Multi-channel SPR sensor based on an array of diVraction grat-
ings [38]. Fig. 6. Concept of multi-channel SPR biosensor.
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current technologies of proteins arrays are based on the
surfaces and formats that were earlier developed for
DNA arrays. However, the chemical aspects of DNA
array surfaces could not be easily adopted since proteins
are chemically and structurally considerably more com-
plex than nucleic acids and in contrast to DNA, they
easily lose their biological activity due to denaturation,
dehydration, or oxidation [57]. Most DNA array pro-
duction techniques were developed for glass supports,
but they can be tailored to noble metal surfaces with
appropriate immobilization chemistries. Combination of
SAMs with covalent coupling of biomolecular recogni-
tion elements or non-covalent streptavidin–biotin sys-
tem as a linker for attachment of biotinylated
biomolecular recognition elements are most frequently
used approaches to development of protein arrays on
gold.
Shumaker-Parry et al. [58] demonstrated microspot-
ting double-stranded DNA on gold for SPR micros-
copy using two approaches. Both methods use
streptavidin and biotinylated oligonucleotides. In the
Wrst method, the robotic microspotter was used to
deliver nanoliter droplets of dsDNAs onto a uniform
layer of streptavidin. In the second method, a streptavi-
din layer was also microspotted on a mixed-alkylthiol
SAM and, subsequently, microspots of dsDNA were
added using microspotting. Self-assembly surface
chemistry and photopatterning have been combined to
develop robust DNA and peptide arrays [59]. In the
Wrst step, a monolayer of 11-mercaptoundecylamine
(MUAM) was assembled on gold surface. This amine-
terminated surface was reacted with 9-Xuorenylmeth-
oxycarbonyl (Fmoc). Then, UV light was used to break
the gold-thiol bonds and create bare gold pads, which
were subsequently Wlled with MUAM. DNA or pep-
tides were then attached to the MUAM using a cova-
lent multi-step chemistry [59]. Finally, the Fmoc was
removed and replaced with a polyethylene derivative to
prevent non-speciWc binding. Another approach to the
patterning of DNA or proteins on gold is based on
microXuidic networks [60]. First, a set of parallel
microchannels from poly(dimethylsiloxane) (PDMS)
was created by replication of a silicon master prepared
photolithographically. PDMS microchannels were
used either to fabricate 1-D arrays consisting of lines
of immobilized ligands or to create 2-D arrays in which
a second set of PDMS microchannels was placed per-
pendicular to a 1-D line array. To create 1-D line
arrays, the microchannels were attached to a gold sur-
face modiWed with MUAM and activating reagents
were introduced into the microchannels. Then, the
DNA or peptides were reacted to the activated func-
tional groups on MUAM. Subsequently, the micro-
channels were removed and the non-speciWc
background was formed using polyethyleneglycol
derivatives. Another approach is based on microcon-
tact printing (CP) which uses the relief pattern on the
surface of an elastomeric PDMS stamp to form pat-
terns on the sensor surface [61]. Various structures
have been created on gold using CP including pat-
terned SAMs [62], proteins [63] or cells [64]. Peptide
arrays have been formed using CP onto reactive
SAMs [65].
4. Multichannel SPR sensor with spectral modulation and 
wavelength division multiplexing
4.1. WDMSPR sensor
In this paper, we demonstrate multi-analyte detection
using a recently developed eight-channel WDMSPR sen-
sor [66]. This sensor is based on a special multireXection
element in which a collimated beam of polychromatic
light is made incident on the SPR sensor surface under
two slightly diVerent angles of incidence (Fig. 4A). Upon
the Wrst incidence on the surface of the sensor (channel
A), light excites an SPP at the outer metal surface at the
wavelength A. The excitation of the SPPs produces a
sharp absorption dip in the spectrum of optical wave cen-
tered at the wavelength A. The reXected light is redi-
rected inside the element and made incident on the metal
Wlm in the second region (channel B) under a diVerent
angle of incidence  (<). At this angle of incidence, the
optical wave couples to an SPP at a longer wavelength B
(B >A) generating a dip in the spectrum of the optical
wave centered at the wavelength B. Consequently, the
wavelength spectrum of the transmitted light exhibits two
SPR dips corresponding to SPRs in two distinct areas of
the metal Wlm, Fig. 7. These areas form two independent
sensing channels. Response of each channel is encoded
into a shift in the position of respective SPR dip.
The WDMSPR system reported herein combines the
wavelength division multiplexing of pairs of sensing
Fig. 7. ReXectivity in the WDMSPR sensing element as a function of
wavelength. Sensing element—SF14 glass, metal layer–gold, thickness
–55 nm, dielectric–aqueous medium, angles of incidence  D 54.6° and
 D 52.5°.
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channel with four parallel light beams to provide the
total of eight sensing channels, Fig. 8. In the developed
prototype of the sensor, polychromatic light from a
halogen lamp (Avalight-Hal from Avantes, Nether-
lands) was coupled into an optical Wber (FT-400-EMT
from Thorlabs, USA) and collimated using two
cylindrical lenses. The collimated light beam was polar-
ized by a dichroic polarizer (Polarcor, USA) and cou-
pled in the WDMSPR sensing element to which a
sensor chip (SF14 glass slide) coated by an adhesion
promoting chromium layer (thickness less than 2 nm)
and SPR-active gold layer (thickness 55 nm) was
attached. The light was made incident on the SPR-
active surface in eight areas denoted as A1–A4 and B1–
B4, Fig. 8. Light beams reXected at the sensing areas
A1–A4 and B1–B4 were collected by four miniature
GRIN lenses (NSG America, USA) and coupled to
four optical Wbers FT-400-EMT (Thorlabs, USA)
connected to a four-channel spectrograph S2000
(Ocean Optics, USA). The SPR spectra were measured
in TM polarization and normalized with spectra
obtained in TE polarization. Measured SPR spectra
were averaged in time and the SPR dip position was
determined by the 5th-order polynomial Wtting and
tracked over time for each sensing channel. An eight-
channel Xow-cell was clamped against the SPR chip to
contain liquid samples during experiments. The Xow-
cell was made of an acrylic substrate with input and
output ports interfacing Xow-cell chambers for each
sensing channel. The Xow-cell chambers were cut into a
gasket made of a 50-micrometer thick polyurethane
sheet using a CO2 laser beam (custom made by Micron-
ics, USA). The volume of each Xow-cell chamber was
2 l. Input Xow-cell ports were connected via tubings
(Upchurch ScientiWc, USA) with two four-channel
peristaltic pumps Reglo Digital (Ismatec, Switzerland)
which controlled the Xow of liquid samples through the
Xow-cell. In the reported experiments, the Xow rate of
50 l/min was used.
4.2. Materials
Antibody solutions were prepared in 10 mM phos-
phate buVer (PB), pH 7.6, at 20 °C. Analyte solutions
were prepared in PBS (10 mM phosphate buVer, 137 mM
NaCl, and 2.7 mM KCl, pH 7.4, at 20°C) containing
bovine serum albumin at a concentration of 100g/ml.
Bovine serum albumin (BSA) was purchased from
Sigma–Aldrich, USA. The C11-chained and C16-chained
alkanethiols (C11-mercapto-1-undecanol and C16-merca-
ptohexadecanoic acid) and the N,N,N,N-tetramethyl-
O-(N-succinimidyl)uronium tetraXuoroborate (TSTU)
used for activation of carboxylic terminal groups on C16
alkanethiol were purchased from Sigma–Aldrich, USA.
Monoclonal aYnity-puriWed antibodies against human
immunoglobulin E (aIgE), human immunoglobulin G
(aIgG), human choriogonadotropin (ahCG), and horse-
radish peroxidase (aPx) were purchased from Seva
Immuno, Czech Republic. Human immunoglobulin E
(IgE) was purchased from Biodesign, USA, human
immunoglobulin G (IgG) was obtained from the Faculty
of Sciences of the Charles University (Laboratory of
Anthropology and Human Genetics), Czech Republic,
human choriogonadotropin (hCG) was purchased from
Calbiochem, USA, and horseradish peroxidase (Px)
from Kem-En-Tec, Denmark. Immune reaction activi-
ties of all immune partners were conWrmed by ELISA
method.
4.3. Chip functionalization
The functionalized method used in this work is based
on thiol-attachment chemistry and spatially controlled
delivery of antibodies using microXuidics. Prior to func-
tionalization, sensor chips were rinsed with Piranha
solution (a 1:3 mixture of 30% hydrogen peroxide and
96% sulfuric acid) for 3 min, then washed with deionized
water and dried with nitrogen stream. A 7:3 mixture of
Fig. 8. An eight-channel SPR sensor combining parallel architecture
with the wavelength division multiplexing of serially ordered channels.
Fig. 9. SPR wavelength change due to the immobilization of aPx, aIgE,
ahCG, and aIgG antibodies, antibody concentration—50 g/ml.
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C11-chained and C16-chained alkanethiols was dissolved
in degassed absolute ethanol with a total thiol concen-
tration of 1 mM. The C16 alkanethiols terminated with a
carboxylic head group were used to anchor an antibody;
C11 alkanethiol chains terminated with a hydroxyl head
group were used to form a non-fouling background.
Sensor chips were immersed in a thiol solution and
stored in a dark place at room temperature for two days.
After the formation of a thiol self-assembled monolayer
(SAM), the sensor chips were rinsed with ethanol, dried
with nitrogen, rinsed with water, and dried with nitrogen
again. The carboxylic terminal groups on the sensor sur-
face were activated by TSTU dissolved in dimethylform-
amide at a concentration of 1 mg/ml for 4 h. After the
activation, the sensor chip was rinsed with water, dried
with nitrogen, and loaded into the SPR instrument.
Antibody attachment was performed in situ by Xowing
phosphate buVer solution with 50 g/ml of antibody
along a sensing channel surface for 15 min (Xow rate
50 l/min). SpeciWcally, identical solutions containing
aPx, aIgE, ahCG, and aIgG were Xowed through pairs
of sensing channels A1 and B1, A2 and B2, A3 and B3,
and A4 and B4, respectively. Then, the antibody solu-
tions were replaced with a phosphate buVer solution
containing natrium chloride at a concentration of 1 M,
which was Xowed through all channels to remove weakly
bound antibodies. The immobilization of the aPx, aIgE,
ahCG, and aIgG antibodies on the thiol-coated SPR
sensing surface was observed using the SPR sensor sys-
tem described in Section 4.1. Fig. 9 shows the sensor
response to the immobilization of antibodies in the sens-
ing channels B1–B4. The sensor response to antibodies
ranges from 9 to 23 nm. This diVerence is believed to be
mainly due to diVerent accessibilities of amino groups
Fig. 10. IgE sensorgrams for solutions containing only IgE (channel
B2) and the mixture of analytes (channel A2).
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Fig. 11. Sensor response as a function of analyte concentration for Px, IgE, hCG, and IgG measured in pure buVer and mixture of all analytes.
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for each type of antibody and electrostatic interaction
between the antibody and the surface. Finally, the sensor
surface was Xushed with BSA dissolved in PBS to inter-
act with the unreacted carboxylic groups.
4.4. Multi-analyte detection
The SPR chip coated with aPx, aIgE, ahCG, and
aIgG antibodies was used for simultaneous detection of
model analytes—Px, IgE, hCG, and IgG. Detection of
these analytes was performed in solutions containing
only a single analyte and in mixtures containing Px, IgE,
hCG, and IgG. First, buVer (BSA-PBS) was Xowed
through all eight sensing channels until a stable sensor
response was reached. Then, the mixture of Px, IgE,
hCG, and IgG was Xowed through the sensing channels
A1–A4 for 15 min. Simultaneously, four solutions con-
taining only the analyte corresponding to the immobi-
lized antibody at the concentration identical to the one
in the mixtures were injected into the sensing channels
B1–B4. After the incubation for 15 min, these samples
were replaced with buVer. This procedure was performed
sequentially with solutions containing Px, hCG, IgG,
and IgE at concentrations of 0.2, 0.5, 0.2, and 0.05 g/ml
(MIX 1); 0.5, 1, 0.5, and 0.1 g/ml (MIX 2); 1, 2, 1, and
0.5g/ml (MIX 3); 2, 3, 2, and 1 g/ml (MIX 4); and 5, 5,
5, and 2 g/ml (MIX 5), respectively. Typical sensor-
grams for samples containing only a single analyte and
in mixtures of analytes are shown in Fig. 10.
The sensor response to an increasing concentration of
pure analytes and analytes in mixtures was simulta-
neously measured. The sensor response was determined
as a diVerence in the resonant wavelength in buVer
before and after the incubation of the sensor surface
with samples. The resulting sensor responses as a func-
tion of concentration of analyte are shown in Fig. 11.
The reproducibility of the measurements was evaluated
in repeated experiments and found to be within § 10% of
the sensor response for Px, hCG, and IgG and § 5% of
the sensor response for IgE. The diVerence in the sensor
response to the same concentration of target analyte in
the absence and in the presence of other analytes was
found to fall within 18%. Moreover, it was observed that
the sensor response to analyte in a mixture was usually
higher than that corresponding to a pure sample con-
taining only analyte.
To investigate the speciWcity of studied biomolecular
interactions, the sensor responses to non-target and tar-
get analytes were compared. The non-target analytes fol-
lowed with the target analyte were sequentially Xowed
Fig. 12. Sensor response to target analytes injected after a sequence of non-target analytes (A1–A4) and sensor response to speciWc analytes without
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through the sensing channels A1–A4. Simultaneously,
solutions with only a speciWc analyte were Xowed
through the sensing channels B1–B4. The same experi-
ment was performed for lower and higher concentra-
tions of analyte molecules. Corresponding sensorgrams
for low and high concentrations are shown in Figs. 12
and 13, respectively. Concentrations of Px, IgE, hCG
and IgG were 0.5, 0.1, 0.5, and 0.5 g/ml, and 5, 2, 2, and
5  g/ml for low and high concentrations, respectively.
As follows from Fig. 12, the low concentrations of
non-target analytes generated basically no response (less
than 0.07 nm) and the subsequent response to the target
analytes produced sensor response of 0.25, 0.30, 0.10, and
0.54 nm for Px, IgE, hCG, and IgG, respectively. These
values agree well with the sensor responses to samples
containing only a target analyte observed in the sensing
channels not in contact with the non-target analytes,
which were found to be 0.30, 0.30, 0.10, and 0.56 nm for
Px, IgE, hCG, and IgG, respectively. High analyte con-
centrations produced non-speciWc sensor responses of
about 0.1, 0.17, 0.03, and 0.22 nm, on aPx, aIgE, ahCG,
and aIgG-coated surfaces, respectively. The subsequent
binding of the target analyte produced sensor responses
of about 0.62, 4.10, 0.24, and 1.00 nm for Px, IgE, hCG,
and IgG, respectively. As follows from the experimental
data, majority of the non-speciWc binding was reversible
(Fig. 13) and the observed non-speciWc response was
about 16, 3, 13, and 22% of the speciWc response to Px,
IgE, hCG, and IgG, respectively. Responses to the same
concentrations of pure analytes incubated with sensing
surfaces unexposed to other analytes were found to be
0.65, 4.3, 0.27, and 1.01 nm for Px, IgE, hCG, and IgG,
respectively; Fig. 13.
The ultimate lowest detection limits of the sensor for
the model analytes were estimated based on the accuracy
of measuring the SPR wavelength that is deWned as three
standard deviations of sensor response noise and was
equal to 0.03 nm for the used WDMSPR sensor system.
In pure samples, the ultimate detection limits were 60,
10, 150, and 30 ng/ml for Px, IgE, hCG, and IgG, respec-
tively. Detection of low concentrations of analytes in
mixtures was limited by the non-speciWc binding and
determined to be 200, 600, 300, and 200 ng/ml, Px, IgE,
hCG, and IgG, respectively.
5. Outlook
A number of surface plasmon resonance (SPR) sensor
platforms and attachment/patterning methods suitable
Fig. 13. Sensor response to a target analyte injected after a sequence of non-target analytes (A1–A4) and directly (channels B1–B4), concentrations of
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for multi-analyte detection have been proposed over the
last decade. So far, the majority of demonstrated SPR
multi-sensors have been able to detect simultaneously
only a limited number of analytes. However, further
advances in development of biomolecular recognition
element arrays and microXuidics for both patterning and
sample distribution are expected to lead to SPR systems
capable of observing and quantifying tens and hundreds
of biomolecular interactions in near future. Implementa-
tions of such multi-analyte sensors will be driven by the
needs of speciWc applications. The main application
areas include pharmaceutical research (high-throughput
systems for drug screening), medical diagnostics (high-
throughput diagnostic tools), food safety (systems for
rapid detection of foodborne pathogens and agents), and
security (devices for early detection and identiWcation of
biological and chemical warfare agents).
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Abstract
We report a new high-throughput surface plasmon resonance (SPR) sensor based on combination of SPR imaging with polarization contrast
and a spatially patterned multilayer SPR structure. We demonstrate that this approach offers numerous advantageous features including
high-contrast SPR images suitable for automated computer analysis, minimum crosstalk between neighboring sensing channels and inherent
compensation for light level fluctuations. Applications of a laboratory prototype of the high-throughput SPR sensor with 108 sensing channels
for refractometry and biosensing are described. In refractometric experiments, the noise-limited refractive index resolution of the system has
been established to be 3× 10−6 refractive index unit (RIU). Experimental data on detection of human choriogonadotropin (hCG) suggest that
in conjunction with monoclonal antibodies against hCG, the reported SPR imaging sensor is capable of detecting hCG at concentrations lower
than 500 ng/ml.
© 2004 Elsevier B.V. All rights reserved.
Keywords:Surface plasmon resonance; SPR imaging; Biosensor; High-throughput screening
1. Introduction
High-throughput chemical sensor and biosensor technolo-
gies are needed in many important areas such as life sci-
ences, drug development, medical diagnostics, food safety
and security. Optical sensors based on surface plasmon reso-
nance (SPR) have been demonstrated to be useful for affinity
biosensing and biomolecular interaction analysis (Rich and
Myszka, 2002; Homola, 2003) and to hold major potential for
applications in these areas. However, the majority of existing
SPR sensing devices offer only a small number of sensing
channels (<10) and thus their throughput is rather limited.
Therefore, in recent years we have witnessed growing ef-
fort towards development of high-throughput SPR sensing
devices.
In traditional multichannel SPR sensors, surface plasmons
are excited in multiple areas and spectral (Nenninger et al.,
1998) or angular (Löfås et al., 1991) distribution of reflected
∗ Corresponding author. Tel.: +420 266 773 448; fax: +420 284 680 222.
E-mail address:homola@ure.cas.cz (J. Homola).
light is analyzed using separate detectors (Nenninger et al.,
1998) or different areas of single detector (Löfås et al., 1991).
The number of sensing channels in spectral SPR sensors can
be further increased by using the wavelength division multi-
plexing (WDM) technique in which surface plasmons in dif-
ferent sensing channels are excited at different wavelengths
(Homola et al., 1999, 2001). A larger number of sensing chan-
nels can be achieved using SPR imaging which is based on
analysis of distribution of intensity of light reflected from
an SPR surface containing multiple sensing areas. Spatially
resolved SPR sensing was introduced byRothenḧausler and
Knoll (1988)who demonstrated SPR microscopy with high
contrast for measurements of ultrathin films. Although mul-
tichannel sensors based on SPR imaging provide lower res-
olutions than the systems based on spectroscopy of surface
plasmons, the SPR imaging systems have been successfully
applied for analysis of polymer networks and monitoring of
thin films formation and electropolymerization (Baba and
Knoll, 2003). SPR imaging has been also applied to studies
of oligonucleotide (Piscevic et al., 1995) and RNA hybridiza-
tion (Nelson et al., 2001), and DNA interaction with polymer
0956-5663/$ – see front matter © 2004 Elsevier B.V. All rights reserved.
doi:10.1016/j.bios.2004.09.025
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functionalized surfaces (Bassil et al., 2003). DNA hybridiza-
tion signal was amplified by the use of biotinylated oligonu-
cleotides and subsequent binding of streptavidin to biotin to
enhance the detection limits with SPR imaging (Jordan et al.,
1997). SPR imaging has been also exploited to study protein
binding to a DNA array (Shumaker-Parry et al., 2004) and
antigen–antibody interactions (Wegner et al., 2003). Detec-
tion of small molecules and observation of their interactions
still remain beyond capabilities of the SPR imaging systems.
In this paper, we report a new high-throughput SPR sensor
based on the combination of SPR imaging with polarization
contrast and a spatially patterned multilayer SPR structure.
This approach offers several significant advantages over
conventional SPR imaging. These include generation of
high-contrast SPR images suitable for automated computer
analysis, minimization of crosstalk between neighboring
sensing channels and compensation for light level fluctu-
ations. Applications of the sensor for refractometry and
biosensing are also described.
2. Sensor concept
2.1. SPR imaging
Surface plasmon resonance imaging is an experimen-
tal method for spatially resolved measurement of refrac-
tive index changes at an SPR-active metal surface. Conven-
tional SPR imaging instruments (Steinerg et al., 1999) utilize
the Kretschmann geometry of the attenuated total reflection
(ATR) method (Raether, 1988), in which a collimated beam
of monochromatic light passes through a prism coupler with
a thin SPR-active metal layer on its base. The light evanes-
cently penetrates through the metal film and excites surface
plasmons at its outer boundary. Intensity of the reflected light
depends on the strength of the coupling of light to a surface
plasmon, which depends on the refractive index at the metal
surface. Therefore, spatial distribution of the refractive index
at the SPR-active surface can be determined by measuring
the distribution of light intensity across the reflected beam by
means of a two-dimensional detector array. An SPR imaging
device can be used as a multichannel SPR sensor if the sur-
face is divided into multiple sensing spots. The smallest spot
from which the SPR signal can be read is in principle given
by the surface area imaged on an individual pixel of the de-
tector array. However, the spatial resolution is limited by the
propagation length of surface plasmons, which is typically
of the order of tens of microns (Somekh, 2002) and the reso-
lution of the imaging optics (interferences from neighboring
sensing spots).
2.2. SPR imaging using polarization contrast and
special SPR multilayer structures
As demonstrated earlier, the surface plasmon resonance
phenomenon can be efficiently observed in the polarization
Fig. 1. (a) SPR imaging with polarization contrast and (b) detail of the SPR
chip with series of pairs of sensing spots.
contrast (Homola and Yee, 1998; Nikitin et al., 2000). In this
geometry, a prism coupler and a chip is placed between two
crossed polarizers and a quarter waveplate. In the imaging
approach proposed herein, the surface of the sensing chip is
not uniformly covered with an SPR-active layer, but with a
pattern of distinct SPR sensing spots separated by uncoated
areas (bare glass), where the light reflects totally without be-
ing influenced by SPR. The first polarizer allocates the same
amount of light intensity to both TE and TM polarizations.
After the reflection on the sensor chip, the light passes through
the quarter waveplate. The polarization of the light reflected
from the uncoated surface areas is converted to linear and ex-
tinguished by the linear polarizer placed between the wave-
plate and the CCD camera (Fig. 1). The TM-polarized light
component interacting with a surface plasmon on the coated
sensor spot undergoes both amplitude and phase change,
while the phase and amplitude of the TE-polarization varies
only slightly. This effect gives rise to bright sensing spots
on a weak background, which are easier to read than images
produced by conventional SPR imaging systems. Moreover,
it reduces crosstalk between neighboring sensing spots and
interference of light not associated with the measured quan-
tity.
In this work, we introduce two different SPR multilayers
designed to support surface plasmons and exhibit opposite
sensitivities to changes in refractive index at the surface. Both
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Fig. 2. Dependence of light intensity on the refractive index of sample for
the two different sensing spots and their ratio. Intensity at bare surface (dark
signal) shown for comparison.
the SPR multilayers are formed on SF2 glass substrate and
consist of a chromium layer, an aluminum oxide buffer layer,
and an SPR-active gold layer (Fig. 1). Theoretical analysis
of light propagation in the multilayer structures in the polar-
ization contrast geometry was performed using the Fresnel
equations and Jones matrix calculus (Saleh and Teich, 1991)
and parameters of the multilayer structures for the SPR imag-
ing system were selected so that the two multilayers exhibited
refractive index sensitivities of opposite signs. The first mul-
tilayer (Spot type I) consists of 4 nm chromium layer, 100 nm
aluminum oxide buffer layer and 40 nm SPR active gold layer
and as follows fromFig. 2, it exhibits dependence of transmit-
ted light on the refractive index typical for conventional SPR
structures in polarization contrast (Homola and Yee, 1998);
the polarization change is small for refractive indices below
the resonance and increases with the refractive index of sam-
ple. The second multilayer (Spot type II) consisting of 14 nm
chromium layer, 100 nm aluminum oxide buffer layer, and
40 nm SPR-active gold layer employs a thicker chromium
layer that acts as a TE–TM phase retarder altering the light
polarization and thus increasing intensity of transmitted light
in the lower refractive index region. An additional phase shift
induced by the SPR decreases the total polarization change
and the intensity measured in the polarization contrast system
drops. An aluminum oxide buffer layer is used to separate the
highly absorbing chromium film from the SPR-active gold
layer to reduce the surface plasmon attenuation.
Fig. 2shows the theoretical dependence of the output light
intensity in the polarization contrast mode for the two sens-
ing Spot types I and II as a function of refractive index at
the surface. The output light intensity for chip area without
any layers is shown for comparison. As follows fromFig. 2,
within the expected operating refractive index range of the
sensor (1.33–1.37), the intensity of light associated with the
Spot type I increases with the refractive index, while the in-
tensity of light associated with the Spot type II decreases with
the refractive index. The ratio of these intensities increases
with the refractive index and is more sensitive to refractive
index than the intensities themselves. In addition, the ratio of
light intensities is independent of the intensity of illumina-
tion and thus can be used to suppress adverse effects of light
source fluctuations on the SPR imaging measurements.
3. Experimental
3.1. Sensor system
A laboratory prototype of the SPR imaging sensor was
constructed using a diode laser (SDL-7501-G1, SDL, Inc.,
USA) emitting at the wavelength of 633 nm, a 1024× 1024
pixel CCD detector (DV–434, Andor Technology, Ireland),
an SF2 glass optical prism and a sensor chip matched to the
prism via a refractive index matching fluid. SPR active spots
were formed on the SF2 glass chips using vacuum evapo-
ration through a micro-fabricated mask. The mask was cut
by a high-power laser into a 200m thick stainless steel foil
with precision of 20m (Micronics Inc., USA). The chips
support 216 sensing spots (dimensions: 400m× 800m)
providing a total of 108 sensing channels. The chip was in-
terfaced with a flow-cell consisting of an acrylic manifold
and a thin Mylar gasket with holes forming chambers con-
fining liquid samples in 10 columns of sensing channels (the
first and last columns contained six pairs of sensing spots
each, the eight central columns contained 12 pairs of sensing
spots each). The flow-cell can be used repeatedly—used My-
lar gaskets are removed, the acrylic manifold is cleaned with
sodium hydroxide solution and new Mylar gaskets are at-
tached to the manifold. Each flow-cell chamber was 2.2 mm
wide and 12 mm long. The depth of the flow-cell chamber
was 70m (50m thick Mylar sheet plus 20m thick ad-
hesive layer). The flow-cell geometry and flow rate were se-
lected based on the theoretical analysis of diffusion limits of
molecular binding based on a two-compartment mass trans-
port model (Myszka et al., 1998). For a flow rate of 50l/min,
the time necessary for the liquid sample to pass one measur-
ing spot is about 0.25 s which together with the diffusion
coefficient for the investigated biomolecule (human chori-
ogonadotropin, hCG) translated to the transfer coefficient of
about 10−5 ms−1. Under these conditions, the binding ki-
netics is reaction-limited unless the association rate constant
exceeds 2× 10−5 M−1 s−1 which is not the case for the hCG
antigen/antibody pair used in this work as a model system. A
peristaltic pump Reglo (Ismatec SA., Switzerland) was used
for sample injection.
Fig. 3a shows a typical image of the array of sensing spots
obtained in the polarization contrast mode. As expected, sens-
ing spots produce a high intensity signal while the uncoated
areas produce very weak background signal. Although the
observed sensing spots are of approximately the same di-
mensions and regularly distributed, a permanent mapping of
sensing spots on the CCD detector pixels makes the system
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Fig. 3. Dependence of light intensity on the sample refractive index. (a)
Image of the SPR sensing chip for rows of sensing spots exposed to different
refractive indices; (b) resulting calibration curves for two different types of
sensing spots.
rather susceptible to small errors in system alignment and
chip to chip variability. Therefore, we developed a computer
routine for automatic mapping of the sensing spots. This rou-
tine uses one spot with operator-defined borders as a mask
and calculates the correlation of this spot with the whole
image. The correlation image shows sharp peaks reaching
maxima in locations where the mask overlaps precisely with
another sensing spot. The coordinates of the CCD pixels of
maximum correlation are recorded and the areas of the CCD
used for intensity averaging for each sensing spot are defined
around these locations. This method allows selecting zones
of signal readout identically for all measuring spots, and for
measurements on different SPR chips. In the performed ex-
periments, detected light intensity was averaged across the
central part of each measuring spot (typically 250 CCD pix-
els per channel). Transmitted light intensity was normalized
in pairs of measuring channels and calibrated using experi-
mental refractometric calibration data. The automated chan-
nel mapping based on the auto-correlated image analysis was
found to be a fast, reproducible and robust technique inde-
pendent of illumination fluctuations across different sensing
spots. Unlike other object recognition approaches, this ap-
proach is also insensitive to parasitic bright features in the im-
age originating from imaging imperfections and chip surface
defects.
Control experiments were performed using a dual-channel
sensor based on spectroscopy of surface plasmons (Plasmon
II) (Homola et al., 2002). In the Plasmon II system, a colli-
mated beam of polychromatic light is used to excite surface
plasmons via the attenuated total reflection in a prism coupler.
The light reflected from two separate areas of the SPR-active
surface is coupled into a dual-channel spectrograph and spec-
tral position of SPR dip in each channel is measured. The
Plasmon II instrument provides a refractive index change as
low as 10−7 RIU. The flow-cell concept used in Plasmon II
is the same as that used in the imaging system described in
earlier in this Section. It consists of an acrylic manifold and
a Mylar gasket forming two flow chambers, each 3 mm wide
and 10 mm long. The depth of the flow-cell determined by the
thickness of the Mylar gasket was also 70m, thereby pro-
viding similar hydrodynamic conditions for the interaction
between free biomolecules in solution and their biospecific
partner immobilized on sensor surface as the flow-cell used
in the SPR imaging system.
3.2. Reagents
Solutions were prepared in phosphate-buffered physi-
ological saline (PBS, 10 mM phosphate buffer, 137 mM
NaCl, 2.9 mM KCl, pH 7.4 at 20◦C). Bovine serum albu-
min (BSA) was purchased from Sigma-Aldrich, USA. The
C11-mercapto-1-undecanol (C11OH) and C16-mercaptohexa-
decanoic acid (C16COOH) and theN,N,N′,N′-tetramethyl-
O-(N-succinimidyl)uronium tetrafluoroborate (TSTU) used
for activation of the COOH groups were purchased from
Sigma-Aldrich, USA. Monoclonal affinity-purified antibody
against human choriogonadotropin (a-hCG) was purchased
from Seva Immuno Ltd., Czech Republic. Human choriogo-
nadotropin was obtained from Calbiochem, USA. Prior SPR
biosensing experiments, antibody activity was confirmed by
ELISA.
3.3. Preparation of biomolecular coatings
To prepare SPR chips for attachment of antibodies, the
chips were soaked in Piranha solution (1:3 mixture of 30%
hydrogen peroxide and sulfuric acid) for 3 min, then washed
with deionized water and dried with nitrogen stream. A 7:3
mixture of C11OH and C16COOH alkanethiols was dissolved
in absolute ethanol with a total thiol concentration of 1 mM.
The C16COOH was used to anchor an antibody; C11OH alka-
nethiol was used to form a stable non-fouling background.
Sensor chips were immersed in thiol solution and stored in
a dark place at room temperature for 12 h. Then, the chips
were rinsed with ethanol, dried with nitrogen, rinsed with
water and dried with nitrogen again. The carboxylic terminal
groups on the sensor surface were activated by TSTU dis-
solved in dimethylformamide with concentration of 1 mg/ml
for 4 h (Wilchek et al., 1994). After activation, the chips
were rinsed with water, dried with nitrogen and mounted
into SPR instrument. Immobilization of a-hCG on activated
thiols was performed in situ by flowing PBS solution with
100g/ml of a-hCG along the sensor surface for 15 min (flow
rate—50l/min). One of the sensing channels was covered
by a BSA layer using similar procedure to form a refer-
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ence surface for monitoring non-specific adsorption (BSA
concentration—1 mg/ml).
3.4. SPR imaging sensor-based refractometry and
biosensing
To quantify the sensor response to bulk refractive index
variations, a series of liquid samples with known refractive
indices (Cargille Labs, USA) were sequentially injected in the
flow-cell and flowed along the sensor surface while the sensor
response was recorded. Each solution was flowed through the
flow-cell for 5 min at a flow rate of 50l/min. SPR-based
detection of human choriogonadotropin consisted of three
steps. In the first step, the baseline response was established
while solution of BSA in PBS was flowed through the flow-
cell. Then, known amounts of hCG were added to the BSA-
PBS solution to produce solutions with hCG concentrations
0.5, 1.0, 5.0, and 10g/ml and these solutions were injected
and flowed through different sensing channels for 15 min.
Finally, the sample was replaced with buffer. Measurements
were performed at a flow rate of 50l/min.
The hCG detection was performed using the SPR imaging
system and the reference experiment was carried out using
the Plasmon II SPR sensor instrument. As the sensitivity
of SPR sensors to surface refractive index changes depends
on the operating wavelength, which is different for the
two SPR sensor systems, the sensor response needs to be
calibrated. To account for difference in surface refractive
index sensitivity and potentially unequal binding capacities
of the bimolecular coatings used in the two sensing systems,
the sensor calibration was established by normalizing
the sensor response to its response to the attachment of
antibodies.
4. Results and discussion
4.1. Refractometry
The sensor response to refractive index changes is illus-
trated inFig. 3. Fig. 3a shows the image of SPR active surface
where each row of sensing channels is brought into contact
with different liquid sample. The image of the reflected light
intensity shows that with increasing refractive index, one of
the spots becomes darker while the other becomes brighter.
The resulting refractive index calibration curves—shown in
Fig. 3b exhibit a good agreement with the simulations pre-
sented inFig. 2. Fig. 4a presents calibration curve determined
as a ratio of intensities associated with the two different types
of sensing spots. Using this calibration curve, the average sen-
sitivity of the ratio of intensities to refractive index was deter-
mined to be 65 RIU−1.Fig. 4b shows results of refractometric
experiments performed simultaneously in five sensing chan-
nels. These data show close agreement between the responses
of different channels and suggest that the channel-to-channel
response variability is less than 4% of the average sensor re-
Fig. 4. (a) Calibration curve of SPR imaging refractometric sensor and (b)
s nsor response to changes in the refractive index observed simultaneously
in five sensing channels.
sponse. Analysis of the baseline noise was also performed
and it was determined that a typical standard deviation of
noise in the intensity ratio is between 2× 10−4 and 3× 10−4
which in terms of refractive index resolution translates to
about 3–5× 10−6 RIU. The individual noise of SPR signal
for sensing Spot types I and II was divided by the respective
experimental sensitivity to refractive index changes yielding
the refractive index resolutions 1.2× 10−5 and 3× 10−5 RIU
for Spot types I and II, respectively. Clearly, the noise of the
ratio of the intensities in Spot types I and II is smaller by a
factor of 5 than the noise of individual intensities which justi-
fies the proposed pairing of the sensing spots. This observed
improvement is mainly due to the fact that besides the photo-
electron statistics (shot noise) (Nenninger et al., 2002), major
sources of noise in this SPR imaging system are laser emis-
sion fluctuations and mechanical vibrations which are highly
correlated across the whole image and therefore their con-
tribution can be minimized by the sensing spot pairing. To
confirm this assumption, we investigated noise correlation
coefficient between sensing Spot types I and II and found
about 90% correlation.
Further noise reduction and resolution improvement could
be achieved through reduction of detector noise. This can be
achieved by increasing averaging either from a larger surface
area (requires lowering the number of sensing channels or
using CCD detectors with a larger number of pixels) or by
sequential acquisition of several CCD images.
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Fig. 5. Detection of different concentrations of hCG using (a) SPR imag-
ing system and (b) dual-channel sensor based on spectroscopy of surface
plasmon (Plasmon II).
4.2. Biosensing
The response of the developed SPR imaging sensor to
different concentrations of hCG is shown inFig. 5a. When
the hCG solution is injected into the sensor flow-cell, fast
increase in the normalized signal occurs. This increase is as-
sociated with the specific binding of hCG to a-hCG molecules
at the sensor surface. After switching back to the BSA solu-
tion, the signal drops slightly and levels off at a lower level.
The difference between this new level and initial baseline is
associated with the amount of bound hCG. For high hCG con-
centrations, the initial fast binding is followed with a slower
binding. This behavior has been observed with this particu-
lar biomolecular pair and may be associated with behavior
beyond the pseudo-first order reaction model (e.g. rebind-
ing) or with the non-specific binding of the hCG to an almost
saturated surface. However, as the hCG–ahCG pair is only
used as a model system illustrating ability of the imaging
system to observe biomolecular interactions, a detailed anal-
ysis of the observed interaction is beyond the scope of this
work. Specific sensor responses observed 15 min after the
injection of hCG, were determined to be 3.2, 5.5, 9.1, and
11.2 relative units (RU) for hCG concentrations 500, 1, 5 and
10g/ml, respectively. Basically no response was observed
in the reference channel, where hCG was flowed at a concen-
tration of 1g/ml. The response of the Plasmon II and the
SPR imaging sensor were recalibrated to identical relative
units by normalizing the hCG antigen response to the sensor
response to a-hCG attachment.
The SPR imaging sensor response agrees well with the
response of the dual-channel Plasmon II sensor system in
which sensor hCG concentrations of 1 and 10g/ml were
detected; the discrepancy in sensor responses is less than 15%
and can be attributed to variations in the surface concentration
of antibodies in different sensing channels and differences in
flow conditions.
These experimental results indicate that the SPR imaging
sensing device is capable of detecting hCG in concentrations
lower than 500 ng/ml. In order to assess sensor response
channel-to-channel variability for affinity biosensing ap-
plications, we applied the same concentration of hCG
(10g/ml) to 12 sensing channels and compared their
responses. All the responses fell within 8% from the average
sensor response. This observed reproducibility is worse
by a factor of 2 than that observed for the refractometric
measurements. It is likely to be due to variations in the
surface concentration of antibodies in different sensing
channels and differences in flow conditions in different areas
across the chip. The ultimate performance is limited by noise
in the sensor response. As follows from comparison of data
in Fig. 5a and b, the SPR imaging system exhibits noise,
which is larger by a factor of 10 than that of its spectroscopic
counterpart. This is mainly due to the fact that the Plasmon
II system is based on spectroscopy of surface plasmons and
therefore exploits 2 orders of magnitude more measurements
to calculate sensor response. The wavelength-modulated
Plasmon II system typically employs 200 intensity values
(determined for different wavelengths) while the SPR
imaging system utilizes two light intensities (corresponding
to the two spots with different SPR multilayers).
5. Conclusions
We report a novel surface plasmon resonance sensor with
over a hundred sensing channels based on the combination
of SPR imaging with polarization contrast and a spatially
patterned multilayer SPR structure. This approach provides
high-contrast SPR images suitable for automated computer
analysis, minimum crosstalk between neighboring sensing
channels and inherent compensation for light level fluctua-
tions. We evaluated the SPR imaging sensor for refractome-
try and determined that the sensor provides a refractive index
resolution better than 5× 10−6 RIU, which presents an im-
provement by a factor of 5 over conventional intensity mea-
surements. Channel-to-channel variability was determined to
be less than 4% of sensor response. In conjunction with mon-
oclonal antibodies against human choriogonadotropin, the
sensor was applied to detection of hCG and demonstrated to
detect hCG levels below 500 ng/ml.
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Abstract8
We report a new multichannel biosensor combining an optical platform based on surface plasmon resonance (SPR) imaging on special multilayers
and polarization contrast with a spatially-resolved functionalization. We demonstrate that the optical platform offers a considerably higher sensitivity
and resolution than the conventional SPR imaging. The spatially-resolved functionalization based on microspotting applied to immobilization of
short oligonucleotides is shown to provide a surface concentration of oligonucleotide probes higher by 80% than the flow-through functionalization
method. The sensor can perform 64 independent measurements simultaneously and its limit of detection (LOD) for 23-mer oligonucleotides was
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1. Introduction18
Monitoring of biomolecular interaction in microarray for-19
mats has been increasingly applied in molecular biology, medi-20
cal research and diagnostics, drug development and food safety.21
A wide range of molecular interactions were utilized in microar-22
rays, including DNA–DNA, protein–protein, protein–DNA,23
protein–peptide or antigen–antibody interactions. Conventional24
methods for readout of microarrays typically require fluorescent25
or other labeling which increases the assay time and costs, and26
can disturb the binding interaction leading to false negatives [1].27
Moreover, fluorescent compounds are invariably hydrophobic,28
which can produce a background signal leading to false positives29
[2]. In order to overcome these limitations, label-free measure-30
ment technologies have been researched worldwide. Optical31
biosensors based on surface plasmon resonance (SPR) present32
an emerging platform for label-free monitoring of biomolecu-33
lar interactions [3]. In the last decade, several approaches to the34
development of high-throughput SPR sensors have been pro-35
posed. They are based either on SPR imaging [4,5], SPR imaging36
in the polarization contrast [6] or spectroscopy of surface plas-37
mons on an array of diffraction gratings [7]. The SPR imaging38
∗ Corresponding author. Tel.: +420 2 66773448; fax: +420 2 84680222.
E-mail address: homola@ure.cas.cz (J. Homola).
sensors were demonstrated to detect short oligonucleotides in 39
concentrations as low as 10 nM [8]. 40
In this paper, we combine a novel SPR biosensor platform 41
based on highly sensitive SPR imaging on special spatially 42
patterned multilayers and polarization contrast with a spatially- 43
resolved functionalization based on microspotting technique to 44
provide a platform for parallelized detection of oligonucleotides. 45
2. SPR platform for parallelized measurements 46
The optical platform used herein is based on the SPR imag- 47
ing of special multilayers in polarization contrast [6]. In this 48
approach, a light wave is made incident on a dielectric substrate 49
supporting two types of special metal-dielectric multilayers 50
(Spots type I and II) (Fig. 1). A monochromatic light (wave- 51
length, 635 nm) polarized with a plane of polarization, oriented 52
at 45◦ with respect to the plane of incidence, is made inci- 53
dent through a dielectric substrate on the boundary supporting 54
metal-dielectric multilayers (Fig. 1). The light incident on the 55
bare dielectric-sample interface undergoes total reflection and 56
is reflected as an elliptically polarized wave. The light inci- 57
dent on the multilayers couples with the surface plasmons at the 58
interface between the gold layer and dielectric sample, which 59
alters both the intensity and polarization of the reflected light 60
wave. Polarization of light reflected from the bare surface is 61
turned into linear by means of a quarter-wave plate with the 62
1 0925-4005/$ – see front matter © 2006 Elsevier B.V. All rights reserved.
2 doi:10.1016/j.snb.2006.09.009
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Fig. 1. Scheme of the SPR imaging sensor surface with surface plasmon on two
types of metal-dielectric multilayers.
polarization axis oriented at 45◦ with respect to the plane of inci-63
dence and the resulting light wave is extinguished by an output64
polarizer (polarizer at the angle of 168◦ with respect to the plane65
of incidence). The light reflected from the multilayers earns a66
phase shift from the quarter-wave plate and passes through the67
output polarizer. The multilayer structures are designed in such68
a way that the intensity of light associated with the Spot type I69
increases with the refractive index of sample, while the intensity70
of light associated with the Spot type II decreases. Therefore, if71
the sensor response is defined as a ratio of the intensities of light72
reflected from the Spots type I and II, the sensitivity is higher73
than the sensitivity for each individual spot. In addition, this74
approach allows eliminating the effect of light level fluctuations75
on the sensor output as the ratio of the intensities is insensitive to76
fluctuations of light occurring in both the areas. The multilayers77
need to be optimized in terms of sensitivity to refractive index78
and complexity/feasibility of fabrication. Based on the results79
of our recent optimization study, we designed a new system of80
multilayers consisting of 3 nm titanium film, 200 nm aluminum81
oxide and 40 nm gold layer (Spot type I) and 12 nm titanium82
film, 200 nm aluminum oxide and 40 nm gold layer (Spot type83
II). Simulated intensity of transmitted light for both the types of84
multilayers and the ratio of the two intensities is shown in Fig. 2.85
The simulations suggest that the dependences of the intensity on86
Fig. 2. Dependence of light intensity on the refractive index of sample for two
different types of sensing spots (lower plot) and their ratio (upper plot).
the refractive index for the two respective spot types intersect 87
close to their maximum slopes (the maximum slopes occur at 88
1.338 RIU for Spot Type I and at 1.332 RIU for Spot type II). 89
Therefore, the interval of maximum slopes of individual inten- 90
sities is associated with the optimum sensor performance and 91
corresponds to the normalized signal close to 1. 92
The sensor sensitivity to bulk refractive index across the oper- 93
ating range of 1.328–1.34 is depicted in Fig. 3. The sensitivity 94
is compared to the sensitivity of the previously reported design 95
[6] and to the sensitivity of TM reflectivity used in the con- 96
ventional SPR imaging. Sensitivities of sensors based on the 97
polarization contrast and metal-dielectric multilayers were cal- 98
culated with the angle of incidence of 61◦ so that the normalized 99
signal of one (optimum sensor operation) is associated with the 100
refractive index of 1.332 RIU. The sensitivity of the conventional 101
SPR imaging was calculated assuming the angle of incidence of 102
60.2◦, at which the reflectivity equal to 1/3 corresponds to the 103
refractive index of 1.332 RIU. As shown in [9], reflectivity equal 104
to 1/3 yields the maximum slope of reflectivity and subsequently 105
the highest sensitivity (gold layer thickness, 53 nm). As follows 106
from Fig. 3, the sensitivity reported increases with the refractive 107
index. This increase in the sensitivity is approximately propor- 108
tional to the increase in the normalized signal. For the normalized 109
signal equal to 1, the sensor exhibits sensitivity of 210 RIU−1 110
which exceeds the sensitivity of the previous SPR sensor with 111
polarization contrast [6] by a factor of 2.5 (at 1.332 RIU) and 112
the sensitivity of the conventional SPR imaging by a factor of 6. 113
There are two contributions to the six-fold increase in sensitiv- 114
ity: (i) the use of opposite slopes improve sensitivity of the ratio 115
by a factor of 2 and (ii) the sensitivity scales with the increase 116
of normalized signal by a factor of 3. 117
In SPR biosensors, the refractive index changes are induced 118
in a very close proximity of the sensor surface. Therefore, the 119
surface sensitivity is typically used to characterize the sensor 120
response to the refractive index or thickness changes within a 121
thin dielectric layer at the sensor surface. The surface sensitiv- 122
ity SS is defined as a change in the sensor response due to a 123
Fig. 3. Sensor sensitivity as a function of refractive index for three SPR sensing
platforms: (1) conventional SPR imaging; (2) SPR imaging sensor with polariza-
tion contrast and chromium-based multilayers; and (3) optimized SPR imaging
sensor with polarization contrast and titanium-based multilayers.
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unit change of refractive index within a dielectric layer of a unit124
thickness. It can be shown that at a fixed wavelength, the surface125
sensitivity of an SPR sensor is proportional to the bulk refractive126
index sensitivity [10]. The sensor response to the change of sur-127
face refractive index was calculated using the Fresnel equations128
yielding SS = 2.2 nm−1 RIU−1 at the normalized signal equal to129
1. The change of the sensor response can be translated to the130
surface coverage of immobilized molecules using the Feijter’s131





where Γ is the surface coverage expressed in molecules per unit135
area, R is the change of normalized sensor signal due to the136
binding, MW is the molecular weight of adsorbed molecules and137
the term ∂n/∂c is the bulk refractive index increment of analyte.138
In this work, the refractive index increment for streptavidin and139
oligonucleotides was assumed to be 0.18 cm3/g [12].140
The sensor consisted of a light source, SPR coupling optics141
and two-dimensional detector array. A collimated laser light142
(wavelength, 635 nm, SDL Inc., USA) passed through polarizer143
and was totally reflected from the SPR coupling prism made144
from SF2 glass. The reflected light traveled through a quarter-145
wave plate and a polarizer and was projected onto a CCD camera146
(Andor Technology, Ireland) by means of telecentric imaging147
optics (Fig. 4). A pattern of alternating sensing Spots type I and148
II was prepared on a glass sensor chip that was optically matched149
to the coupling prism. Prior to the deposition of thin films using150
the electron beam evaporation in vacuum, the chips were cleaned151
in a UV ozone cleaner (Jelight Company Inc., USA). Sensing152
spots (800 m × 400 m) were defined during the evaporation153
using a mask from a 200 m thick stainless steel foil (Micron-154
ics Inc., USA). Spot type I structure consisted of 3 nm titanium155
layer, 200 nm aluminum oxide and 40 nm gold layer; Spot type156
II structure consisted of 12 nm titanium layer, 200 nm aluminum157
oxide and 40 nm gold layer. The digital image acquired from the158
CCD camera every 3–6 s displayed regular matrix of bright sens-159
Fig. 4. Scheme of the SPR imaging setup with polarization contrast and special
multilayers.
Fig. 5. Sensor refractive index calibration. Relative intensities reflected from
Spots type I and II measured for 10 different refractive indices (lower plot)
and the normalized signal as their ratio (upper plot). Simulated data shown for
comparison.
ing spots on a dark background. Experimental results reported 160
below were measured simultaneously in 64 sensing channels 161
(normalized signals were calculated from 128 sensing spots). 162
The flow-cell was attached to the sensor surface to contain a liq- 163
uid sample during the experiments. The sensor surface contained 164
eight separate flow-chambers, each with a volume of 2 l. 165
In order to demonstrate the increased sensitivity of the opti- 166
mized sensing structure, a model refractometric experiment was 167
performed using liquid samples with different refractive indices 168
(Cargille Labs, USA). Measured intensities from the two types 169
of sensing spots and their ratio are depicted in Fig. 5. The 170
experimentally determined sensitivity of the normalized sensor 171
response to refractive index was found to differ from the the- 172
oretical estimate by less 10%. In order to maximize the signal 173
to noise ratio of measured intensities, the utilized CCD detector 174
was operated close to the saturation (the maximum resolvable 175
intensity). Under these conditions, noise of the measured inten- 176
sity is directly proportional to the square root of the intensity. 177
This assumption allows calculating the standard deviation of 178
the normalized signal (the ratio of intensities of Spots type I 179
and II) that together with the sensor sensitivity determine the 180
sensor resolutions. It can be shown that changes in the normal- 181
ized signal from 0.5 to 1 and from 1 to 4.5 (within the operating 182
range of the sensor) are accompanied with an increase of noise 183
by a factor of 1.6 and 7.4, respectively. The same changes of 184
normalized signal correspond to an increase in sensitivity by 185
a factor of 2 and 5.5, respectively. Detailed analysis then indi- 186
cate that the sensor resolution varies across the whole operating 187
range (refractive indices between 1.328 RIU and 1.34 RIU) by 188
less than 25%. This conclusion was confirmed experimentally 189
and an average noise of the sensor response was determined to 190
be (4.5 ± 1) × 10−4. This value translates to a refractive index 191
resolution of (2 ± 0.5) × 10−6 RIU. 192
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3. Spatially-resolved functionalization193
The spatially-resolved functionalization of SPR chips was194
performed using the method combining the microspotting tech-195
nique and the biotin–streptavidin coupling chemistry. In this196
method, streptavidin was covalently attached to an alkanethio-197
late self-assembled monolayer and then the biotinylated oligonu-198
cleotides were coupled to streptavidin [13,14]. A 3:1 mixture of199
C11(EG)2 and C16COOH alkanethiols was dissolved in abso-200
lute ethanol with a total thiol concentration of 1 mM (C11(EG)2201
and C16COOH alkanethiols were from Prochimia, Poland and202
Sigma–Aldrich, USA, respectively). The C16COOH was used203
for the attachment of streptavidin, while C11(EG)2 alkanethi-204
ols were used to form a stable non-fouling background. Sensor205
chips were immersed in thiol solution, heated to 40 ◦C for206
15 min and then stored in a dark place at a room tempera-207
ture for 12 h. Then, the chips were rinsed with ethanol, dried208
with nitrogen, rinsed with deionized water and dried with209
nitrogen again. The carboxylic terminal groups on the sensor210
surface were activated for 2 h in N,N,N′,N′-tetramethyl-O-(N-211
succinimidyl)uronium tetrafluoroborate (TSTU, purchased from212
Sigma–Aldrich, USA) dissolved in dimethylformamide with a213
concentration of 2 mg/ml [15].214
The sensing areas of the chips were coated with streptavidin215
(purchased from Sigma–Aldrich, USA) which was dissolved216
in 10 mM sodium acetate (SA) buffer (pH 5.0 at 20 ◦C) and217
microspotted onto individual sensing channels. Volume of 300 nl218
was found to form a droplet with diameter of 1.3 ± 0.2 mm219
on the SPR chip surface and thus cover a pair of neighboring220
sensing spots. Reproducibility of the volume of the droplets221
formed using this method was estimated using analytical bal-222
ance (Mettler-Toledo, USA) to about 92%. The streptavidin was223
allowed to bind to the alkanethiol monolayer for 60 min and then224
the SPR chips were functionalized with different oligonucleotide225
probes in such a way that each pair of measuring spots was226
coated with one type of probe. The model deoxyribooligonu-227
cleotide probes used in this work included (i) biotin-(TEG)2-228
5′-d(CAG TGT GGA AAA TCT CTA GCA GT)-3′ (=BdO23);229
(ii) biotin-(TEG)2-5′-T23-3′ (=BdT23); (iii) biotin-(TEG)2-5′-230
A23-3′ (=BdA23) and their complementary targets with the231
following sequences (i) 5′-d(ACT GCT AGA GAT TTT CCA232
CAC TG)-3′ (=CdO23); (ii) 5′-d(A23)-3′ (=dA23); and (iii) 5′-233
d(T23)-3′ (=dT23), (deoxyribooligonucleotides were purchased234
from Masaryk University, Czech Republic). The biotinylated235
oligonucleotide probes in 10 mM phosphate buffer containing236
15 mM MgCl2 (PBM, pH 7.4 at 20 ◦C) were microspotted on237
the top of the streptavidin spots and incubated for 120 min.238
The concentrations of streptavidin and oligonucleotide solutions239
used in microspotting were calculated in such a way that each240
droplet of streptavidin solution contained enough streptavidin241
to form two complete monolayers (0.3 M) and each droplet of242
oligonucleotide solution contained 1.5 oligonucleotides per each243
binding pocket of streptavidin (2 M) [16]. The surface drying244
during the microspotting process was carefully avoided as drying245
of the functionalized surface can result in a loss of streptavidin246
reactivity. Therefore, the incubation of the microspotted surface247
took place in a humidity chamber with saturated vapor pressure.248
Fig. 6. Concept of functionalization of the multichannel SPR sensor.
After the microspotting, the sensor chips were rinsed with PBM 249
in order to wash off the unreacted probes and streptavidin and 250
then stored in PBM at 4 ◦C (Fig. 6). 251
In order to allow for comparison of binding properties of 252
the oligonucleotide chips prepared by microspotting with those 253
prepared by conventional flow-through method [15], a series 254
of reference chips were functionalized using the conventional 255
flow-through procedure. In this procedure, the sensor chips 256
were functionalized directly in the SPR sensor system while the 257
response to binding was monitored in situ. First, SA buffer was 258
flowed across the sensor chip with a self-assembled monolayer 259
of mixed alkanethiols prepared using the procedure described 260
earlier in this section. SA buffer containing 50 g/ml of strepta- 261
vidin was flowed across the sensor surface for 12 min and then 262
the solution was replaced with an SA buffer. After a short incu- 263
bation with 10 mM phosphate buffer containing 0.75 M NaCl 264
(pH 7.4 at 20 ◦C) to remove non-covalently bound streptavidin 265
and deactivate residual carboxylic groups, the sensor surface 266
was flushed with PBM. Then, a 50 nM solution of biotiny- 267
lated oligonucleotides was flowed across the sensor surface for 268
12 min. The sensor surface was divided into measuring and ref- 269
erence groups of channels using separate flow-chambers of the 270
flow-cell. Measuring channels were modified with BdO23 probes 271
and reference channels were modified with BdT23 or BdA23 272
probes. Finally PBM buffer was flowed along the surface to 273
wash off any unbound probes (Fig. 7). 274
The surface density of streptavidin layer produced using the 275
flow-through method was calculated using Eq. (1) from the sen- 276
sor response to the streptavidin monolayer saturation as well as 277
from the sensor response after removal of the unbound strep- 278
tavidin (see Fig. 7a). The corresponding surface concentrations 279
of streptavidin were determined to be 1.9 × 1012 SA/cm2 and 280
1.14 × 1012 SA/cm2, respectively. While the higher concentra- 281
tion is relevant for the optimization of the microspotting of strep- 282
tavidin, where the saturation has to be reached from a limited 283
volume of the droplet, the lower number provides an estimate 284
of binding pockets available for biotinylated oligonucleotides at 285
the sensor surface. The surface density of immobilized biotiny- 286
lated oligonucleotides BdO23 (Fig. 7b) was estimated to be 287
about 2.2 × 1012 oligonucleotides per cm2, which corresponds 288
to about two biotinylated oligonucleotides per a molecule of 289
streptavidin.
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Fig. 7. Typical sensor response to immobilization of (a) streptavidin (measured
in 32 channels) and (b) biotinylated oligonucleotides (measured in 8 channels).
4. Detection of oligonucleotides290
In order to determine the cross-talk among the sensing chan-291
nels and to evaluate potential of the presented approach for292
parallelized screening of molecular interactions, we performed293
an experiment in which a solution containing a specific oligonu-294
cleotide (concentration, 50 nM) was flowed along the sensor295
chip with neighboring sensing channels functionalized with296
complementary oligonucleotides (all present within a single297
flow-chamber, see Fig. 6). This experiment was carried out298
using three different solutions; each solution containing only299
one of oligonucleotides with a sequence complementary to the300
sequence of one of the immobilized probes. These measure-301
ments were performed simultaneously, using different areas302
of the SPR sensor chip confined in different flow-chambers.303
Fig. 8 presents response of the sensing channels to differ-304
ent oligonucleotides. Clearly, the sensing channels with probes305
complementary to the oligonucleotide in solution produced a306
strong sensor response, while the sensing channels with differ-307
ent oligonucleotides generated no response at all. Each of the308
hybridization events was measured simultaneously in three or309
four sensing channels (depending on the layout of sensing spots310
within each flow-chamber) and the sensor responses were found311
Fig. 8. Detection of three oligonucleotides using an array of complementary
probes microspotted on the sensor surface. Probe sequences are given at the ver-
tical axis. Error bars indicate the peak-to-peak variations in the sensor response.
to fall within ±7% from the average sensor response. This exper- 312
iment suggests that the presented multichannel SPR platform 313
can be combined with the microspotting functionalization tech- 314
nique to allow for parallelized measurements with no cross-talk 315
among neighboring sensing channels. 316
In order to assess detection capabilities of the developed sen- 317
sor platform, detection experiments were performed in which the 318
sensor response to different concentrations of oligonucleotides 319
was measured. In these experiments, sensor chips functional- 320
ized with BdO23 probes (sensing channels) and BdT23 probes 321
(reference channels) were used and samples containing different 322
concentrations of CdO23 in PBM buffer were flowed across dif- 323
ferent flow-chambers of the flow-cell. Typical sensor response 324
to different concentrations of CdO23 is shown in Fig. 9. For com- 325
parison, the detection experiment was repeated using the SPR 326
sensor chips and functionalized using the flow-through tech- 327
nique (Fig. 10). 328
As follows from comparison of the sensor responses 329
for the microspotting and flow-through functionalization 330
(Figs. 9 and 10), the equilibrium sensor response at 50 nM con- 331
centration obtained using the microspotting functionalization is 332
higher by a factor of about 1.8 than the response obtained on 333
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Fig. 9. Detection of oligonucleotides using the multichannel SPR sensor func-
tionalized using the microspotting technique. Temporal sensor response mea-
sured for three different concentrations of CdO23 oligonucluotide. Response of
a reference channel for CdO23 concentration of 50 nM shown for comparison.
the sensor chip functionalized using the flow-through technique.334
This result indicates, that the microspotting procedure yields a335
surface density of probes higher by 80%, which translates to336
4 × 1012 oligonucleotides per cm2 (this result was calculated337
using Eq. (1)). The higher surface concentration of probes can be338
associated with a slower immobilization of probes driven only339
by the diffusion in the droplet volume and longer incubation340
times. This result is comparable with the results obtained using341
SPR chips functionalized under no flow conditions in a cuvette342
by Su et al. who obtained surface coverage as high as 4.3 × 1012343
oligonucleotides per cm2 [14]. This indicates that when the344
parameters of the microspotting process are controlled properly,345
robust functionalization with a high density of probes accessible346
to target analytes can be achieved. For direct biosensor-based347
detection of oligonucleotides, it is useful to define the sensor348
Fig. 10. Detection of oligonucleotides using the multichannel SPR sensor func-
tionalized using the flow-through technique. Temporal sensor response measured
for three different concentrations of CdO23 oligonucluotide. Response of a ref-
erence channel for CdO23 concentration of 50 nM shown for comparison.
Fig. 11. Calibration curves for the SPR sensor-based detection of CdO23
oligonucleotides determined for two method of functionalization (microspot-
ting and flow-through functionalization). Error bars indicate the peak-to-peak
interval of measured binding rates.
response to analyte as the binding rate of the analyte to the 349
receptors in an initial phase of the binding experiment (see 350
Fig. 9). In this experiment, the binding rates were calculated 351
using a linear regression applied to a portion of the kinetic 352
sensor response fulfilling the criterion that the standard devi- 353
ation of the fit was smaller than two standard deviations of the 354
baseline noise (for instance, binding rates for 1 nM and 50 nM 355
concentrations were calculated using first 13 min and 1 min of 356
the binding, respectively). The determined binding rates were 357
plotted against the concentration of oligonucleotide (Fig. 11). 358
Clearly, the higher surface concentration of probes was achieved 359
using the microspotting technique results in higher binding rates 360
for all the concentrations of the target oligonucleotides. 361
As follows from Figs. 9 and 11, the sensor shows a strong 362
response even to oligonucleotide concentrations as low as 1 nM. 363
If we define the limit of detection (LOD) as a concentration of 364
analyte that results in the sensor response equal to three standard 365
deviations of the baseline noise [17], the LOD for this model 366
oligonucleotide system is approximately 100 pM. This detec- 367
tion limit is better by two orders of magnitude than the best 368
detection limits demonstrated using the SPR imaging technol- 369
ogy [8] and comparable to best detection limits obtained using 370
high-performance SPR sensors based on spectroscopy of surface 371
plasmons in a small number of sensing channels (<5) [15,18]. 372
5. Conclusions 373
We demonstrate a new multichannel SPR biosensor based on 374
the SPR imaging platform with an array of special multilayers 375
and polarization contrast and the spatially-resolved function- 376
alization based on the microspotting technique. We show that 377
the optical approach presented herein offers considerably higher 378
sensitivity than the competing multichannel SPR sensing plat- 379
forms such as SPR imaging and allows to measure changes in 380
the refractive index as small as 2 × 10−6 RIU. The optimized 381
microspotting technique employed for the functionalization of 382
the sensor with oligonucleotide probes was found to provide at 383
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least 80% more binding sites than the conventional flow-through384
functionalization. The limit of detection for model oligonu-385
cleotides was demonstrated to be about 100 pM which makes386
this sensor by far the most sensitive high-throughput SPR plat-387
form used for detection of oligonucleotides.388
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5
6
a Institute of Radio Engineering and Electronics, Academy of Sciences of the Czech Republic, Chaberská 57, 182 51 Prague, Czech Republic7
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Abstract11
This paper describes the direct label-free detection of antibodies against the Epstein-Barr virus (anti-EBNA) using a surface plasmon resonance
(SPR) biosensor. The antibody detection was performed using the immunoreaction between anti-EBNA and a respective synthetic peptide (EBNA-
1), which was conjugated with bovine serum albumin (BSA–EBNA) and immobilized on the sensor surface. Three immobilization chemistries
for the attachment of BSA–EBNA were investigated to optimize ligand density and minimize loss of EBNA-1 immunoreactivity. The developed
SPR biosensor functionalized with the optimal immobilization method was calibrated and characterized in terms of detection limit, reproducibility,
regenerability and storability. It was demonstrated that the sensor is capable of detecting concentrations of anti-EBNA as low as 0.2 ng/ml (∼1 pM)
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1. Introduction1
The Epstein-Barr virus is one of the most common viruses,2
which attack the immune system of humans. The infection3
course varies from asymptomatic infection to various diseases4
such as infectious mononucleosis in countries with the temper-5
ate climate, Burkitt’s lymphoma in Africa and nasopharyngeal6
carcinoma in China. The focus of laboratory testing is to dis-7
tinguish active illness from past infections and negativity. Cur-8
rently blood of patients is tested for the presence of non-specific9
hemaglutinins and hemolysins produced by a human body as10
a response to the virus as well as for the presence of specific11
immunoglobulins against the Epstein-Barr virus proteins, i.e.12
early antigen, viral capsid antigen and nuclear antigen (EBNA),13
especially EBNA-1. Diagnostic tests for the presence of anti-14
EBNA in human blood serum are performed using indirect15
∗ Corresponding author. Tel.: +420 266773448; fax: +420 284680222.
E-mail address: homola@ure.cas.cz (J. Homola).
1 Tel.: +420 221911472; fax: +420 224922797.
two-step immunoassays with enzymatic, radio or fluorescent 16
labeling (Gomara et al., 2000). The use of labeled secondary 17
ligands contributes to assay time and costs. Antigens required to 18
bind host antibodies are prepared either from infected cells or as 19
recombinant proteins. An attractive alternative are synthetic pep- 20
tides that mimic specific immunoreactive epitopes and reduce 21
non-specific reactions and cross-reactivity of the assays. More- 22
over, routine and inexpensive peptide synthesis makes them 23
more affordable than the recombinant proteins (Gonzalez et al., 24
1997). 25
Direct, label-free biosensors, such as surface plasmon res- 26
onance (SPR) biosensors, present an interesting alternative to 27
conventional methods. SPR biosensors measure refractive index 28
changes produced by the binding of analyte to its biospecific 29
partner immobilized on the sensor surface. In the last decades, 30
several SPR sensor platforms have been developed (Shumaker- 31
Parry and Campbell, 2004; Stabler et al., 2004; Piliarik et 32
al., 2005) and applied to detection of biological and chemi- 33
cal substances and study of molecular interactions (Karlsson 34
and Falt, 1997; Goodrich et al., 2004). Various approaches to 35
the immobilization of molecules on the surface of SPR sensor 36
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(usually gold) have been also developed. These include proce-37
dures based on physicochemical interactions such as chemisorp-38
tions (Nuzzo and Allara, 1983), covalent binding (Lofas et al.,39
1995), hydrophobic and electrostatic coupling (Koubova et al.,40
2001) and non-covalent high-affinity biomolecular linkers such41
as streptavidin-biotin (Busse et al., 2002) or complementary42
oligonucleotides (Ladd et al., 2004).43
In this work, we report a novel method of detection of anti-44
EBNA which utilizes a biosensor platform based on surface45
plasmon resonance and a special synthetic peptide (EBNA-1)46
as a receptor. Three different immobilization methods based on47
covalent coupling (Lahiri et al., 1999), electrostatic (Koubova48
et al., 2001) and hydrophobic interactions are examined for49
the immobilization of the peptide on the SPR sensor surface.50
The resulting anti-EBNA biosensor is characterized in terms51
of detection limit, reproducibility, regenerability and stora-52
bility. The performance of the biosensor is compared with53




Bovine serum albumin (BSA) was purchased from Sigma–58
Aldrich, USA. The C16-chained alkanethiol (C16-59
mercaptohexadecanoic acid) and the N,N,N′,N′-tetramethyl-60
O-(N-succinimidyl)uronium tetrafluoroborate (TSTU) used61
for the activation of carboxylic terminal groups on C16-62
alkanethiol were purchased from Sigma–Aldrich, USA. The63
C11-chained di(ethylene glycol)-terminated alkanethiol was64
purchased from Prochimia, Poland. Dextran sulfate (DS), N,N-65
dimethylformamid (DMF) and glutaraldehyde 50% (GA) were66
obtained from Sigma–Aldrich, USA. Absolute ethanol was67
purchased from Merck, Czech Republic. Mouse monoclonal68
affinity-purified antibodies against human Epstein-Barr virus69
(anti-EBNA) and against human Herpes virus (anti-HSV), both70
IgG2b isotype, were obtained from ExBio, Czech Republic.71
Synthetic peptides were synthesized using the Merrifield’s72
method of solid phase peptide synthesis (Fields and Noble,73
1990) in VIDIA, Czech Republic. The amino acid sequences74





BSA–peptide conjugates were prepared in VIDIA, Czech80
Republic using the protocol described by Coligan et al. (1995)81
and glutaraldehyde as a cross-linking agent. Solutions of82
the conjugates for SPR measurements were prepared (I) in83
phosphate buffer saline (PBS) consisting of 10 mM phosphate84
buffer, 137 mM NaCl, 2.9 mM KCl, pH 7.4 at 20 ◦C or (II) in85
0.1 M citrate buffer (CB), pH 4.0 at 20 ◦C or (III) in 10 mM86
sodium acetate buffer (SA), pH 5.0 at 20 ◦C, depending on87
the immobilization chemistry. Solutions of antibodies were88
prepared in PBS containing bovine serum albumin at a con-89
centration of 5 mg/ml. For experiments involving human blood90
Fig. 1. Scheme of an eight-channel SPR sensor with four parallel light beams
and the wavelength division multiplexing of sensing channels (upper picture).
Spectrum of transmitted light with two SPR dips before (– – –) and after the
binding (—) (lower picture).
serum samples, the solutions were mixed with human blood 91
serum to a resulting serum concentration of 1% (v/v). 92
Goat-anti-mouse IgG antibodies labeled with horseradish 93
peroxidase were obtained from Southern Biotechnology Asso- 94
ciates, USA. A sample of human blood serum was obtained 95
from the University Hospital Motol, Prague; the serum was 96
tested to be negative for anti-EBNA. Polystyrene Nunc-Immuno 97
LockWellTM modules for ELISA tests were purchased from 98
Schoeler-Pharma, Czech Republic. 99
2.2. SPR sensor 100
In this research, we used a recently developed SPR sen- 101
sor platform based on the spectroscopy of surface plasmons 102
(Homola et al., 2001) and wavelength division multiplexing 103
(WDM) (Homola et al., 2002; Dostalek et al., 2005). This sensor 104
combines the wavelength division multiplexing of two serially 105
ordered sensing channels in a special sensing element with four 106
parallel light beams (see Fig. 1) to yield the total of eight sensing 107
channels. Broadband light from a halogen lamp is collimated and 108
polarized, and then introduced into the WDM–SPR sensing ele- 109
ment interfaced with a sensor chip made of SF-14 glass coated 110
by an adhesion-promoting titanium film (thickness, 2 nm) and a 111
gold film (thickness, 55 nm). Upon the first incidence on the gold 112
film, each light beam excites a surface plasmon at a certain wave- 113
length (∼650 nm). The reflected light is redirected towards the 114
gold film at a different angle of incidence and excites a surface 115
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excitation of the surface plasmons gives rise to two narrow dips117
in the spectrum of transmitted light (Fig. 1). The transmitted light118
is collected into four optical fibers and coupled to a four-channel119
spectrograph. Acquired spectra are analyzed in real time by a120
special software that allows tracking the resonant wavelength121
in each sensing channel (Nenninger et al., 2002). A flow cell122
with eight separate flow chambers is interfaced with the chip to123
contain a liquid sample during the experiments. Each flow cham-124
ber covers the area, where the surface plasmon is excited—the125
sensing channel. The flow chambers are designed to provide a126
laminar flow along the sensor surface. The height of the flow127
chambers is rather small (50 m) to facilitate diffusion of the128
analyte to the surface of the sensor. The volume of each flow129
chamber is about 1 l. A peristaltic pump is used to flow liquid130
samples over each sensing channel at a flow rate of 30 l/min.131
In order to compensate for the non-specific sensor response132
and thus provide more accurate results, in each binding experi-133
ment, two sensing channels (one short-wavelength and one long-134
wavelength) are coated with a reference peptide (BSA–peptide135
conjugate). This peptide was derived from CMV and was of the136
same length and of a similar molecular weight as EBNA-1 and137
exhibited no immunoreactivity to anti-EBNA. When the analyte138
(anti-EBNA) is flowed over the sensor surface, the SPR wave-139
length shift measured in the measuring and reference channels140
are subtracted to account for temperature fluctuations (causing a141
drift in the sensor response) and non-specific adsorption of non-142
target molecules in the sample to sensor surface (see Fig. 1).143
The shift in the resonant wavelength shown in Fig. 1 is propor-144
tional to the refractive index change at the sensor surface and can145
be calibrated to the surface concentration of bound molecules.146
The calibration coefficient interrelating the sensor response and147
the concentration of analyte is proportional to the molar weight148
of the molecules (Liedberg et al., 1993) and depends on the149
resonant wavelength (Dostalek et al., 2005). It was estimated150
from a theoretical model (Homola, 2006) that a shift in the151
resonant wavelength of 1 nm corresponds to a change in the152
surface concentration of BSA of about 10−13 mol/cm2 when153
measured at the wavelength of 800 nm and 5 × 10−14 mol/cm2154
at the wavelength of 650 nm. All sensorgrams obtained from155
short-wavelength sensing channels are therefore recalibrated to156
the operating wavelength of the long-wavelength sensing chan-157
nels (800 nm).158
2.3. Measurement protocols159
2.3.1. SPR sensor functionalization160
Prior to the functionalization, the sensor chips were cleaned161
in an UV–ozone cleaner for 15 min, then washed with deionized162
water and dried with a stream of nitrogen.163
2.3.1.1. Peptide immobilization via covalent coupling (CHEM164
I). A 7:3 mixture of C11-chained and C16-chained alkanethiols165
was dissolved in degassed absolute ethanol with a total thiol166
concentration of 1 mM. The C16-alkanethiols terminated with167
carboxylic head groups were used to anchor BSA–peptide conju-168
gates to the sensor surface via amino coupling; C11-alkanethiols169
terminated with di(ethylene glycol) groups were used to form a170
stable non-fouling background. Sensor chips were immersed in 171
a thiol solution at a temperature of 40 ◦C for 10 min and stored 172
in dark at room temperature for up to 2 days to allow the alka- 173
nethiols to form a self-assembled monolayer (SAM). Then, the 174
chips were rinsed with ethanol, dried with nitrogen, rinsed with 175
water and dried with nitrogen again. The carboxylic terminal 176
groups on the sensor surface were transformed into reactive 177
N-hydroxysuccinimidyl esters with N,N,N′,N′-tetramethyl-O- 178
(N-succinimidyl)uronium tetrafluoroborate (Knorr et al., 1989; 179
Wester et al., 1996). Sensor chips were immersed in a solution 180
of TSTU in degassed DMF (2 mg/ml), then sonicated for 1 min 181
and shaken for 2 h. The chips were rinsed with water, dried with 182
nitrogen and immediately mounted into the SPR instrument. 183
The attachment of peptide was performed in situ. SA buffer was 184
flowed through the flow cell until a stable baseline was estab- 185
lished; then SA solution with 25 g/ml of each BSA–peptide 186
conjugate was brought in contact with the sensor surface for 187
35 min. Then, the SA buffer was injected again. Finally, the sen- 188
sor surface was flushed with PBS and BSA to deactivate the 189
residual carboxylic groups. 190
2.3.1.2. Peptide immobilization via electrostatic coupling 191
(CHEM II). BSA–peptide conjugate or pure BSA assemblies 192
were formed on the gold surface from CB buffer, pH 4.0 193
via adsorption on a slightly negatively charged gold surface 194
(Koubova et al., 2001). Concentrations of BSA–EBNA and 195
BSA–CMV in the measuring and reference channels were 196
50 g/ml; the incubation time was 20 min. After switching to 197
pure CB, dextran sulphate was flowed along the sensor sur- 198
faces for 10 min at a concentration of 1 mg/ml. DS is negatively 199
charged in the CB solution of pH 4.0. After repeating injection 200
of CB, BSA–EBNA and BSA–CMV were injected and flowed 201
over the measuring and reference channels for 20 min. Then, 202
CB buffer was injected to remove the loosely bound peptide. 203
Finally, the assemblies were incubated with 0.5 wt.% glutaralde- 204
hyde in CB for 20 min to cross-link the BSA–peptide layers. 205
DS and loosely bound ligands were washed out from the cross- 206
linked peptide network with PBS. The uncoated areas of the 207
surface were covered with BSA by incubating the sensor surface 208
with PBS buffer containing 0.5 wt.% BSA. In order to compare 209
the surface density of the immobilized BSA–peptide conjugates 210
with the surface density of a BSA layer and quantify the effect 211
peptide conjugation, a BSA double-layer was formed using the 212
same protocol. 213
2.3.1.3. Peptide immobilization via hydrophobic interactions 214
(CHEM III). The BSA–peptide conjugate was adsorbed on the 215
gold surface by means of hydrophobic interaction. PBS solution 216
(pH 7.4) containing BSA–peptide conjugates at a concentration 217
of 50 g/ml was flowed along the sensor surface for 20 min. 218
Then, PBS was injected and flowed along the sensor surface 219
until the stable baseline was reached. The 0.5 wt.% glutaralde- 220
hyde was flowed for 20 min to cross-link the assemblies. PBS 221
was injected again to wash off the loosely bound ligands and 222
finally the uncoated areas of the surface were covered with BSA 223
by incubating the sensor surface with PBS buffer containing 224
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2.3.2. Characterization of anti-EBNA SPR biosensor226
To evaluate the used immobilization methods in terms of anti-227
EBNA binding capacity, measurements of anti-EBNA binding228
to EBNA-1 in measuring channels and CMV in reference chan-229
nels was performed. Buffer (0.5 wt.% BSA in PBS) was flowed230
in the measuring and reference channels until stable baselines231
were achieved. Then, a solution containing anti-EBNA at a con-232
centration of 0.2 ng/ml was injected and flowed for a period233
of 15 min. The solution was replaced with buffer which was234
flowed for 10 min. Then another solution with a higher concen-235
tration of anti-EBNA was injected and the whole procedure was236
repeated. Concentrations of anti-EBNA were 0.2, 2, 20, 200 and237
2000 ng/ml. Sensor regenerability was determined using the fol-238
lowing procedure. PBS buffer was injected until a stable baseline239
was established. Then, a solution of anti-EBNA at a concen-240
tration of 200 ng/ml was flowed along the sensor surface for241
10 min. After a short incubation in PBS, regeneration reagent242
was injected and flowed for 5 min. Then PBS buffer was flowed243
over the sensor surface until a stable baseline was reached and244
then the anti-EBNA solution was injected. Several regeneration245
reagents, such as hydrochloric acid, glycine, formic acid, etc.,246
with different concentrations or pH values were tested in terms247
of their ability to disrupt the anti-EBNA/EBNA-1 bond. Sodium248
hydroxide at a concentration of 30 mM was found to be the most249
efficient regeneration agent both in terms of reproducibility and250
maintaining immunoreactivity of the peptide.251
To determine reproducibility of the SPR sensor-based detec-252
tion of anti-EBNA, a series of 6 sensor chips with the total253
number of 14 measuring channels functionalized with EBNA-1254
was used. A series of solutions of anti-EBNA containing an255
increasing concentration of anti-EBNA (0.2, 2, 20, 200 and256
2000 ng/ml) was flowed across the sensor surface for 15 min.257
The measurement was repeated after the sensor surface regen-258
eration.259
Sensor chip storability was investigated by repeating the260
detection of anti-EBNA at a concentration of 200 ng/ml imme-261
diately after the functionalization and after the chip was stored262
in a container with PBS for 2, 7 and 30 days.263
To test ability of the sensor to detect anti-EBNA in complex264
matrices, the detection of anti-EBNA dissolved in BSA contain-265
ing 1% (v/v) human serum was performed. These experiments266
were performed using the same procedure as that used for the267
determination of sensor reproducibility.268
2.3.3. ELISA method269
ELISA microwells were coated overnight with BSA–peptide270
conjugates (measuring surfaces with BSA–EBNA and ref-271
erence surfaces with BSA–CMV) at a concentration of272
10 g/ml in 0.05 M carbonate–bicarbonate buffer, pH 9.6. The273
uncoated areas in the wells were blocked with 1% BSA in274
carbonate–bicarbonate buffer, washed and stored at a tem-275
perature of 4 ◦C. Antibodies were diluted in a special buffer276
developed by VIDIA, Czech Republic and used in commercial277
immunoassays to detect anti-EBNA antibodies in patients’ sera.278
This PBS-based buffer containing bovine serum, bovine serum279
albumin, detergents, preservatives and stabilizers contained anti-280
EBNA at concentrations ranging from 0.1 to 4000 ng/ml. Exper-281
iments with human blood serum samples were performed using 282
solutions of anti-EBNA in the VIDIA dilution buffer containing 283
1% (v/v) human blood serum. Anti-EBNA solutions were incu- 284
bated with antigen-coated wells for 1 h at a room temperature. 285
The wells were washed five times with VIDIA wash buffer and 286
the bound anti-EBNA was detected using the Goat-anti-mouse 287
antibody labeled with horseradish peroxidase. The enzymatic 288
reaction was stopped after 10 min. The optical density was mea- 289
sured with an ELISA reader (SLT Spectra) at a wavelength of 290
450 nm. The specificity of the studied peptide/antibody system 291
was confirmed by measuring the sandwich assay immunoreac- 292
tion between BSA–CMV and anti-EBNA at a high anti-EBNA 293
concentration (160 ng/ml). No significant signal was observed 294
(data not shown here). 295
3. Results and discussion 296
3.1. Comparison of functionalization methods 297
The functionalization methods employed in this research 298
were based on three different physicochemical principles and a 299
spatially controlled delivery of the peptide to the sensor surface 300
using microfluidics. The sensorgrams illustrating the binding of 301
receptors (BSA–EBNA) and reference ligands (BSA–CMV) are 302
shown in Fig. 2. For CHEM II, the sensor response only to the 303
second layer of BSA–peptide conjugates is shown. The result- 304
ing surface coverage of immobilized ligands (BSA–EBNA and 305
BSA–CMV) were calculated from the difference of the sensor 306
response to surface without any ligands (prior to the binding) 307
and ligand-coated surface (after washing off the loosely bound 308
ligand) in the same buffer. The bar graph in Fig. 2 shows the lig- 309
and (BSA–EBNA and BSA–CMV) surface coverage obtained 310
for each immobilization method. 311
Fig. 2. Surface coverage of BSA–EBNA and BSA–CMV conjugates produced
using different immobilization methods. Immobilization of BSA–EBNA (mea-
suring channel; black line) and BSA–CMV (reference channel; gray line) via
covalent attachment to the thiol-coated surface (CHEM I), electrostatic coupling
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Fig. 3. Sensor response to different concentrations of anti-EBNA for the mea-
suring and reference sensing channels. Sensor surface was functionalized using
CHEM III.
As follows from Fig. 2, the three immobilization method yield312
considerably different amounts of immobilized BSA–peptide313
conjugates, ranging from 5 × 10−14 to 1.9 × 10−12 and314
4 × 10−13 to 2.4 × 10−12 mol/cm2 for BSA–EBNA and315
BSA–CMV, respectively.316
The highest surface density of EBNA-1 was achieved using317
the electrostatic coupling-based immobilization method. It sug-318
gests that pH 4.0 was sufficient for making BSA–peptide con-319
jugates positively charged and physicochemical properties of320
the peptide did not significantly influence the isoelectric point321
of BSA. The obtained level of BSA–EBNA agreed well with322
the coverage observed with bare (non-modified) BSA, when a323
BSA double-layer was prepared using the same method (data324
not shown here).325
The lowest surface density of EBNA-1 was obtained with the326
covalent attachment of BSA–EBNA to the SAM (CHEM I), even327
though the composition of the SAM was optimized to ensure the328
maximum BSA coverage (Ladd et al., 2004). This result suggests329
that the non-polarity of the EBNA-1 peptide resulting from its330
amino acid sequence (alanine and glycine alternation) negatively331
influences the EBNA-1 binding to the hydrophilic layer of NHS-332
ester-terminated and di(ethyleneglycol)-terminated groups of333
alkylthiolates on the sensor surface. The highest coverage of334
BSA–CMV was achieved using CHEM III. We believe that this335
is due to the high ratio of polar amino acids in the peptide and336
due to the presence of lysins in the CMV amino acid sequence,337
which increases the probability of the amide bond formation338
with esterificated carboxylic groups. The effect of hydropho-339
bicity of BSA–EBNA is also apparent from the comparison340
of the amount of BSA–EBNA and BSA–CMV immobilized341
using CHEM III—a higher surface density was achieved for342
BSA–EBNA than for BSA–CMV conjugates.343
In order to evaluate the immunoreactivity of the immobilized344
EBNA-1, the detection of anti-EBNA binding to EBNA-1 (and345
to CMV as reference surface) was carried out for each immo-346
bilization method. A typical sensorgram corresponding to the347
binding of anti-EBNA to EBNA-1 and reference CMV surface348
prepared using CHEM III is shown in Fig. 3. The interaction349
Fig. 4. Sensor response to the binding of anti-EBNA to the EBNA–BSA coatings
produced using CHEM I, II and III for different anti-EBNA concentrations.
between the immobilized EBNA-1 and anti-EBNA was highly 350
specific for all the used immobilization methods (only very low 351
non-specific binding to the BSA–CMV-coated reference surface 352
was observed). This observation was further confirmed by the 353
injection of anti-HSV (antibody of the same isotype IgG2b as the 354
anti-EBNA, but with no immunoreactivity to EBNA-1) at con- 355
centrations of 2 g/ml and 20 g/ml which generated no sensor 356
response (data not shown here). A reference-compensated sen- 357
sor response to anti-EBNA calculated as a difference between 358
the sensor response prior to the binding of anti-EBNA and after 359
washing the sensor surface with buffer for 10 min for a series of 360
different antibody concentrations is shown in Fig. 4. The sen- 361
sor response is proportional to the concentration of anti-EBNA, 362
however, differs for the used immobilization methods. Although 363
the BSA–EBNA coverage was highest for CHEM II, the largest 364
amount of bound antibody was observed, when the peptide was 365
immobilized using CHEM III (Fig. 4). These results suggest that 366
a low pH of the buffer used in CHEM II decreases the peptide 367
immunoreactivity to anti-EBNA. Therefore, CHEM III was used 368
in all the SPR biosensing experiments presented below. 369
3.2. Sensor regeneration and reusability 370
Sensor surface with captured anti-EBNA was regenerated 371
using sodium hydroxide at a concentration of 30 mM for 372
5 min. Repeated detection-regeneration cycles were performed 373
10 times directly after the functionalization and after storing the 374
sensor chip for 30 days in a controlled environment. 375
Fig. 5 shows a typical sensor response to anti-EBNA regen- 376
eration/measurement cycles before and after the sensor chip 377
storage. The sensor response to the analyte binding was found 378
to reach the same amplitudes on the regenerated surface and 379
after the binding of a lower concentration of anti-EBNA (as 380
in Fig. 3). This is in agreement with simulations which sug- 381
gest that the binding rate increases linearly with the amount of 382
free receptors. In experiments presented in Fig. 3, about 90% of 383
receptors remain unoccupied (until an anti-EBNA concentration 384

















6 H. Vaisocherová et al. / Biosensors and Bioelectronics xxx (2006) xxx–xxx
Fig. 5. Detection/regeneration cycles for anti-EBNA obtained immediately after
the functionalization and after 30 days of storage. Each cycle consisted of buffer
(incubation time ∼5–10 min), anti-EBNA binding at a concentration of 0.2 ng/ml
(10 min), buffer (5 min), removal of anti-EBNA by 30 mM NaOH (5 min) and
buffer (∼5–10 min).
insignificant (less than 10%). Clearly, the regeneration resulted386
in a total removal of the antibody from the sensor surface. No387
significant loss in the sensor sensitivity was observed for up to388
10 regeneration/measurement cycles and the sensor chip did not389
exhibit any significant decrease in sensitivity after storing the390
chip up to 30 days.391
3.3. Sensor reproducibility392
The sensor response to an increasing concentration of anti-393
EBNA was measured. The sensor response was calibrated to the394
amount of receptors immobilized on the gold surface. The stan-395
dard deviation of the sensor response obtained using different396
sensor chips was found to be in the range of 8–18% (depend-397
ing on the anti-EBNA concentration), yielding the measure-398
ment reproducibility of 82–92%. Reproducibility of the binding399
experiments on a single chip was better than 90% for concen-400
trations of anti-EBNA from 0.2 to 2000 ng/ml. The calibration401
curve depicted in Fig. 6A (as squares) shows the dependence402
of the absolute sensor response to a 15 min incubation of the403
sensor with anti-EBNA solutions. The error bars indicate the404
standard deviation for the set of measurements on different 405
chips. 406
The results of the SPR measurements were compared with 407
the results obtained with ELISA. ELISA measurements of the 408
optical density (OD) (indirect detection) were performed 32 409
times (eight times using one titration plate, totally repeated four 410
times) for each concentration of anti-EBNA. OD obtained from 411
blank sample produced by BSA–CMV peptide was subtracted. 412
Experimental error was calculated as a standard deviation of OD 413
variability obtained from 32 experiments. To determine standard 414
deviation of OD variability (instrumental error), each OD was 415
measured 10 times. The standard deviation of the OD was found 416
to fall between 5% (at high concentrations) and 20% (at low con- 417
centrations). 418
3.4. Detection limit 419
The limit of detection (LOD) is defined as the concentration 420
of analyte that induces the smallest resolvable change in the 421
sensor response, usually assumed as three standard deviations of 422
the baseline noise (Thomsen et al., 2003). For the reported SPR 423
biosensor, the LOD was estimated to be 0.1 ng/ml. Detection of 424
anti-EBNA at this level was not performed in our experiments, 425
however, the concentration of 0.2 ng/ml (∼1 pM) was clearly 426
detectable both in the buffer and 1% human blood serum. The 427
limit of detection for ELISA was determined to be 1 ng/ml. 428
3.5. Detection of anti-EBNA in human serum 429
All antibody concentrations in the range 0.2–2000 ng/ml 430
were detected also in 1% human blood serum. Sensor responses 431
to analyte in serum and in buffer are compared in Fig. 6A. Only 432
very low non-specific binding was observed for measurements 433
in serum. A typical sensorgram obtained during the anti-EBNA 434
binding from human serum in measuring (BSA–EBNA) and 435
reference (BSA–CMV) channels is displayed in Fig. 6B. This 436
demonstrates the potential of the developed sensor for the detec- 437
tion of anti-EBNA in even more concentrated human blood 438
serum samples. 439
Fig. 6. (A) Sensor response to different concentrations of anti-EBNA in buffer (the error bars indicate the chip to chip reproducibility). Sensor responses to the same
concentrations of anti-EBNA in 1% human serum shown for comparison. (B) Temporal sensor response to the binding of anti-EBNA at a concentration of 2 g/ml
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4. Conclusions440
An SPR sensor for detection of anti-EBNA utilizing syn-441
thetic peptide EBNA-1 as a recognition element was developed.442
Three different methods were investigated for the immobiliza-443
tion of EBNA-1 conjugated with BSA on the sensor surface444
to obtain the highest sensitivity of the sensor to anti-EBNA.445
Non-polar amino acid composition of the EBNA-1 peptide was446
found to significantly influence the amount of immobilized447
BSA–EBNA conjugate. Although the highest amount of immo-448
bilized receptors was obtained using the electrostatic coupling-449
based immobilization method, the highest immunoreactivity of450
EBNA-1 was achieved with the immobilization method based451
on the physical adsorption of BSA–EBNA conjugates to the452
gold surface in physiological conditions. Thus, the hydropho-453
bic interactions as the principle of ligand immobilization for454
CHEM III was best compatible with the non-polar structure of455
EBNA.456
Sensor response to anti-EBNA exhibited a high degree of457
reproducibility (standard deviation < 18%). The limit of detec-458
tion for the direct detection of anti-EBNA was estimated to459
be 0.1 ng/ml, which is lower by an order of magnitude than460
the limit of detection of ELISA. The minimum experimentally461
observed concentration of anti-EBNA was 0.2 ng/ml. The pro-462
cedure for the regeneration of SPR sensor chips was developed463
and only a minor loss in sensor sensitivity was observed after 10464
regeneration/measurement cycles. It was demonstrated that the465
developed peptide-coated sensor chips can be stored for at least466
30 days with no loss in the sensor sensitivity. The demonstrated467
detection limit was reproduced in a diluted human blood serum.468
The ability of the developed SPR biosensor to directly detect469
anti-EBNA at clinically relevant levels illustrates the potential470
of this technology for medical diagnostics.471
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Chaberská 57, 182 51 Prague,
Czech Republic
2Charles University, Faculty of
Mathematics and Physics,
Ke Karlovu 3, 121 16 Prague,
Czech Republic
3 Institute of Organic Chemistry
and Biochemistry,
Academy of Sciences of the
Czech Republic,
Flemingovo n. 2, 166 10
Prague, Czech Republic
Received 12 October 2005;
revised 7 December 2005;
accepted 8 December 2005
Published online 19 December 2005 in Wiley InterScience (www.interscience.wiley.com). DOI 10.1002/bip.20433
Abstract: We have optimized surface plasmon resonance (SPR) biosensor technology for a rapid,
direct, and low-consumption label-free multianalyte screening of synthetic oligonucleotides (ONs)
with modified internucleotide linkages potentially applicable in antisense therapy. Monitoring of
the ONs hybridization is based on the formation of complex between the natural oligonucleotide
probe immobilized on the sensor surface and the ON in solution in contact with the sensor surface.
An immobilization chemistry utilizing the streptavidin–biotin interaction was employed to obtain
desired ligand density and high hybridization efficiency. It was demonstrated that the sensor is ca-
pable of detecting complementary 23-mer ONs in concentrations as low as 0.1 nM with high speci-
ficity and reproducibility. # 2005 Wiley Periodicals, Inc. Biopolymers 82: 394–398, 2006
This article was originally published online as an accepted preprint. The ‘‘Published Online’’ date
corresponds to the preprint version. You can request a copy of the preprint by emailing the
Biopolymers editorial office at biopolymers@wiley.com
Correspondence to: H. Vaisocherová; e-mail: vaisocherova@
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INTRODUCTION
A great deal of research has been recently focused on
development of strategies for gene therapy based on
specific oligonucleotides (ONs). The antisense concept
consists in binding of the ON to its complementary tar-
get sequence in a specific mRNA blocking translation
of a deleterious gene. Due to the instability of DNA
ONs in living cells, their synthetic analogs are
employed.1,2 The search for novel types of ON modifi-
cations can benefit from methods allowing real-time
observation and quantification of NA hybridization
with high specificity and good signal-to-noise ratio.
Direct, label-free biosensors, such as surface plas-
mon resonance (SPR) biosensors, present an interesting
alternative to conventional NA-hybridization screening
that requires enzymatic amplification and/or radio- or
fluorescent labeling. SPR biosensors detect refrac-
tive index changes produced by the analyte binding
to its biospecific partner immobilized on the sensor
surface.3–5
Typical concentrations of short ON targets used in
NA hybridization studies using SPR biosensors were at a
micromolar level,6,7 however, some experiments involv-
ing lower concentrations, i.e., 10100 nM, have been
carried out.5,8–10 Hybridization efficiencies (percentage
of immobilized ligands present in complexes with inter-
acting partner) as high as 60–80% have been reported.8
In this work, we describe application of a recently
developed multichannel SPR biosensor for parallelized
monitoring of ON hybridization.
EXPERIMENTAL
Reagents
The C16-chained alkanethiol (C16-mercaptohexadecanoic acid)
and streptavidin from Streptomycea avidinii were purchased
from Sigma–Aldrich, St. Louis, MO, USA. The C11-chained
di(ethylene glycol)-terminated alkanethiol was purchased from
Prochimia, Sopot, Poland. Biotinylated deoxyribooligonu-
cleotide probes (23-mers) with sequence of biotin-(TEG)2-
50-d(CAG TGT GGA AAA TCT CTA GCA GT)-30
(BdO23), biotin-(TEG)2-5
0-(dA23)-30 (BdA23), and their com-
plementary targets 50-d(ACT GCT AGA GAT TTT CCA
CAC TG)-30 (CdO23), dT23, and dT15 were purchased from
LMFR of Masaryk University in Brno, Czech Republic.
Biotinylated ribunucleotide probes biotin-(TEG)2-5
0-(rA23)-
30 (BrA23) were purchased from Dharmacon, Lafayette, CO,
USA. Synthetic homothymidine oligonucleotides (15-mers)
with chemically modified sugar-phosphate backbones were
prepared as described elsewhere.11
SPR Sensor
The SPR sensor platform used in this work is based on the spec-
troscopy of surface plasmons12 and wavelength division multi-
plexing (WDM).13 This sensor combines wavelength division
multiplexing of two serially ordered sensing channels with four
parallel light beams (see Figure 1) to yield the total of eight
sensing channels. Broadband light from a halogen lamp is colli-
mated, polarized, and then directed into the WDM-SPR sensing
element interfaced with a chip made of SF-14 glass coated by
an adhesion-promoting titanium film (2 nm thickness) and a
gold film (55 nm). Upon the first incidence on the gold film, the
light beam excites a surface plasmon at a wavelength 650
nm. The reflected light is redirected again toward the gold film
at larger angle of incidence and excites a surface plasmon at
longer wavelength (800 nm). This arrangement generates two
narrow dips in the spectrum of the light leaving the sensing ele-
ment (Figure 1). The output light is coupled to a four-channel
spectrograph connected to a computer running a data acquisi-
tion and real-time data processing.14 A flow-cell with eight
separate flow chambers (each with a volume of 1 L) aligned
to the eight measuring spots is interfaced with the chip. A peri-
staltic pump is used to flow liquid samples along the sensor sur-
face; a flow rate of 30 L/min was used.
In each binding experiment one sensing spot was coated
by an ON of noncomplementary sequence to form a reference
channel. The SPR wavelength shift measured at the meas-
uring channel and that obtained at the reference one were sub-
tracted to account for a nonspecific adsorption and for tem-
perature fluctuations.
Immobilization of Oligonucleotide Probe
The method of ON probes immobilization on the gold sur-
face employed herein is based on the coupling of biotinyl-
ated probes to the streptavidin assemblies via a noncovalent,
high-affinity, and stable streptavidin–biotin bond.8,15,16 Strep-
tavidin is a tetrameric molecule with dyad symmetry, there-
fore each streptavidin contains four equivalent binding pockets
for biotin.17 Streptavidin is fixed via the covalent attachment
to an alkanethiolate self-assembled monolayer18 and the de-
livery of probes to the sensor surface is spatially controlled using
microfluidics. A 7:3 mixture of C11-chained and C16-chained
alkanethiols was dissolved in degassed absolute ethanol with
a total thiol concentration of 1 mM. Sensor chips were im-
mersed in the solution at temperature of 408C and stored in a
dark place at room temperature for up to 2 days. The alkane-
thiols self-organize on a clean gold surface forming a self-
assembled monolayer. The C16 alkanethiols terminated with
a carboxylic head group were used to anchor streptavidin by
amino coupling; C11 alkanethiols terminated with a di(ethy-
lene glycol) group formed a stable nonfouling background.
The carboxylic terminal groups on the sensor surface were
activated by TSTU and then replaced with reactive N-
hydroxysuccinimidyl-esters. The chips were rinsed with water,
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dried, and immediately mounted into the SPR instrument.
Streptavidin attachment was performed in situ at 208C. First,
10 mM sodium acetate (SA) buffer (pH 5.0) was flowed along
the sensor surface until the baseline was achieved, then, SA
solution with 50 g/mL of streptavidin was brought into con-
tact with the sensor surface for 20 min and the SA buffer was
injected again. After a short period of incubation with 10 mM
phosphate buffer containing 0.75 M NaCl (pH 7.4) to remove
noncovalently bound ligands and deactivate residual carbox-
ylic groups, the sensor surface was flushed with 10 mM phos-
phate buffer containing 15 mMMgCl2 (PBM). A 50 nM solu-
tion of biotinylated ONs was then flowed along the sensor
surface for 15 min followed by PBM injection.
Because SPR response is proportional to the mass of the
adsorbed/captured molecules, it is possible to determine
binding stoichiometry of biotinylated ONs to streptavidin
as a ratio between sensor responses to ON and streptavidin.
The stoichiometry was determined from the total of 30
sensing channels (4 different sensor chips) as 2.9 6 0.4 ON
molecules per 1 streptavidin. This result suggests that the
streptavidin is favorably oriented and maintains its binding
activity upon immobilization.
Measurement Protocols
All detection experiments were carried out at a temperature
of 258C. To determine reproducibility of the SPR sensor
response to DNA hybridization, a series of seven sensor
chips functionalized with BdA23 was used. The dT23 detec-
tion was performed as follows: PBM buffer was flowed
along the sensor surface until a stable baseline was
achieved. Solution of dT23 at a concentration of 100 nM
then was flowed along the functionalized sensor surface for
20 min followed by PBM buffer.
To characterize the sensor in terms of detection limit,
binding of CdO23 to BdO23 was performed using the fol-
lowing procedure: after stable baselines were achieved with
flowed PBM buffer, CdO23 solution of the lowest concen-
tration was flowed for a period of 10 min and replaced with
the buffer for next 10 min. Another solution with a higher
concentration of CdO23 then was injected and the whole
procedure was repeated.
Measurements on synthetic modified ONs were per-
formed on the BrA23 surface created on one 8-channel sensor
chip using an experimental procedure similar to the one
described above for the dT23 detection. Concentrations of all
the targets were 50 nM and the incubation time employed for
this experiment was 20 min.
RESULTS AND DISCUSSION
Sensor response to dT23 binding to BdA23 immobilized
on the sensor surface obtained from seven individual
FIGURE 1 Scheme of the eight-channel SPR WDM sensor
(bottom) and typical detected normalized dual spectrum (top)
before (dashed line) and after (solid line) the analyte binding.
FIGURE 2 Sensor response to dT23 binding to BdA23 immobilized on the sensor surface
obtained from 7 individual sensor chips (A). Sensor response to CdO23 binding to BdO23 and
BdA23 surface, respectively, with increasing target concentration (B).
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sensor chips is shown in Figure 2A. Sensor response
was calibrated to the amount of receptors (BdA23) im-
mobilized on the sensor surface. Relative standard de-
viation of amplitudes of sensor responses obtained for
different sensor chips was determined to be 5%.
Sensor response to increasing concentrations of
CdO23 binding to BdO23 surface (fully complemen-
tary sequence) and BdA23 surface (reference) is
shown in Figure 2B. Clearly, the detection of DNA
hybridization using the developed SPR biosensor is
highly specific (see gray line in Figure 2B). The
noise-limited detection limit of the SPR sensor was
calculated as a triple of baseline noise standard devi-
ations and was determined to be 0.1 nM. This value
is better by two orders of magnitude in comparison
with the detection limits achieved by other SPR bio-
sensors previously reported.5–10 The hybridization
efficiency was found to be more than 85% for sys-
tem BdO23–CdO23.
Real-time observation of hybridization of syn-
thetic modified and natural dT15 with immobilized
rON complement using the eight-channel SPR sys-
tem is shown in Figure 3; a scheme of the internu-
cleotide linkage modification is attached to each
sensorgram. Different binding kinetics suggest dif-
ferent interaction mechanisms associated with the
insertion of internucleotide linkage modification.
This primary screening with very low sample and
time consumption enables primary choice of pro-
spective candidates for antisense therapy. Moreover,
if we compare the modified ON sensor response
amplitudes to those obtained from ligand (BrA23)
immobilization and calibrate the values to unified
molecular weight, we can conclude that a stoichiom-
etry of formed complexes was higher than 1:1, which
indicates that triplexes were also formed in addition
to duplexes for selected modified ONs (Figure 3).
Triplex formation was also observed in case of the
natural BdA23–dT23 system. Detailed analysis of
complex stoichiometry is in progress.
CONCLUSION
A surface plasmon resonance biosensor for sensitive
and real-time observation of NA hybridization has
been reported. Biotinylated oligonucleotide probes
were immobilized on the streptavidin surface, which
was created via an optimized version of amine cou-
pling chemistry. The resulting SPR sensor was
characterized in terms of detection limit and repro-
ducibility. This sensor enables rapid DNA/RNA ol-
igonucleotide screening with high chip-to-chip
reproducibility (>95%), specificity, and hybridiza-
tion efficiency (>85%). The detection limit for
detection of 23-mer hybridization as low as 0.1 nM
( 0.7 ng/mL) was achieved. This sensor can be
applied to primary screening and stoichiometry pre-
diction of synthetic modified oligonucleotides.
The authors thank Kateřina Mrkvová, Praskovia Boltovets,
and Soňa Voslářová (IREE, Prague, Czech Republic) for
kind help in carrying out the reported experiments. This pro-
ject was supported by the Grant Agency of the Czech Repub-
lic (contracts 303/03/0249, 102/03/0633, and 202/05/0628).
FIGURE 3 Multianalyte screening of synthetic modified oligonucleotide interactions with
BrA23 in comparison with natural dT15; X, presence of depicted internucleotide linkage modifica-
tion (X) in 15-mer homothymidine sequence.
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In this work, an oligonucleotide chip functionalization method based on 
formation of mixed carboxylic group-terminated and oligo(ethylene glycol)-
terminated alkanethiols, amide bond formation between streptavidin and 
activated carboxylic group and biotinylated oligonucleotide probe binding to  
streptavidin was modified to reach a high streptavidin and oligonucleotide probe 
density and accessibility to target molecules. A systematic investigation of 
immobilization parameters such as streptavidin binding buffer pH or salt 
concentration, probe spacer length, and concentration of reagents was carried 
out. The DNA-sensor with optimized immobilization method was capable to direct 
detection of short ON hybridization at subnanomolar level with high 
reproducibility, specificity, efficiency and regenerability. The resulting sensor 
immobilization and detection characteristics were compared with well established 
method of immobilization utilizing self-assembled monolayer (SAM) composed of 
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PB phosphate buffer  
PBS phosphate buffer saline  
PBM phosphate buffer with addition of magnesium ions  
PBNa phosphate buffer with addition of natrium ions  
SA   sodium acetate buffer 
 
Keywords: surface plasmon resonance biosensor, oligonucleotide detection, 





Detection and characterization of nucleic acids (NAs) allow the identification 
of biological samples and are of great interest in molecular bioligy. The analysis 
relies on sensitive and specific detection of hybridization between short 
oligonucleotide (ON) probes and target nucleic acid sequence. Molecular biology 
techniques such as polymerase chain reaction (PCR), blotting techniques, DNA-
based gene sequencing, reactions based on reverse transcription, DNA-based 
ELISAs, etc. routinely utilize hybridization reaction [1, 2]). Basically DNA 
hybridization can be detected in bulk [3-5] or using ON probe immobilized on the 
sensor surface (surface-based hybridization) [6-9]. Currently, there is an 
explosive interest regarding the use of surface-based hybridization due to 
potential of DNA chips development enabling simultaneous screening of 
hundreds of DNA or RNA samples in array format [10-13]. 
Using common hybridization-based instruments, the actual hybridization 
process can not be monitored and typically only the final NA complex is detected. 
The lack of information about hybridization process still hampers the full 
exploitation of hybridization-based techniques. Moreover, the read-out system 
typically requires labeling of the oligonucleotide probes with radioactive isotopes, 
chemiluminiscent or fluorescent molecules [14]. 
Surface plasmon resonance (SPR) biosensors allow direct and label-free 
detection of hybridization reaction [7, 15-18]. Kinetic properties of ON interactions 
can be determined due to the ability of the SPR sensors to monitor the binding of 
target ON to surface-immobilized probe in real time [7, 19-21]. These 
characteristics together with potential array platform of SPR sensors 
development [22, 23] make SPR biosensors excellent candidates for further DNA 
or RNA chip applications. Recently, the trend inn SPR genosensors development 
is to lower the detection limits of hybridization detection to make SPR sensors 
comparable with the common and well established fluorescence or radioactive-
based DNA microarrays. 
The lowest concentrations of short ON targets that were detected directly and 
without any additional (enzymatic, electrochemical, fluorescent) amplification by 
current SPR biosensors,  were at a nanomolar level [15, 24, 25], moreover in 
many SPR-based studies, ON hybridization at a micromolar level was exploited 
[21, 26-29],  
A method of probe immobilization influences significantly the sensitivity and 
efficiency of the sensor and thus it is a fundamental step during SPR biosensor 
development [30-32]. A common goal of surface chemists is to develop a robust 
procedure for immobilization of probes on the sensor chip with high stability, 
reproducibility, sensitivity and efficiency with minimal impact on probe 
hybridization activity. 
Various immobilization procedures for attachment of ON probes on gold SPR 
sensor surface have been reported. Two most common strategies are as follows: 
(1) assembly of thiol-terminated oligonucleotide probes on gold [32-34], and (2) 
coupling of biotinylated probes to the streptavidin assemblies via a non-covalent 
highly affinitive streptavidin-biotin interaction [30, 35, 36]. Streptavidin is a 
tetrameric protein with dyad symmetry and with extremely high affinity to biotin 
(Kd~10
-15 M) [37]. Each streptavidin contains with four equivalent binding pockets 
for biotin [38].  
In commercially available SPR biosensors, streptavidin coating is prepared 
using “amine coupling chemistry” based on covalent attachment of streptavidin 
by primary amines to activated carboxylate groups in carboxymethyl groups-
terminated dextran matrix. The transformation of carboxymethyl groups into the 
reactive N-hydroxysuccinimidyl esters (process of activation) is performed using  
N-hydroxysuccinimide (NHS) and N-ethyl-N’-(3-diethylaminopropyl) carbodiimide 
(EDC) reagents [39, 40]. This method (if you start from clean gold) is rather 
laborious, and problems with stability [2], non-specific binding [41] and 
reproducibility [30] were reported.  
In this work, a more robust method of covalent attachment of streptavidin to 
NHS-ester-terminated alkanethiolates [39, 41] followed with coupling of 
biotinylated probes was used to achieve high DNA-sensor sensitivity, 
reproducibility, efficiency and specificity. This procedure (assembly of mixed 
alkanethiols, activation of carboxylic groups, streptavidin and probes attachment) 
was optimized in terms of reagent concentrations, buffer salt composition, pH, 
and probe spacer length. As it was reported in our previous work, the resulting 
SPR sensor is capable to detect concentrations of ON probes as low as 0.1nM 
with high reproducibility and specificity [18], In this work, the achieved high 
hybridization efficiency, streptavidin binding accessibility and sensor 
regenerability are further compared with a well established protocol of another 
functionalization strategy where streptavidin is non-covalently attached to the 







The C16-chained alkanethiol (C16-mercaptohexadecanoic acid), and 
streptavidin from Streptomycea Avidinii were purchased from Sigma-Aldrich, 
USA. The C11-chained di(ethylene glycol)- terminated alkanethiol was purchased 
from Prochimia, Poland. The C15-chained  alkanethiol linked to a biotin 
headgroup by three ethylene glycol groups was obtained from the University of 
Washington, USA. The N,N,N',N'-Tetramethyl-O-(N-succinimidyl)uronium 
tetrafluoroborate (TSTU) (pure, ≥98%) was purchased from Sigma-Aldrich, USA. 
Absolute ethanol was purchased from MERCK, Czech Republic. The anhydrous 
N, N-dimethylformamide (DMF) (≥99.8%) was from Sigma-Aldrich, USA. Formic 
acid and bovine serum albumin were purchased from Sigma-Aldrich, USA. 
Biotinylated deoxyribooligonucleotide probes (23-mers, HPLC-purified) with 
sequence of biotin-(TEG)2-5’-d(CAG TGT GGA AAA TCT CTA GCA GT)-3’ (= 
BdO23), biotin-(TEG)2-5’-(dA23)-3’ (= BdA23) and the target oligonucleotide 5'-
d(ACT GCT AGA GAT TTT CCA CAC TG)-3’ (= CdO23) with a complementary 
sequence to BdO23  were purchased from LMFR of Masaryk University in Brno, 
Czech Republic. 
The buffer solutions used for streptavidin or oligonucleotide binding were of 
compositions as follows: PB (1.4 mM KH2PO4, 8 mM Na2HPO4.12H2O, 2.7 mM 
KCl, pH 7.4 at 20°C); PBS (1.4 mM KH2PO4, 8 mM Na2HPO4.12H2O, 137 mM 
NaCl, 2.7 mM KCl, pH 7.4 at 20°C), PBM (1.4 mM KH2PO4, 8 mM 
Na2HPO4.12H2O, 15 mM MgCl2, pH 7.4 at 20°C); PBNa (1.4 mM KH2PO4, 8 mM 
Na2HPO4.12H2O, 0.75 M NaCl, 2.7 mM KCl, pH 7.4 at 20°C); and SA (1 mM 
sodium acetate, pH 5.0 at 20°C). 
 
 
2.2 SPR sensor 
 
In this research, we used a recently developed SPR sensor platform based 
on the spectroscopy of surface plasmons [45] and wavelength division 
multiplexing (WDM) [46]. This sensor combines the wavelength division 
multiplexing of two serially ordered sensing channels in a special sensing 
element with four parallel light beams (see Figure 1) to yield the total of eight 
sensing channels. Broadband light from a halogen lamp is collimated and 
polarized, and then introduced into the WDM-SPR sensing element interfaced 
with a sensor chip made of SF-14 glass coated by an adhesion-promoting 
titanium film (thickness - 2 nm) and a gold film (thickness - 55 nm). Upon the first 
incidence on the gold film, each light beam excites a surface plasmon at a certain 
wavelength (~ 650 nm). The reflected light is redirected towards the gold film at a 
different angle of incidence and excites a surface plasmon at a different 
wavelength (~ 800 nm). The sequential excitation of the surface plasmons gives 
rise to two narrow dips in the spectrum of transmitted light (Figure 1). The 
transmitted light is collected into four optical fibers and coupled to a four-channel 
spectrograph. Acquired spectra are analyzed in real time by a special software 
that allows tracking the resonant wavelength in each sensing channel [47]. A 
flow-cell with eight separate flow chambers is interfaced with the chip to contain 
the sample during the experiments. Each flow chamber covers the area, where 
the surface plasmon is excited – the sensing channel. The flow chambers are 
designed to provide laminar flow along the sensor surface. The height of the flow 
chambers is rather small (50 µm) to facilitate the diffusion of the analyte to the 
surface of the sensor. The volume of each flow chamber is about 1 µl. A 
peristaltic pump is used to flow liquid samples over each sensing channel at a 
flow rate of 30 µl/min. 
 
Figure 1 Scheme of an eight-channel SPR sensor with four parallel light beams and the 
wavelength division multiplexing (WDM) of sensing channels (lower picture). Spectrum of 
transmitted light with two SPR dips before (------) and after the binding (_____) (upper picture). 
 
In order to compensate for the non-specific sensor response and thus provide 
more accurate results, typically in reported experiments one sensing channel  
was coated with a reference ligand, especially with bovine serum albumin (BSA) 
for monitoring of potential non-specific binding of biotinylated probes, or with ON 
(BdA23) with fully non-complementary base sequence to target molecule(CdO23). 
When the analytes were flowed over the sensor surface, the SPR wavelength 
shift measured in the measuring and reference channels are subtracted to 
account for temperature fluctuations (causing a drift in the sensor response). 
The shift in the resonant wavelength shown in Figure 1 is proportional to the 
refractive index change at the sensor surface. A typical SPR-sensorgram as the 
nanometers over time obtained from the analyte binding to receptor immobilized 
on the sensor surface is shown in the Figure 2. Three phases of measurement 
can be distinguished: washing the sensor surface with buffer till the stable 
baseline is achieved (Fig. 2, I.), flowing with the solution of analyte over the 
sensor surface - complex formation with immobilized biomolecular partner is 
monitored (Fig. 2, II.), washing the sensor surface with the same buffer as before 
the analyte injection – dissociation of complexes can be measured (Fig 2, III.). 
The level of bound analyte to the sensor surface is determined as the difference 
in sensor response nanometers of the buffer equilibrium level after washing the 
bound surface and baseline level obtained from flowing with the same buffer 
before injection of the analyte solution. 
 


















































Figure 2 The typical SPR sensorgram corresponding to real-time measurement of analyte 
binding; In the first phase, the functionalized sensor surface is washed with buffer (I.), then the 
solution of analyte is injected and biomolecular complex formation can be occurred (II.), washing 
the solution with the same buffer as in the phase I. to monitor a potential dissociation and to 
achieve a level of not-removed analytes. 
 
The sensor response can be calibrated to the surface concentration of bound 
molecules. The calibration coefficient interrelating the sensor response and the 
concentration of analyte is proportional to the molar weight of the molecules [48] 
and depends on the resonant wavelength. It was estimated from a theoretical 
model that a shift in the resonant wavelength of 1 nm corresponds to a change in 
the surface concentration of streptavidin of about 1.8x1011molecules/cm2 when 
measured at the wavelength of 750 nm. It can be shown, that the sensor 
response per unit mass coverage is comparable for most proteins and single-
stranded or double-stranded oligonucleotides [49]. Therefore the 
probe/streptavidin binding ratio and target/probe hybridization efficiency can be 
calculated from the ratio of sensor responses when different molecular weigths of 
these ligands are taken into account. To allow comparable sensor response 
quntification all sensorgrams were recalibrated to the sensitivity at operating 
wavelength of 750 nm. 
 SPR sensor chips, SF14 glass chips 32mmx18mmx1.5mm (Schott, USA), 
were coated with 2 nm of Ti and 55 nm of Au by electron beam evaporation. 
These chips were exhaustively rinsed with absolute ethanol and water and dried 
with nitrogen stream. These substrates were then cleaned in UV ozone cleaner 
for 15 minutes, washed with water and dried with nitrogen stream. The cleaned 
sensor chips were stored in desiccator before use. 
 
2.3 Functionalization of the sensor chips 
  
 To save the purity of the SPR chips, the majority of manipulations with the 
chips was performed in the flow box (Schoeller-Pharma, Czech Republic). 
 
MHA method 
 Functionalization method that was systematically investigated herein “MHA 
method” utilized covalent attachment of streptavidin to ω-carboxyalkylthiol- 
(MHA) and self-assembled monolayer via amide bond forming chemistry followed 
with biotinylated oligonucleotide target coupling [41]. The di(ethylene 
glycol)alkylthiols (OEG) were also present in the SAM to form a non-fouling 
background. 
A typical MHA-functionalization procedure was as follows: 
 A molar 7:3 mixture of C11-chained (OEG) and C16-chained (MHA) 
alkanethiols was dissolved in degassed absolute ethanol with a total thiol 
concentration of 1 mM. Sensor chips were immersed in thiol solution at 
temperature of 40°C and stored in a dark place at room temperature for up to 2 
days. Then, the chips were rinsed with ethanol, dried with nitrogen, rinsed with 
water and dried with nitrogen again. The carboxylic terminal groups on the 
sensor surface were transformed into reactive N-hydroxysuccinimidyl esters with 
N,N,N',N'-Tetramethyl-O-(N-succinimidyl)uronium tetrafluoroborate (TSTU) in this 
way: A sensor chip was immersed in solution of TSTU in argon (≥99.999%)-
bubbled DMF (1 mg/ml), and slightly shaked at a temperature of 20°C for 1 h. 
The sensor chip was rinsed with water, dried with nitrogen and immediately 
mounted into the SPR instrument. 
Streptavidin attachment was performed in situ (Figure 3) by flowing sodium 
acetate (SA) buffer until the baseline was achieved, then SA solution with 
50 µg/ml of streptavidin was brought into the contact with the sensor surface for 
15 minutes. Then the SA buffer was injected again. After short chip incubation 
with 10 mM phosphate buffer containing sodium chloride at concentration of 0.75 
M, pH 7,4 at 20°C (PBNa) to remove all non-covalently bound ligands from the 
surface, the sensor surface was flushed with SA again. Phosphate buffer with 
addition of magnesium ions (PBM) was injected. Solutions of biotinylated 
oligonucleotide targets (BdO23 and BdA23, respectively) were flowed along the 
sensor surface for 15 minutes at concentration of 50nM followed with PBM 
injection. 

















































































Figure 3 A typical sensorgram corresponding to DNA chip functionalization with MHA method; 
The resulting streptavidin and ON probe surface densities are indicated. Arrows indicate time of 
injection of solution of particular analyte or buffer. 
 
As you can see from figure 3, streptavidin and oligonucleotide probe surface 
densities can be determined from measured sensorgrams. These values in 
dependence of various factors, such as molar fraction of MHA, concentration of 
TSTU, use of inert argon atmosphere during activation process, buffer salt 
composition, pH, and ON probe spacer length were monitored. 
 
BAT method 
A 4:1 molar mixture of C11-chained di(ethylene glycol) alkanethiol (OEG) and 
biotinylated alkanethiol (BAT) was dissolved in absolute ethanol with a total thiol 
concentration of 100nM [50, 51]. The C15-chained alkanethiol chain linked to a 
biotin head group by three ethylene glycol groups, was used as the specific 
binding element. The clean sensor chips were immersed in BAT/OEG thiol 
solution as it was described above and stored for up to 2 days at room 
temperature. After cleaning the sensor surface with ethanol and water, the 
sensor chips were mounted into SPR instrument. Streptavidin solution (50 µg/ml) 
in PB buffer was flowed along the sensor surface for 15 minutes. After short-time 
switching to PB buffer, PBM buffer was injected. Fifteen-minutes incubation of 
probes BdO23 and BdA23, respectively, both at concentration of 50 nM was 
followed. 
 
2.4 Detection of DNA hybridization on surface prepared using both MHA 
and BAT method 
 
Detection of ON hybridization: Hybridization buffer (PB or PBS buffer with 
addition of magnesium and/or natrium ions in concentration range 0-20mM) was 
flowed over the functionalized sensor surface (measuring and reference) until the 
stable baseline was achieved. ON target CdO23 in hybridization buffer was 
injected at concentration of 100nM and incubated for 15 minutes. Hybridization 
buffer was then injected again. 
Regeneration of the sensor surface:  Regeneration of the sensor chips was 
performed using the following procedure: after binding of the target (CdO23) to 
immobilized probe BdO23 in PBM buffer at concentration of 100 nM, the solution 
was replaced with PBM buffer for a short time. Then, the sensor surface was 
incubated with the regeneration reagent ( 2% HCOOH) for 3 minutes and 
switched to PBM buffer until a stable baseline was achieved. After that, the same 
solution of target was injected again and the whole procedure was repeated. 
Calibration curve measurements: After reaching a baseline with PBM buffer, 
the ON target CdO23 was sequentially injected for 8 minutes over the 
functionalized sensor surface at concentration of 0.2, 0.5, 1, 2, 5, 10, 25, 100 and 
200 nM. PBM buffer was injected again. Between individual injections of CdO23 
the sensor surface was regenerated using regeneration procedure described 
above except for concentrations of CdO23 lower than 2 nM for which the 
regeneration was not carried out (the amount of complexes formed from ONs 
injected at such low concentrations was much smaller in comparison with the 





Ellipsometric measurements in this study were performed using spectral 
ellipsometer with a rotating analyzer (SE850, Sentech, Germany). The sensor 
chips for ellipsometric experiments were functionalized with SAM using the same 
procedure as it was used for SPR measurements. The cleaned gold chips were 
used as a reference. The gold permittivity was modeled by a Drude model with 
three Lorentz oscilators, the thickness of the layer was fixed to 55nm. To achieve 
a reliable fit, each sensor chip was measured at angles of incidence 50, 60 and 
70 degrees in the range from 400 to 1600nm. The measured molar ratios of 
C16COOH were 0, 0.1, 0.3, 0.6 and 1. Measurements at angles of incidence 50, 
60 and 70 degrees in the range from 400 to 800nm was performed in a set of 




3. RESULTS AND DISCUSSION 
 
3.1 Optimizing a self-assembled monolayer formation  
 
To validate the assembly of the alkanethiols and homogeneity of the formed 
self-assembled monolayer (SAM) on the surface, the thickness of the SAM 
versus χ(MHA) was measured by optical ellipsometry in a set of spots from 
different positions of each sensor chip. Refractive index of thiolate layer was 
supposed to be 1.45. The increasing thickness with the increasing molar fraction 
of MHA in the mixture of alkanethiols was measured (Figure 4). Especially for the 
χ(MHA) of 0.3, the averaged thickness of the SAM of (1.8±0.1) nm was obtained. 
The standard deviation error of 12% shows a good homogeneity of the SAM 
formed in the whole area of the sensor surface. 
 




































Figure 4 A thickness of alkanethiolate monolayer formed on gold sensor surface in dependence 
on the MHA molar fraction in solution of MHA/OEG alkanethiols prepared before chip incubation. 
 
To find an optimal molar fraction of MHA in MHA/OEG solution that was 
prepared for formation of SAM on the clean gold sensor surface, a set of sensor 
chips covered with SAM of different MHA fraction was prepared. A total 
concentration of alkanethiols in SAM solution was hold constant (1 mM) and the 
molar fraction of MHA was varied from 0 - 1. Streptavidin binding was then 
monitored in four different sensing channels on each individually prepared sensor 
chip under the same binding conditions. The resulting surface density vs. molar 
fraction of MHA is shown in the Figure 5. It was found that χ(MHA) of 0.3 was 
sufficient value that reaches the maximal streptavidin coverage. ),  
In the study of Lahiri et al. [41], the same value (0.3) of longer chained 
alkanethiol fraction present in a mixed formed SAM was observed to reach the 
maximal sensor coverage with other proteins , i. e. cytochrome c (MW of 12.4 
kDa) and lysosyme (MW of 14.4 kDa. Compared to streptavidin (MW of 60 kDa) 
these proteins are much smaller and thus of higher diffusivity coeficient. This 
result suggests that streptavidin diffusion through the flow cell to the sensor 
surface under the measuring conditions (streptavidin concentration of 50µg/ml, 
flow rate 30µl/min, flow cell dimensinons) did not influence the binding reaction 
(amide bond formation) A specificity of streptavidin binding was confirmed using 
sensor chip pretreated only with OEG (χ(MHA)=0.0). No significant sensor 
response to streptavidin binding to the SAM composed of OEG was found 
(Figure 5). 




































Figure 5 Streptavidin surface coverage on activated SAM in dependence of molar fraction of 
MHA. Total thiol concentration was 1 mM, streptavidin was injected in SA buffer for 15 minutes at 
concentration of 50µg/ml. Non-covalently bound ligands were removed from the surface by short-
time washing the surface with PBNa buffer. The final streptavidin level was determined as a 
wavelength shift between the sensor response obtained after 10 minutes washing of the 
streptavidin surface with PB buffer (injected after incubation with PBNa buffer) and the level of the 
PB before injection of streptavidin. 
 
 
3.2 Optimizing activation of carboxylic groups 
 
After washing the sensor chip in ethanol and water, each sensor chip was 
immersed in activation solution to create the reactive NHS-esters. The N,N,N',N'-
Tetramethyl-O-(N-succinimidyl)uronium tetrafluoroborate (TSTU) dissolved in 
DMF as the activation reagent was used [52, 53]. A significant positive effect of 
inert (argon-degassed) conditions during the activation process was observed 
(data not shown). Air humidity interfered with formation of NHS-esters and thus 
could lower the yield of the required reaction. 
A strong dependence of percentage of activated carboxylic groups monitored 
by streptavidin binding on sensor chip activated by TSTU in DMF in argon-
degassed conditions on concentration of TSTU in DMF (see Figure 6) was 
observed. The activation time of 2 hours with slight shaking under argon 
atmosphere was constant across the performed experiments. This time was 
previously found to be long enough for activation of maximal amount of 
carboxylic groups (data not shown). It was found that DMF-solution containing 
TSTU at concentration of 2 mg/ml almost activated the maximal streptavidin-
accessible amount of carboxylic groups and thus this concentration was used for 
all further experiments. 





































Figure 6 Effect of TSTU concentration on activation efficiency monitored by level of immobilized 
streptavidin (time of activation: 2 hours, streptavidin was injected over the activated SAM in PB 
buffer at a concentration of 50µg/ml for 20 minutes at flow rate 30µl/min). 
 
 
3.3 Optimizing streptavidin binding 
 
Streptavidin binding buffer composition was investigated. MHA molar ratio 
(0.3), activation process (1 hr under inert atmosphere with TSTU concentration of 
2 mg/ml), streptavidin concentration (50 µg/ml), and streptavidin incubation time 
(20 minutes) were hold constant, A strong dependence of streptavidin coverage 
on pH and salt concentration of sodium acetate buffer (SA) was observed (Figure 
7A). Buffer pH of 5.0 that is by 1 lower than is the value of streptavidin isoelectric 
point (~6) was found to be optimal to reach the maximal streptavidin coverage. 
This result is a good agreement with that obtained for other proteins in the study 
of Lahiri et al. [41]. It was further found that addition of salt (natrium chloride) into 
streptavidin binding solution significantly decreased the streptavidin coverage. 
This effect is probably caused by the fact that added ions can decrease the 
electrostatic attraction between the positively charged streptavidin and slightly 
negatively charged sensor surface of mixed alkanethiolates. 
To confirm the streptavidin binding activity after immobilization at particular 
conditions displayed in the Figure 4A, biotinylated probe coupling to free 
streptavidin layer was monitored. The concentration of ON probes (100nM), 
binding buffer (PB) and incubation time were constant. The resulting ON probe 
surface coverage levels are shown in the Figure 7B. It was found that maximal 
streptavidin coverage yields also maximal sensor coverage with ON probes 
suggesting that there are not any steric hindrances or repulsions in probe binding 






Figure 7 Streptavidin binding buffer optimization: A) Effect of salt concentration and pH on 
streptavidin binding carried out in 1 mM sodium acetate buffer, B) Immobilized levels of 
oligonucleotide probes BdO23 that were injected at concentration of 100nM in PB buffer over 
streptavidin layer prepared in SA buffer by the particular conditions displayed in the Figure 6A; 
(The values of NaCl concentrations and pH displayed in Figure 4B are referred to streptavidin 
binding buffer) 
 
Effect of streptavidin concentration in injected SA buffer solution (incubation 
time was 20 minutes) was investigated. Figure 8 shows the final streptavidin 
coverage levels (that were averaged from four independent experiments) in 
dependence on streptavidin concentration in injected solution. From that we 
concluded that concentration of 50 µg/ml was a good compromise between 
sample consumption and immobilized ligand density, so we used this 
concentration in all other experiments. 







































Figure 8 Surface coverage with streptavidin (in sensor units) in dependence on streptavidin 
concentration in SA buffer (interaction time 20 minutes, flow rate 30 µl/min). Streptavidin solutions 































































































individual sensing channels over the activated sensor surface. The final levels were averaged 
from four individual sensor chips. 
 
 
3.4 Optimizing biotinylated probe binding 
 
Oligonucleotide probes used in this study were modified with biotin at their 5'-
end through the inserted spacer. The probe binding buffer was PB, concentration 
of probe (BdO23) was 50 nM, and incubation time was 15 minutes. 
Tri(ethyleneglycol) (TEG) was chosen as a spacer due to its slightly hydrophilic 
properties, which makes this spacer well compatible with the proteins and NAs. 
This spacer length was optimized herein. The obtained probe coverage levels for 
spacer lengths (TEG), 2x(TEG), and 3x(TEG) were 2.2 nm, 3.7 nm and 3.6 nm, 
respectively, after conversion to unique molecular weight of probes, showing a a 
surprisingly high effect of spacer length on probe binding to streptavidin pockets. 
The highest probe coverage was obtained for a probe containing a spacer with 
length of 2x(TEG) (=hexa(ethyleneglycol))). This longer spacer probably 
increased the mobility of the bound ONs that increased the accessibility of 
unbound streptavidin binding sites and thus the probability of binding of another 
probe molecule to free streptavidin pocket was higher. Further increase of probe 
coverage with increasing of spacer length was not observed, thus the 
hexa(ethyleneglycol spacer was the chosen as the optimal length. 
The concentration-dependent sensor response to binding of BdO23 probe 
containing hexa(ethyleneglycol spacer is shown in the Figure 9. It was found that 
under experimental conditions the probe concentration in PB buffer solution of 
50nM is sufficient enough to reach the saturation level of accessible streptavidin 
binding sites. The specificity of the biotinylated probe-streptavidin binding was 
confirmed with the flowing of BdO23 at concentration of 1 µM for 20 minutes 
along the surface functionalized with bovine serum albumin. No response was 
observed (data not shown). 






































Figure 9 Sensor response to biotinylated probe (BdO23) binding with different concentration to 
streptavidin layer; binding buffer was PB, incubation time was 15 minutes. 
 
 
3.5 Optimizing target binding 
 
As it was shown in the part 3.4, concentration of 23-mer probe of 50 nM is 
sufficient to reach the saturation level on streptavidin surface under the 
experimental conditions and similarly the target concentration of 100nM was 
found to reach the probe saturation level (Figure 12A). Using these 
oligonucleotide concentrations and using previously optimized parameters, an 
hybridization efficiency (=percentage of immobilized probes present in complexes 
with complementary oligonucleotide target) was investigated.  
To increase the hybridization efficiency (HE%), effect of MgCl2 concentration 
in hybridizing buffers (PB and PBS) was studied. Hybridization efficiency was 
than calculated as a HE% = saturation level of bound CdO23 [nm] / saturation 
level of BdO23 [nm] x 1.1. Coefficient 1.1 was a conversion factor to different 
molecular weights of BdO23 (7.9 kDa) and CdO23 (7.0 kDa). A strong dependence 
of HE% on concentration and types of present ions was observed (Figure 10). 
The best hybridization conditions were measured in the presence of high 
concentration of magnesium ions (concentration of MgCl2 in PB was higher than 
15mM). That shows a stabilizing effect of magnesium divalent ions on surface-
based DNA hybridization of short oligonucleotides. Addition of magnesium ions 
into the buffer containing NaCl at concentration of 137 mM (PBS) had not such 
positive effect on HE% as it was observed for PB buffer. This suggests that high 
concentration both of monovalent and divalent ions in hybridizing buffer has a 
negative effect on HE%. Presence of monovalent and divalent ions in hybridizing 
solution can increase the probe-target repulsion and thus to reduce the 
oligonucleotide complex fomration Buffer of composition of 10 mM phosphate 
buffer, 15 mM MgCl2, pH 7.4 at 20°C (=PBM) was used in all other experiments 
for binding of oligonucleotides (probes and targets). 


































 10 mM PB (without NaCl), pH 7.4
 10 mM PB,137 mM NaCl, 
        2.7 mM KCl, pH 7.4 (PBS) 
 
Figure 10 Effect of concentration of addition of NaCl and MgCl2 into the hybridizing buffer on 
hybridization efficiency. Targets with complementary sequence were injected over the 
streptavidin/probe layer in hybridization phosphate buffer at concentration of 100 nM for 15 
minutes. 
 
It was observed by other SPR groups, that HE% of surface-hybridization is 
strongly dependent on density of immobilized probes, and the decreasing HE% 
with increasing probe density was reported [32, 49]. Hybridization efficiencies as 
high as 60% have been reported for amine coupling chemistry in case of 
maximal density of immobilized probes on the sensor surface [49]. Using MHA 
method with optimized parameters reported herein the HE% of ≥85% was 
achieved in case of a maximal available probe density. 
 
 
3.6 MHA functionalization procedure with optimized parameters 
 
The procedure of functionalization of the DNA-chip via MHA method with the 
optimized parameters was summarized as follows: 
 Clean the sensor surface (gold) in UV ozone cleaner for 15 minutes, 
exhaustively wash it with water (milliQ) and dry with nitrogen stream. Immerse 
the clean sensor chip into alkanethiolate OEG and MHA ethanol solution at a 
total thiol concentration of 1 mM with a MHA molar fraction of 0.3 at temperature 
of 40°C. After 10 minutes incubation at 40°C store the chip in this solution in a 
dark place at room temperature for up to 2 days. Rinse the chip with ethanol, dry 
with nitrogen stream, rinse with water and dry with nitrogen again. Immerse the 
sensor chip in solution of TSTU in argon degassed DMF (2 mg/ml), and slightly 
shake it for 1 h under inert atmosphere. Then rinse the sensor chip with water, 
dry with nitrogen and immediately mount it into the SPR instrument. 
After short-time incubation of the sensor surface with SA buffer, inject 
streptavidin in SA buffer at concentration of 50 µg/ml for 15 minutes at room 
temperature with flow rate 30 µl/min. Switch to SA buffer again. Flow with PBNa 
buffer along the streptavidin coated surface for 5 minutes to remove all non-
covalently bound ligands. Flush the sensor surface again with SA to monitor the 
final streptavidin immobilization level. Switch to PBM buffer. Inject a solution of 
biotinylated oligonucleotide targets at concentration of 50 nM until the plateau is 
achieved (typically for 15 minutes using flow rate 30 µl/min). Switch to PBM 
buffer again. When the stable baseline is reached, the sensor is ready for ON 
targets detection. 
The reproducibility of DNA and RNA chips preparation was calculated from 
the ON probe coverage values obtained from 7 individually prepared sensor 
chips and 3 channels per one sensor chip. The chip-to-chip reproducibility was 
91%, on-chip reproducibility was 96% (in terms of standard deviation 
calculations). Figure 11 shows the sensor response to BdO23 binding to 
streptavidin obtained from 3 individual sensing channels. 



































Figure 11 Sensorgrams corresponding to BdO23 probe binding to streptavidin obtained from 
three individual sensing channels; concentration of BdO23 was 50nM, sensor chip was prepared 
using optimized MHA method 
 
 
3.7 Detection of DNA hybridization using an SPR sensor functionalized by 
optimized MHA method 
 
A high specificity and chip-to-chip reproducibility (≥95%) of ON hybridization 
detection via the optimized-MHA-method  functionalization was reported in our 
previous study [18].  
The regeneration procedure to remove target molecules from immobilized 
probes without lost of probe hybridization activity was applied using 2% freshly 
prepared solution of formic acid and incubation time of 3 minutes. It was 
confirmed from the experiments including repeated injection of CdO23 at 
concentration of 100 nM followed with the regeneration procedure, the sensor did 
not significantly lose its sensitivity to ON hybridization detection for minimally 10 
measurement/regeneration cycles (data not shown here).  
Sensor response to ON hybridization detection represented by increasing 
concentration of CdO23 in the range 0.2nM – 200nM on MHA-method 
functionalized sensor chip is displayed in Figure 12A. A detail of detection of ON 
hybridization for low target concentrations is shown in the Figure 12B. After 
measurement with CdO23 at concentration of ≥2nM the sensor surface was 
regenerated using the protocol that was described above. The theoretical noise-
limited detection limit of the SPR sensor was calculated as the analyte 
concentration that generates the sensor response of the triple of baseline noise 
standard deviations and was determined to be 100 pM (see Figure 12B). The 
lowest concentration of 23-mer ON target that was detected with reported 
reproducibility (>95%) [18] was 200 pM (Fig. 12B). 
The calibration curve of developed ON-sensor was determined as the binding 
rate of ON target binding curve injected at particular concentration versus that 
concentration. This approach was previously shown to be suitable for rapid 
biosensor data analysis [54]. The resulting calibration curve is displayed in Figure 
12C. The linearity of the measured calibration curves is in a good agreement with 
the theoretical Langmuir isotherm of concentration-dependent target binding 
profile. 




























































































































































Figure 12 Detection of ON (23-mer) hybridization on sensor chip functionalized with BdO23 probe 
using the optimized MHA method; A) Sensor response to increasing concentration of CdO23 
target (incubation time 8 minutes, regeneration of the sensor surface was performed using 2% 
HCOOH in 3 minutes long flowing) B) a detail of the ON hybridization detection for the target 
concentration range 0.2 nM- 2nM. C) a resulting sensor calibration curve ;the measuring metrics 
were switched off during incubation of sensor surface with HCOOH due to its high resonant shift 
that was not under our study. 
 
 
3.8 A comparison of MHA and BAT functionalization methods 
 
 Detection of ON hybridization was carried using the sensor chips prepared via 
both MHA (with optimized parameters) and BAT methods. The summary of 
results is shown in the Table 1. A high probe/streptavidin binding ratio (~3.2) for 
optimized MHA method suggests a very good accessibility of streptavidin to ON 
probes binding and thus very good streptavidin binding efficiency (at average 
only one binding pocket became to be inaccessible for biotinylated probe after 
streptavidin immobilization). The achieved probe/streptavidin ratio is more than 
two times higher in comparison with the value of ~1.2 that was determined for 
maximal sensor coverage with the streptavidin and probes in the work of Su et al. 
[55] for amine coupling chemistry without optimizing parameters. This difference 
is probably due to better accessibility of NHS-esters followed with higher mobility 
of streptavidin in the SAM in our approach, because longer chained (C16) reactive 
alkanethiols were present in the SAM compared to C11 chained alkanethiols in 
reference study. Our results suggest that by the optimizing functinalization 
conditions the streptavidin can be attached to the sensor surface with high 
density as well as without significant disruption of its biological activity.  
 The streptavidin/probe binding ratio for BAT method (~1.7) was comparable 
with that obtained in the reference study (~1.5) [49]. This value is still lower than 
expected value of 2 when assuming that two binding sites were not occupied 
after streptavidin binding to biotin-terminated alkanethiols. The reason for that is 
maybe in steric hindrances due to tight arrangement of streptavidin molecules on 
the sensor surface. By varying the BAT/OEG ratio and other immobilization 
parameters we could probably get closer to the expected value of 2. 
 The hybridization efficiency (86%) of MHA method achieved on the sensor 
surface with maximized probe coverage was much higher than the HE% 
obtained for BAT method (64%). This result suggest a very good availability of by 
MHA-method immobilized probes for ON target detection showing a great 











Table 1 A comparison of optimized MHA method and BAT method in terms of 








Streptavidin  (8.9 ± 0.7) nm (13.0 ± 0.7) nm 
Biotinylated probe (3.8 ± 0.3) nm (2.9 ± 0.1) nm 










A method of DNA chip functionalization (MHA method) based on formation of 
self-assembled monolayer followed with covalent attachment of streptavidin and 
non-covalent biotinylated oligonucleotide binding was investigated using an 
home-made multi-channel SPR biosensor and optical ellipsometry herein. A 
systematic optimization of parameters influencing the ligand density and activity 
such as buffers salt composition, pH, reagent concentrations, spacer length, etc. 
was carried out to develop a robust, effective and reproducible DNA chip 
functionalization method. The resulting procedure of oligonucleotide 
immobilization was shown to be highly reproducible (≥91% and ≥95% for chip-to-
chip and on-chip reproducibility, respectively) with the small ON probe 
consumption (concentration of probe of 50nM was found to reach the saturation 
level of the streptavidin layer). The high efficiency of streptavidin immobilization 
was shown because more than three binding sites per one immobilized 
streptavidin molecule were available for biotinylated probe binding. It was further 
shown that SPR sensor with this optimized immobilization method enables a 
rapid direct detection of short oligonucleotides with high specificity, reproducibility 
and regenerability over the three orders of magnitude of target concentration 
(100 pM – 200 nM). The resulting sensor detection limit of 100pM for 23-mer 
oligonucleotides was one hundred times lower than typically reported detection 
limits of SPR-based direct ON detections.  
The resulting sensor performance was compared to previously optimized and 
well establish method of streptavidin immobilization to biotin-terminated 
alkanethiols (BAT method). Using approach optimized in this work, a significant 
increase of hybridization efficiency was achieved (86% for MHA method vs. 63% 
for BAT method in case of maximal available sensor coverage with streptavidin 
of biotinylated probes). 
The results show a great potential of application of optimized protocol of MHA 
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Integration of a double-stranded DNA copy of the human immunodeficiency 
virus (HIV) genome into the host cell chromosome is a crucial step in HIV replication 
and therefore presents an attractive target for drug development. The process of 
integration is catalyzed by retroviral integrase (IN). The catalysis proceeds in two 
reactions: 3'-processing reaction, where 5' phosphorylated dimer (pGT) is specifically 
cleaved from both ends of viral long terminal repeats (LTR) yielding a processed 
DNA and strand transfer reaction, in which the exposed 3'-hydroxyl groups of the 
processed ends are joined to 5’ phosphates in the host DNA [1]. The catalytical 
activity of IN has been demonstrated in vitro using oligonucleotide (ON) substrates 
that mimic the viral LTR ends [2, 3] and techniques such as polyacrylamide gel 
electrophoresis (PAGE) [4], fluorescence resonance energy transfer (FRET) [5] or 
microtiter plate assays [6, 7]. However, these methods yielded different DNA-binding 
specificity or activity [2, 8]. Moreover, these techniques are rather laborious and require 
fluorescent or radioactive labeling thus increasing the complexity of the assay. 
In this work, we demonstrate label-free monitoring of IN strand transfer activity 
using a surface plasmon resonance (SPR) biosensor. In addition, the effect of four 
different divalent metal cofactors (Mn2+, Mg2+, Ni2+ and Co2+) on IN binding ability to 
LTR mimic as well as to triplex ON was also examined. The results obtained using 
the SPR method were compared with those obtained from PAGE. 
SPR biosensors are based on measuring refractive index changes in the 
proximity of a metal (gold) surface which are produced by the binding of analyte to its 
biospecific partner immobilized on the metal surface [9]. In this work, we employ a 
recently developed eight-channel SPR sensor based on spectroscopy of surface 
 2 
plasmons and wavelength division multiplexing [10]. Each sensing channel of a sensor 
chip coated with self-assembled monolayer of alkanethiols with covalently 
immobilized streptavidin, was functionalized with biotinylated ONs[11]. For monitoring 
of the IN-catalysed strand transfer, four sensing channels were modified with the un-
processed ds-LTR mimic (23-mer) (SS’23) with terminal ...CAGT-3’ sequence and 
four channels with triplex T23*A23*T23 used as a reference. . 
Solutions of IN with particular metal cofactor were injected into the appropriate 
channels (each type of metal cofactor per one pair of measuring and reference 
channels was used), Figure 1. It was found that IN forms stable complexes with both 
ds-LTR mimic and triplex in the presence of all examined ions. The amount of 
enzyme that remained bound to ONs after washing the sensor surface with buffer 
was in average 1.5-times higher for triplex than for  ds-LTR mimic. The amount of 
bound enzyme to both ds-LTR mimic and triplex in the presence of Mg2+ and Mn2+ 
cofactors was up to two times higher than in the presence of Co2+ and Ni2+. This 
suggests that Mg2+ and Mn2+ cofactors stabilize the IN-DNA complex much better 
than remaining cations. While Mn2+ exhibits the highest stabilizing effect on the 
binding of IN to ds-LTR mimic , the Mg2+  is generally known to stabilize the triplex 
DNA [12] as well as better binding of IN to triplex. As demonstrated previously, IN 
forms stable complexes with both DNAs in the presence of metal ions[1]. The ds-LTR 
mimic binds preferentially to the catalytic site of IN but also in some extent to other 
sites in the IN multimer, thus also serving as a target DNA. In contrast, triplex 
occupies mostly target site within the IN multimer. The existence of the strong metal 
dependent interaction between IN and DNA triplex and its possible connection with 
some IN function is subject of further study. Similarly, the strong binding of IN to „Y“ 
intermediate has been previously reported and was supposed to be connected with 
its disintegration activity [13]. 
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Figure 1 Sensorgrams corresponding to HIV-1 Integrase binding to (SS’)23 and (TAT)23 
oligonucleotides in the presence of different metal ions. Concentration of each ion in buffer was 8mM; 














To detect the strand transfer reaction, 5´-phosphorylated self-complementary 
12-mer ON (pTS12) serving as a target DNA was passed over the surface of the 
sensing channels with IN-DNA complexes. The arrangement of the strand transfer 














Figure 2 Scheme of the strand transfer reaction monitored using SPR biosensor. In the first step, the 
ON representing viral LTR end was immobilized on the sensor surface. Then HIV IN was added and 
shortly incubated with the sensor surface. Finally, the solution of 5’-phophorylated self-complementary 
12-mer ON pTS12 representing target DNA was injected to the sensing channel. The strand transfer 
reaction proceeded for 30 min resulting in integration of the immobilized processed viral DNA to the 
target DNA. 
 
Sensorgram of the strand transfer reaction (Figure 3) shows that the reaction 
was mostly detected in the presence of Mn2+ and moderately detected in the 
presence of Mg2+ ions. This is in agreement with previous reports where in vitro 
strand transfer reaction was preferentially detected in the presence of Mn2+ [14] . The 
fact that pTS12 was covalently bound to the SS’23 in the presence of Mn
2+ and Mg2+ 
was confirmed by exhaustive washing of the surface with aqueous 2% formic acid to 
remove all non-covalently bound ligands. The final increase in sensor response in 
measuring channels corresponded well to the level obtained from pTS12 binding to 
SS´23 (data not shown). These results were reproduced in several independent 
experiments using de novo functionalized chips. 
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Figure 3 SPR-sensor based monitoring of IN strand transfer activity: Sensor response corresponding 
to pTS12 joining to IN-(SS’)23 complex (A) and IN-(TAT)23 complex in the presence of different metal 
ions; concentration of pTS12 was 100nM, incubation time was 25 min.  
 
To confirm the SPR results, a similar system (the same IN and ONs except for 
the length of the SS’23 that was 21-mer SS’21) employed using radiolabeled ONs and 
separation of products by PAGE. The product of the strand transfer reaction was 
observed in the presence of Mn2+. Nevertheless, the actual process of integration 
could not be monitored using this method. 
 
In conclusion, we demonstrated that the SPR technique allows sensitive label-
free real-time observation of strand transfer reaction in the presence of metal 
cofactors. We anticipate that further advances in SPR sensor instrumentation and 
functionalization chemistries will allow screening large libraries of compounds as 
possible inhibitors of the HIV-1 IN activity as well as improving sensitivity of 
monitoring of strand transfer reaction. 
 
EXPERIMENTAL 
Oligonucleotides: Biotinylated 23-mer ON probe representing a viral DNA substrate 
(S23) was of the sequence biotin-(TEG)2-5’-d(CAG TGT GGA AAA TCT CTA GCA 
GT)-3’. The homopurine reference probe was of the sequence biotin-(TEG)2-5’-
d(A)23-3’. S’23 (5'-d(ACT GCT AGA GAT TTT CCA CAC TG)-3') and dT23 were of 
complementary base sequences to S23 and dA23, respectively. Self-complementary 
12-mer serving as the DNA target substrate was of a sequence 5'-d(ACC GAC GTC 
GGT)-3' (pTS12). The ONs used in PAGE as donor substrates (OO’)21 were fully 
complementary; O21 was of 5’-d(GTG TGG AAA ATC TCT AGC AGT)-3’ sequence. 
HIV-1 IN binding (SPR): Chips coated with duplexes (SS´23) (spots 2, 4, 6, 8) and 
triplexes (TAT23, spots 1, 3, 5, 7) were prepared for detection of IN binding. All the 
SPR experiments were carried out at room temperature in Tris (20mM Tris, 50mM 
 5 
NaCl, pH7.4 at 20°C) containing 0.05% BSA with addition of particular divalent ion 
(Ni2+, Mn2+, Co2+ and Mg2+, respectively) at a concentration of 8mM. The solutions 
were first flowed through the eight channels until the baselines were achieved; 
solution containing a particular cofactor was flowed along one measuring and one 
reference surface. Then, in the same order, solutions of HIV-1 integrase with an IN 
concentration of 25µg/ml in Tris buffer containing particular cofactor were injected. 
After 15 minutes incubation, buffers were injected again. 
Strand transfer reaction (SPR): To study IN strand-transfer activity, buffer solutions 
with particular divalent ions containing 12-mer ON (pTS12, 100nM) were passed over 
the surface of the sensing channels after the injection of the HIV IN. The individual 
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1
Introduction
Advances in the life sciences (e.g., genomics, proteomics, molecular engineer-
ing) have improved the treatment of a wide range of diseases, resulting in an
improved public health and a longer life expectancy. In developed countries,
lifestyle diseases such as cardiovascular disease have become a major public
health concern and one of the leading causes of mortality. Modern health care
increasingly involves diagnostic methods based on the monitoring of disease
biomarkers in bodily fluids, as some of these markers allow for identification
of a disease at its very early stage even before its symptoms can be found.
In addition, the monitoring of concentrations of biological markers in bodily
fluids can help determine predispositions for the disease and disease pro-
gression. Furthermore, the detection of biological markers can help redefine
the diseases and their therapies by shifting the emphasis of traditional prac-
tices of depending on symptoms and morphology to a more rational objective
molecular basis. While biomarkers for certain diseases are established and al-
ready in clinical use (e.g., prostate-specific antigen for prostate cancer), the
search for reliable diagnostic biomarkers for other diseases continues [1].
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Currently, most methods for the determination of biomarkers in bod-
ily fluids are carried out in hospitals or specialized laboratories. These in-
clude enzyme-linked immunosorbent assay (ELISA), chemiluminescent, im-
munofluorescent, radiological, and microscopic assays. The immunoassays
utilize antibodies as biomolecular recognition elements and, due to the ad-
vances in antibody engineering and synthesis of humanized antibodies [2],
present one of the fastest growing diagnostic technologies. However, these
methods are rather laborious and time-consuming and offer limited automa-
tion and integration of the various operational steps [3]. Detection formats
typically require labeling and the use of additional reagents to report bind-
ing of the analyte to the receptor [4]. The labeling prolongs assay time,
increases costs, and can disturb receptor binding sites leading to false nega-
tives. Moreover, fluorescent compounds are invariably hydrophobic, and in
many screening methods, background is a significant problem potentially
leading to false positives. Furthermore, at present there are no accepted im-
munoassay tests for certain serious diseases (e.g., cancer) that are sufficiently
specific, sensitive, fast, and economically sustainable.
An ideal screening platform should be rapid, sensitive, specific, robust,
simple-to-use, and have sufficient throughput to be widely applicable in med-
ical diagnostics. In addition, the determination of an analyte should prefer-
ably be carried out directly in tested samples (e.g., blood, plasma, urine,
saliva, cerebrospinal fluid) with limited or no sample preparation. Diagnos-
tic instruments allowing continuous monitoring of analyte concentration,
which is not possible using conventional homogeneous and heterogeneous
immunoassays, are also desirable. Biosensors present a promising alternative
to established diagnostic technologies and can potentially meet many of these
requirements. Surface plasmon resonance (SPR) biosensors offer a label-free
direct measurement platform for rapid screening of medically relevant ana-
lytes. Recent advances in SPR sensor hardware, biorecognition elements and
their immobilization, and sensor data analysis have made SPR biosensors
a strong candidate for development of new analytical systems for medical
diagnostics.
In the following section, we review the state of the art in applications of
SPR biosensor technology for detection of disease biomarkers such as anti-
gens and antibodies related to cancer, heart attack, and other diseases. Review
of SPR applications in the field of hormone detection and monitoring of drug
serum levels is also reported.
2
Cancer Markers
Early diagnosis is the key to successful treatment for most types of cancer.
Conventional diagnostic methods such as X-ray imaging, computer tomog-
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raphy, or ultrasound are not appropriate for early stage cancer diagnostics
because they detect already formed tumors. Detection of biological markers
of cancer that are produced as the cancer grows is a helpful tool in cancer
diagnostics and monitoring. For example, the prostate-specific antigen (PSA)
– a biomarker of prostate cancer – can be detected in blood even before the
cancer can be diagnosed by the conventional methods [5]. Diagnostic tests
based on detection of biomarkers are non-invasive and less expensive than
conventional methods such as biopsy of tissues (liver, kidneys, and testicles)
and examinations involving mammography, ultrasonography, X-ray imag-
ing instruments, or radiological and cytological devices. This makes cancer
biomarker tests more applicable to large scale population screening, or repet-
itive screening of an individual [6].
There is a vast effort in research laboratories worldwide to identify new
cancer biomarkers present in the circulatory system [7] and gene markers
present in the human genome [8]. In the past two decades, hundreds of thou-
sands of substances have been investigated as potential biomarkers for cancer
diagnosis, but only about 50 serological tumor markers are currently avail-
able [9] and only 12 cancer biomarkers are recognized by the US Food and
Drug Administration (FDA) [10]. Biomarkers of malignancy already in clin-
ical use include PSA as the marker of prostate cancer [11, 12], carcinoembry-
onic antigen (CEA) marker (colorectal, breast cancer) [13, 14], cancer antigen
(CA) marker CA 15-3 (breast cancer) [15], CA 125 (ovarian cancer) [16] car-
bohydrate antigen CA 19-9 (pancreas, colon, stomach cancer) [17], and alpha
fetoprotein (AFP) marker (liver, testicular cancer) [18]. Many other poten-
tial cancer markers such as beta hCG (testicular cancer), calcitonin marker
(thyroid cancer), and thyroglobulin marker (thyroid cancer) are under eval-
uation [8, 19, 20].
PSA is one of the most widely used cancer biomarkers. It is a chymotryp-
sin-like serine protease that is produced by epithelial cells of the prostate
gland and secreted into the prostatic fluid. Prostate-cancer invasion disrupts
the epithelial membrane barrier leading to elevated serum levels of PSA. De-
tection of PSA in blood can therefore be useful in the diagnosis of prostate
abnormalities and for evaluation of prostate cancer therapy efficacy [21]. Two
different forms of PSA are immunologically detectable: the free form (MW
34 kDa) and a complex with α-1-antichymotrypsin (MW 96 kDa). Diagnostic
assays developed for detection of PSA (e.g., enzyme-linked immunosorbent
assays) detect total PSA concentrations down to 0.1 ng mL–1 [22, 23].
An immunoassay for the detection of PSA in PBS buffer based on a dual-
channel SPR instrument with angular modulation (IBIS II) has been re-
ported [24]. This work compared direct and sandwich detection of PSA on
planar- and hydrogel-type sensor surfaces. Amplification with colloidal gold
and latex microspheres, respectively, was employed in the sandwich assay.
Sensor chips with carboxylated matrices of different thicknesses were used.
Mouse monoclonal antibodies against PSA were immobilized on the both
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types of chip surfaces via amine coupling chemistry. The first amplification
step consisted of incubation with rabbit anti-PSA polyclonal antibodies. In
experiments employing latex amplification, incubation with biotinylated goat
anti-rabbit IgG was followed with streptavidin-coated latex microspheres. In
experiments with gold microspheres, detection continued with immersion
in a solution containing goat anti-rabbit IgG-coated colloidal gold. The chip
with a thinner dextran matrix was found to lead to a higher sensor sensitiv-
ity for both the direct and sandwich detection formats. Specifically, detection
limits of 0.15 ng mL–1 and 2.4 ng mL–1 were determined for the detections
Fig. 1 Detection of PSA in buffer directly and using sandwich assay format. The signals
generated upon binding of the different partners [PSA (• bottom), biotinylated secondary
antibody ( middle) and 20 nm gold nanoparticles modified with streptavidin ( top)]
are shown for: a PSA concentrations varying between 73 pg mL–1 and 100 ng mL–1;
b PSA concentrations between 73 pg mL–1 and 20 ng mL–1 [25]
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Fig. 2 Sensorgrams and calibration curve for different IL-8 concentrations in saliva
supernatant premixed with 10 mg mL–1 of CM dextran sodium salt. a Sensorgrams
corresponding to enhanced detection by secondary antibody for different IL-8 con-
centrations (5 nM, 2 nM, 1 nM, 500 pM, 250 pM, and 0 pM labeled as A, B, C, D, E,
and F, respectively). b Calibration curve covering the IL-8 concentration range from 0
to 2 nM [26]
employing gold particle enhancement on planar-type and gel-type sensor
surfaces, respectively.
Huang et al. investigated detection of PSA using direct and sandwich im-
munoassay formats using an SPR sensor Biacore 2000 [25]. PSA-receptor
molecules consisting of a single domain antigen-binding fragment were co-
valently immobilized on the sensor surface via a mixed alkanethiol self-
assembled monolayer (SAM). PSA concentrations as low as 10 ng mL–1 were
detected in buffer. It was demonstrated that a sandwich assay involving a bi-
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otinylated secondary antibody and streptavidin-modified gold nanoparticles
lowered the limit of detection for PSA below 1 ng mL–1. Signal levels corres-
ponding to direct and amplified PSA detections in buffer are displayed in
Fig. 1.
Yang et al. [26] measured levels of interleukin-8 (IL-8) protein in the
saliva of healthy individuals and patients with oropharyngeal squamous cell
carcinoma using a Biacore X instrument. A sandwich assay using two mon-
oclonal antibodies, which recognize different epitopes on the IL-8, was used.
Monoclonal antibody against IL-8 was immobilized onto a dextran surface
via amine coupling chemistry. Saliva samples were first centrifuged to clar-
ify the supernatants. The supernatants were then aspirated and separated
from the cellular pellet. The detection limit for IL-8 was determined to be
2.5 pM (∼ 0.02 ng mL–1) for detection in buffer and 184 pM (∼ 1.5 ng mL–1)
for detection in saliva samples. Sensorgrams corresponding to IL-8 binding
at different concentrations and a calibration curve for secondary antibody-
enhanced detection of IL-8 (sandwich assay) are displayed in Fig. 2.
Nayeri et al. [27] presented an SPR (Biacore 2000)-based direct qualita-
tive detection of hepatocyte growth factor (HGF), which is an angiogenic
growth factor related to breast cancer, in reconstituted fecal samples from pa-
tients with infectious gastroenteritis (n = 20) and normal controls (n = 10)
(dissolved in distilled water at a dilution rate of 1 : 6). Mouse anti-human
HGF monoclonal antibodies and recombinant human HGF receptor were im-
mobilized on a dextran surface. The proportion of antibody-positive patient
samples detected by SPR correlated well with results obtained using ELISA.
3
Heart Attack Markers
Diagnosis of cardiac muscle injury relies on the detection of biomarkers such
as troponin I (TnI), troponin C (TnC), myoglobin, fatty acid binding protein
(FABP), glycogen phosporylase isoenzyeme BB (GPBB), C-reactive protein
(CP), urinary albumin, creatine kinase myocardial band (CK-MB), and brain
(B-type) natriuretic peptide in blood and urine [28–30].
Troponin complex is a heteromeric protein which plays an important role
in the regulation of skeletal and cardiac muscle contraction. It consists of
three subunits, troponin I (TnI), troponin T (TnT), and troponin C (TnC).
Each subunit is responsible for part of troponin complex function. For more
than a decade, the cardiac form of Tn I (cTn I) has been known as a reliable
marker of cardiac tissue injury. The greatest advantage of detection of cTn I
is its cardio-specificity [31].
Detection of human cTn I (29 kDa) in serum, utilizing direct and sandwich
immunoassay formats, was carried out by an SPR sensor with wavelength
modulation [32]. Biotinylated antibodies against cTn I were immobilized on
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an avidin layer created using amine coupling chemistry on an activated SAM.
Sensor responses to cTn I binding to immobilized antibody in serum samples
were compared with standard solutions containing known concentrations of
cTn I. Two detection modes for cTn I were demonstrated: (1) direct detection
of cTn I with a detection range of 2.5–40 ng mL–1, and (2) a sandwich assay
with a detection limit of 0.25 ng mL–1 and detection range of 0.5–20 ng mL–1.
Detection of myoglobin and cTn I markers was carried out using a home-
made two-channel multimode SPR fiber-optic sensor [33]. The two respec-
tive biomolecular recognition elements, human anti-myoglobin and human
anti-cardiac troponin I, were immobilized on a dextran surfaces via amine
coupling chemistry. Both myoglobin and cTnI were detected in buffer at con-
centrations lower than 3 ng mL–1.
4
Antibodies
Antibodies are soluble proteins (immunoglobulins) secreted by B-lympho-
cytes in response to exogenous and endogenous antigens. Antibodies specif-
ically bind to antigens to form antigen–antibody complexes. Antigens in this
complex are typically inactive and thus interaction of antigen with other host
molecules is blocked. These antibodies are referred to as neutralizing or in-
hibiting antibodies. In contrast, there are antibodies with a stimulating effect,
i.e., they activate bound molecules. An example of disease caused by activat-
ing antibody is Grave’s disease when antibodies function as ligands to cell
receptors. Presence of specific antibodies in the circulatory system can thus
serve as a biomarker of various diseases such as microbial infection, virus
infection, allergy, autoimmune disease, or tissue injury.
Direct detection of antibodies against Epstein–Barr virus (anti-EBNA) in
1% human serum was carried out using a wavelength-modulated SPR biosen-
sor (sensor setup description in [34, 35]). Synthetic peptides were used as
receptors and immobilized on the sensor surface in the form of BSA–peptide
conjugates via hydrophobic and electrostatic interactions [36]. A sensor cal-
ibration curve was established for an anti-EBNA concentration range of
0.2–2000 ng mL–1 (Fig. 3). The sensor response showed reproducibility better
than 82% for all concentrations and multiple chips and over 90% for meas-
urements performed on a single chip. The lowest detection limit for the direct
detection of anti-EBNA was found to be 0.2 ng mL–1. A procedure for regen-
eration of the sensor was developed and was demonstrated to allow at least
10 repeated anti-EBNA detection experiments without a significant loss in
sensor sensitivity. In addition, it was demonstrated that the sensor chips can
be stored for 30 days without deterioration in performance (Fig. 4).
The presence of antibodies against human respiratory syncytial virus
(RSV) in 26 patient sera was detected using an SPR biosensor (Biacore 2000)
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Fig. 3 a Sensor response to anti-EBNA detection obtained from three individual sensing
channels on regenerated surface. b Sensor calibration curve
Fig. 4 Sensor responses to anti-EBNA binding obtained using one sensor chip immedi-
ately after functionalization and after 30 days of storage
by McGill et al. [37]. Monoclonal antibodies against the virus glycoproteins
(F- and G-glycoproteins) were covalently attached to a dextran matrix via
amine coupling chemistry and then used to immobilize the respective virus
glycoproteins. Serum samples isolated from patient respiratory tracts were
diluted in HBS buffer (1 : 10), filtered (0.22 µm filter), and injected into the
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sensor surfaces. It was shown that, in contrast to an immunofluorescence
assay, the SPR biosensor was capable of recognizing the antigenic differ-
ences between the two different contemporary genotypes of the virus (G- and
F- virus glycoproteins). In order to confirm that the material binding to virus
antigen was immunoglobulin, monoclonal mouse anti-human IgG was in-
jected after each serum sample. In all SPR measurements the detection of
antibodies was genotype specific.
Isotype-specific anti-adenoviral antibodies in patients dosed with adeno-
viral-based gene therapy vectors were detected using a Biacore 3000 by Abad
et al. [38]. In this assay, whole intact virus was immobilized on the sensor sur-
face (dextran matrix) using amine coupling. The binding of antibodies from
patient blood sera (1 : 10 diluted) was measured by SPR sensor and ELISA.
The results obtained by the SPR biosensor were consistent with those ob-
tained using ELISA.
Direct qualitative detection of antibodies against hepatitis G virus from
patient sera was presented by group the of Rojo [39]. A Biacore 1000 im-
munoassay utilized synthetic peptides, which were immobilized on dextran
surface via amine coupling chemistry. Sera from 38 chronic hepatitis C pa-
tients, 36 hemodialyzed patients and 110 control healthy patients (1 : 100
dilution) were tested for the presence of specific antibodies. The results were
in good agreement with those obtained using ELISA.
The detection of antibodies against herpes simplex virus type 1 and type 2
(HSV-1, HSV-2) in 1 : 100 diluted human sera with HBS buffer using the Bia-
core X instrument is reported in the work of Wittekindt et al. [40]. Peptides,
used as a biorecognition element, were biotinylated and immobilized on the
streptavidin-coated sensor chip. Two peptides from a series of eight peptides
selected from segments of HSV-1 and HSV-2 gB, respectively were identified
as immunogenic. Employing both peptides, a good agreement between the
SPR biosensor and immunoblotting (reference method) was obtained (corre-
lation 83% and 86% for antibodies against HSV-1 and HSV-2, respectively).
An angular modulation-based SPR biosensor for syphilis screening has
been reported by Severs et al. [41]. Antibodies against the causative organ-
ism Treponema pallidum were detected in serum (1 : 20 diluted in Tris buffer)
using sensor chips coated with recombinant Treponema pallidum membrane
protein A (TmpA) and blocked with 0.1% gelatin. Direct and sandwich as-
say formats were used for detection. It was shown that the direct detection
of antibodies in serum was not sufficiently reproducible, most likely due to
non-uniformity of patient serum samples. In contrast, the results obtained
with the SPR sandwich assay for ten blind-coded sera corresponded well with
conventional syphilis tests (Trepanema pallidum haemagglutination assay,
fluorescent treponemal antibody-absorbed test, venereal diseases research
laboratory flocculation test, and TmpA-based ELISA test).
Monitoring plasma levels of anti-protein S antibodies following Varicella–
Zolter virus infection has been reported by Regnault et al. [42], who used
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an SPR sensor (Biacore X) to detect the presence of antibodies to protein S
in infected patients [43]. Immobilization of protein S and IgG, respectively
on dextran surfaces was carried out using amine coupling chemistry. Direct
qualitative detection of antibodies was performed in diluted plasma (1 : 5) of
patient sera samples each day during a 45-day infection. Twelve plasma sam-
ples from healthy patients were used as a control for potential non-specific
binding.
Direct and sandwich format detection of antibodies against glucose 6-
phosphate isomerase (GPI) in synovial fluids of rheumatoid arthritis and
osteoarthritis patients (diluted 1 : 100 in HEPES) using a Biacore 2000 is
presented in the work of Kim et al. [44]. Recombinant human GPI pro-
teins produced from E. coli were immobilized on the dextran sensor surface
via amine coupling chemistry. The synovial fluid samples from rheumatoid
arthritis patients showed a significantly higher level of antibodies binding to
the recombinant GPI proteins than samples from osteoarthritis patients.
Wilkop et al. reported the use of an SPR imaging sensor and a micro-
contact printed array for parallelized detection of antibodies against cholera
toxin (CT) [45]. Immobilization of the toxin was performed by combining
the microprinting method with the covalent linkage of the protein to NHS-
activated terminal groups on a self-assembled monolayer of thiols. Detection
of anti-cholera toxin IgG (anti-CT IgG) was demonstrated for antibody con-
centrations ranging from 10 to 100 µg mL–1, Fig. 5.
An assay for diagnosing type I diabetes mellitus based on the detection
of anti-glutamic acid decarboxylase (GAD) antibodies in buffer by a Bia-
core 2000, is presented in [46, 47]. Biotinylated GAD was immobilized on
a streptavidin-coated surface. The effect of mixed SAM composition (dif-
fering in ratios of hydroxyl- and carboxyl-terminated alkanethiols) on the
sensitivity of the sensor was investigated. On SPR sensor chips prepared
with the optimized SAM composition (10 : 1 ratio of 3-mercaptopropanol
to 11-mercaptoundecanoic acid), a concentration of anti-GAD as low as
0.75 µg mL–1 was detected.
An SPR sensor-based detection of antibodies against granulocyte macro-
phage colony stimulating factor (GM-CSF) was performed in the work of
Rini et al. [1]. GM-CSF is cytokine that is involved in human immunother-
apy protocols for various cancers including prostate cancer [48]. Antibodies
against GM-CSF were induced in prostate cancer patients by repeated admin-
istration of GM-CSF and their presence in patient sera was monitored using
a Biacore 2000 (sera diluted 1 : 5) and ELISA (sera diluted 1 : 20). The GM-
CSF antigen used as a biomolecular recognition element was immobilized on
the carboxymethylated dextran on the surface of the SPR sensor via amine
coupling chemistry. The measurements performed using the SPR biosensor
revealed that all 15 prostate cancer patients treated with GM-CSF produced
GM-CSF reactive antibodies, which was in agreement with reference ELISA
measurements.
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Fig. 5 Detection of anti-CT antibodies with printed CT proteins. a Images of printed
CT patterns before and after incubation with increasing amount of anti-CT antibodies
(background corrected). From left to right: sensor surface before incubation with anti-CT;
after exposure to anti-CT (0.001 mg mL–1); and after exposure to anti-CT (0.002 mg mL–1)
b Concentration-dependent response to anti-CT binding to CT (measuring surface) and
BSA (reference surface), respectively [45]
Direct detection of antibody against insulin in patient sera using an SPR
sensor Biacore 2000 is presented in [49]. Purified human insulin was used as
a biorecognition element and immobilized on the sensor surface via amine
coupling chemistry. Test sera samples were pretreated to remove insulin and
filtered before SPR measurements. Insulin antibodies were detected in eight
selected patient sera samples and fell in the range 2.91–16.3 µg mL–1.
5
Hormones
Monitoring concentrations of female hormones is important for female dis-
ease diagnostics as well as for fetal health monitoring. The most important
female cycle biomarkers, which are typically measured in clinical laboratory
tests or commercial test strips, include follicle stimulating hormone (FSH) as
a marker of non-pregnancy, luteinizing hormone (LH) as a marker of ovu-
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lation, and human chorionic gonadotropin hormone (hCG) as a marker of
pregnancy.
Direct detection of hCG in buffer in the concentration range 0.05–1 µg mL–1
was demonstrated using a wavelength modulation-based SPR sensor, Fig. 6.
A regeneration protocol was developed that allowed repeated use of the sen-
sor with measurement reproducibility over 90%. The same group used an SPR
imaging instrument with antibodies against hCG covalently immobilized to
a mixed SAM to detect hCG at concentrations lower than 500 ng mL–1 [50].
Ladd et al. reported SPR sensor-based detection of hCG [51], exploit-
ing a DNA-directed antibody immobilization method. The immobilization
consisted of non-covalent attachment of streptavidin to a biotinylated SAM
followed by binding of biotinylated oligonucleotides to available streptavidin
binding sites. Antibodies chemically modified with oligonucleotides with
a complementary sequence were finally attached to this surface via DNA
hybridization. The detection limit for direct detection of hCG in buffer by
a dual-channel SPR sensor with wavelength modulation was determined to be
0.5 ng mL–1.
Detection of estrone and estradiol in buffer using SPR sensors Biacore 2000
and Biacore 1000 was carried out by Coille et al. [52]. Analyte–BSA conju-
gates and BSA were immobilized in the sensing and reference channels of
a sensor chip, respectively, using NHS-esters. Analyte concentrations detected
using inhibition format in this work were in the range 0.01–3000 ng mL–1.
Fig. 6 Sensorgrams corresponding to binding of hCG at various concentration on anti-hCG
immobilized on the sensor surface and hCG-sensor calibration curve
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Miyashita et al. [53] present an SPR Biacore X-based immunoassay for the de-
tection of 17β-estradiol in buffer. The assay was performed in an inhibition
format, in which 17β-estradiol BSA conjugates were immobilized on the sen-
sor surface and the binding of antibody to 17β-estradiol conjugates on the
surface was measured. The 17β-estradiol was detected in the concentration
range 0.47–21.4 nM (∼ 0.14–6.4 ng mL–1).
6
Drugs
Therapeutic drug monitoring is very important for treatment of many seri-
ous diseases (e.g., HIV [54], heart failure [55], Parkinson’s, malaria, cystic
fibrosis, diabetes mellitus [56], etc.) and for treatment of pregnant women,
children, and patients with special conditions (e.g., pre-existing liver damage)
where routine recommended dosing is not always appropriate.
An inhibition assay for the detection of anticoagulatory coumarin deriva-
tive 7-hydroxycoumarin (7-OHC) using a Biacore SPR sensor and competitive
assay was presented by Keating et al. [57]. A 7-OHC conjugated with BSA
was immobilized on a carboxymethylated dextran sensor chip via amine
coupling chemistry. Serum samples (diluted with buffer) were premixed
with a polyclonal anti-7-OHC antibody and injected over the sensor surface.
The binding of excess antibodies to the immobilized conjugate generated
a sensor response inversely proportional to the 7-OHC concentration. The
assay had a measuring range of 0.5–80 µg mL–1. This immunoassay exhib-
ited reproducibility and sensitivity comparable to established methods of
analysis.
Fitzpatrick et al. detected oral anticoagulant warfarin using a Biacore
3000 SPR sensor and an inhibition assay [58]. 4′-Aminowarfarin or 4′-azo-
warfarin–BSA was immobilized on a dextran matrix via amine coupling
chemistry. Detection of warfarin was performed in plasma ultrafiltrate (di-
luted 1 : 100) in a concentration range of 4–250 ng mL–1. The observed cali-
bration curve and residual plot are shown in Fig. 7. A procedure for regener-
ation of the sensor chips was established, allowing for more than 70 binding
cycles.
Direct detection of a cytokine protein, recombinant human interferon-γ ,
using an IBIS SPR sensor is presented in [59]. Several types of sensor
chip coatings, including self-assembled monolayers and hydrogel-derivatized
SAMs, were characterized in terms of their ability to resist non-specific ad-
sorption from plasma. The best results with respect to plasma adsorption
and surface regenerability were obtained with antibodies immobilized on the
dextran-modified 11-mercaptoundecanoic acid SAM. The detection limit for
detection of human interferon-γ in 1 : 100 diluted plasma was established at
250 ng mL–1.
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Fig. 7 Calibration and residual plot for the inhibition assay-based detection of warfarin in
plasma ultrafiltrate (n = 3). The mean normalized response value (RAG/R0) at each ana-
lyte concentration from three independent assays was used to calculate the calibration
curve and to determine the assay variation [58]
Detection of low molecular weight heparin oligosaccharide (Fragmin),
which is an antithrombotic agent, was demonstrated using purified mono-
clonal antibodies immobilized via amine coupling chemistry onto the surface
of a Biacore 3000 [60]. Monoclonal antibodies were immobilized on a sensor
surface prefunctionalized with Fragmin–HSA conjugates. The detection limit
for Fragmin in PBS buffer was determined to be 125 nM (∼ 625 ng mL–1).
The Sakai group [61] developed an SPR sensor-based inhibition im-
munoassay for detection of morphine in buffer and in 1% human urine. They
used an SPR sensor SPR-20 and immobilized morphine–BSA conjugates on
the gold surface via physical adsorption. The addition of morphine to the
anti-morphine antibody solution was found to reduce the SPR signal because
of the inhibition effect of morphine. The detection limit of morphine in 1%
urine was established at 2 ng mL–1.
A Biacore 1000 inhibition assay for the detection of morphine-3-glucuron-
ide (M3G), the main metabolite of heroin and morphine, was demonstrated in
buffer and diluted urine by Dillon et al. [62]. M3G–ovalbumin conjugate was
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immobilized on a dextran matrix via amine coupling chemistry. Two poly-
clonal antibodies were produced, purified, and tested for M3G detection. The
range of detection of M3G in buffer and in urine (diluted 1 : 250) was found
to be 0.7 and 24.4 ng mL–1, respectively.
7
Summary
Recently, we have witnessed an increasing effort to exploit SPR biosensor
technology for medical diagnostics. Detection of a variety of disease biomark-
ers, hormones, and drugs at clinically relevant levels has been demonstrated.
Although many of these detection experiments were performed in pure
model samples with minimal or no matrix interferences, clinical samples have
also been tackled, Table 1.
It is expected that advances in SPR sensor instrumentation (reducing size,
improving sensitivity, increasing throughput), biorecognition elements and
methods for their immobilization (increasing sensitivity and specificity) will
lead to new systems for rapid detection and identification of disease biomark-
ers. These will further extend the applicability of SPR biosensor technology in
medical diagnostics.
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Abbreviations
A Analyte (free reagent in solution)
B Complex of analyte and receptor
D Diffusion coefficient (coefficient of translational diffusion)
Da Damköhler number
h Flow cell height
ka Association rate constant
kd Dissociation rate constant
K Equilibrium association constant (binding affinity)
l Flow cell length
NA Avogadro’s number
PDE Fundamental equation of analyte transport inside flow cell (partial differential
equation)
Pe Peclét number
R Receptor (binding target for the analyte immobilized at the sensor surface)
RU Units of the SPR sensor response (resonance units)
Re Reynolds number
w Flow cell width
[X] Molar concentration of X
x Space coordinate in direction of the analyte flow
2 J. Štěpánek et al.
y Space coordinate in direction perpendicular to the sensor surface
α Free analyte concentration (≡ [A])
α0 Injected analyte concentration
β Surface concentration of receptor (moles per square area)
γ Surface concentration of complex (indexed for various types of complexes when
necessary)
ξ Sensor response (in RU)
ξS Standard sensor response (in RU) corresponding to all receptor sites bound to
analyte in 1 : 1 ratio
1
Introduction
Binding and/or unbinding of biomolecules at the active surface of an SPR
biosensor is controlled by various mechanisms that result in variety of tem-
poral profiles of the SPR biosensor response and in dependence on mi-
croenvironmental conditions. The determination of binding kinetics provides
important new information about interacting molecules. This is commonly
considered one of the greatest advantages of the SPR biosensor technique. Al-
though in ideal cases an appropriate kinetic model of molecular interaction
is able to completely describe the SPR biosensor response, in reality the in-
fluence of hydrodynamic conditions often has to be taken into account [1].
This chapter is devoted to molecular interaction models that correspond to
the processes most frequently encountered at SPR biosensor surfaces. It also




To quantitatively analyze the sensor response to interactions between the
studied biomolecule (analyte) and the surface bound receptors, it is ne-
cessary to employ a relevant mathematical model. The core part of the
model is a kinetic equation that describes how the temporal amounts of
formed/dissociated complexes depend on the momentary local concentra-
tions of the free analyte and the free binding sites of the receptors.
SPR biosensor experiments measure only relative changes in the molecular
mass attached to the sensor surface from the beginning of the interaction be-
ing studied. The response ξ is then directly proportional to the concentration
of the bound analyte (conditions that guarantee a linear sensor response are
assumed throughout the chapter). In the case of a single type of analyte bind-
ing to the receptors in a 1 : 1 stoichiometric ratio, the response is proportional
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to the concentration of the formed complexes:
ξ = const MAγ , (1)
where MA is the mass of the analyte molecule and γ is the surface concen-
tration of the formed complexes. It can be shown that for sufficiently high
analyte concentrations, the sensor response will eventually reach its max-
imum value, which corresponds to all of the receptors being occupied. This
response does not change measurably with further increases in the analyte
concentration. Considering that the maximum possible response for the 1 : 1
stoichiometry is given by:
ξS = const MAβ , (2)
where β is the surface concentration of receptors, it is widely useful to char-
acterize the sensor response by its normalized value:
ξ/ξS = γ/β . (3)
2.1
Pseudo First-Order Kinetics
Whenever we deal with analyte binding to receptors fixed at a sensor sur-
face, the second order reaction model represents the basis of its description.
This model concerns the situation when two partners, A and R, form a single
complex AR. This can be, for instance, binding of an antigen to an antibody,
docking of a substrate to an enzyme with a single binding pocket, or duplex
formation by two complementary chains of nucleic acid. In the case of inter-
actions at the sensor surface, we have to distinguish between the immobilized
receptor R and the analyte A present in the solution. Two processes are con-
sidered by the model: (1) the association process whereby A and R bind to
each other and create the immobilized complex AR and (2) the dissociation
process whereby the complex AR dissociate into two parts, A and R. These
processes are symbolized by:
A + R → AR and AR → A + R . (4)
For the association, it is essential that A and R are in close proximity, i.e., their
distance must be shorter than a critical radius. If this condition is satisfied,
there is a certain probability that within a unit time interval A and R will form
a complex. For a set of given environmental conditions (temperature, pres-
sure, solvent properties) this probability is the same for all neighboring pairs
of A and R, provided we do not consider microscopic conditions such as their
mutual orientation or their instantaneous speeds of translation and rotation.
For a given receptor the probability that any molecule of analyte appears
within the critical distance is proportional to the concentration of A. The total
number of associations per time interval in a particular region is proportional
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to the total number of receptors involved, because they all can create a com-
plex with the same probability. As a result, we obtain a relationship between
the amount of the complexes γ formed per unit time, the instantaneous con-









where ka is a constant that characterizes the chemical reaction in the sense
that it is independent of time and of the reactants concentrations. It is called
the association or forward rate constant.
On the other hand, for each complex there is certain probability that within
a unit time interval it will dissociate into A and R separated by a distance
larger than the critical radius. This probability is the same for all complexes
at the given conditions. The dissociation leads to a decrease of the complex
concentration proportional to its instantaneous value:
dγd
dt
=– kdγ , (6)
where kd is called the dissociation or reverse rate constant. In a real system,
both the association and dissociation processes occur simultaneously. It can





The time dependence of the total complex concentration is then described by













– kdγ . (8)
Both quantities β and γ must be expressed in the same kind of local density.
In the case of a solution phase reaction, we would understand them as mo-
lar concentrations, i.e., number of moles per unit volume. For receptors fixed
on the sensor surface it is more straightforward to define them as surface
concentrations, i.e., number of moles per unit area.
The solution of Eq. 8 depends strongly on how the concentration of the free
analyte α is controlled. In the case of an active sensor surface surrounded by
a solvent occupying certain closed volume V, the analyte can be injected as
a highly concentrated solution [1, 2]. In the ideal case of a perfectly mixed so-
lution, the effect of the injection can be described as an immediate jump in
the analyte concentration from zero to a certain starting value α0. During the
consequent process the free analyte will be consumed by association with the
receptor, while the sum of the free and bound analyte will be kept constant:
αV + γS = α0V = const , (9)
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where S is the sensor area. The temporary change in the complex concentra-













– kdγ . (10)














where K is the equilibrium (association) constant. Sometimes it is also re-
ferred to as the binding affinity. A sense of Eq. 11 is demonstrated in Fig. 1:
changes in the association rate influence how fast both the concentration of
the complexes and that of the free analyte come to equilibrium. Note that
their equilibrium values are not changed, because the equilibrium constant is
fixed.
Fig. 1 Analyte-to-receptor binding after the analyte injection, according to the model
of the second order reaction in closed volume (Eq. 10). Parameters: α0 = 1.5 µM,
β = 10–9 M cm, S = 1 cm2, V = 1 µL, K = 107 M–1. Solid line ka = 4.5×104 M–1 s–1, dashed
line ka = 1.5×104 M–1 s–1
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Very often the number of molecules of analyte in volume V is much higher
than the amount of the receptors at the surface S. In this case, the term γS/V







– kdγ . (12)
Equation 12, originally derived by Langmuir for interactions at a surface in
contact with reactants in solution, is formally identical with the equation de-
scribing a first-order reaction in solution. It is therefore usually referred to as
pseudo first-order kinetics. Its solution is a single exponential function with










Pseudo first-order kinetics is also typical for sensors that employ flow cells,
where the free analyte concentration is primarily controlled by flowing a solu-
tion through the cell. In this case, the free analyte concentration can be either
increased stepwise or decreased stepwise. As a result, an SPR sensorgram usu-
ally consists of two stages: an association stage that begins with the stepwise
increase of the free analyte concentration to a constant value α0, followed by
a dissociation stage where the free analyte concentration is stepped down to
zero. An ideal SPR response corresponding to this experiment (pseudo first-
order kinetics) is shown in Fig. 2.
After a sufficiently long time, the association and the dissociation rates
become practically equal and a dynamic equilibrium state is achieved. The
Fig. 2 Ideal flow-cell sensorgram according to the model of pseudo first-order re-
action (Eq. 12). Parameters: α0 = 1.5 µM, β = 1 nM cm, K = 107 M–1. Solid line ka =
4.5×104 M–1 s–1, dashed line ka = 1.5×104 M–1 s–1. Vertical dashed lines indicate begin-
ning of the association and the dissociation stage
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Fig. 3 Set of sensorgrams (model) suitable for equilibrium analysis (left) and binding
isotherm with indicated equilibrium sensorgram results (right). Model of pseudo first-
order reaction. Parameters: β = 1 nM cm, K = 107 M–1, ka = 4.5×104 M–1 s–1
equilibrium association constant K [3–7] can be determined by measuring
the dependence of the sensor’s equilibrium response on the injected analyte
concentration (binding isotherm). For pseudo first-order kinetics the binding







An advantage of equilibrium analysis is that, in contrast to the other parts of
the sensorgram, the equilibrium phase of the association curve is not affected
by mass transport (see below).
2.2
Other Kinetic Models
In reality, the processes in the active sensor layer may be more complicated
and the sensor response will be a superposition of several parallel or consecu-
tive reactions. We will present some kinetic models that correspond to more
complex molecular interactions at the sensor surface.
Zero order reactions following the initial binding are usually interpreted
as conformational changes of the AR complex. Once the conformation is
changed, the complex cannot dissociate unless it transforms back into its ori-
ginal state. This additional reaction can slow down the kinetics. The model,
first presented in [8], has been applied in a few studies of complex biomolec-
ular systems where the analyte binding may substantially change the physico-
chemical properties of the receptor, such as the interaction of angiotensin II
with a receptor at a lipid membrane [9] or the interactions of sulfated polysac-
charides with immobilized enzyme targets [10]. The reaction scheme of this









Assigning γ1 and γ2 to the concentrations of the complex in particular states:





the corresponding kinetic equations that account for the relationships be-
tween both types of complexes and the free receptor sites can be written as:
∂γ2
∂t












β – γ1 – γ2
)
– kd1γ1 – ka2γ1 + kd2γ2 . (17)
As the conformational change does not influence the mass of the complex, the






Models of parallel pseudo first-order reactions consider the case when two
interactions with different rate constants proceed simultaneously. Such situa-
tions can be attributed to different kinds of receptor sites or to different states
of the analyte [8, 11]. In the first case the model can describe heterogene-
ity of the sensor surface; the second may concern a macromolecular analyte
that can be present in various conformations, protonation states, etc. Besides
two sets of rate constants, the models also require specification of propor-
tion p between the two fractions of the receptor or analyte. For the model
































Results of this model are illustrated in Fig. 4. For the case with two states of
the analyte, the equations are analogous to the previous ones except that the
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Fig. 4 Kinetics and sensorgram according to the model of two parallel pseudo first-
order reactions attributed to two kinds of receptors (Eq. 19). Parameters: α0 = 1.5 µM,
β = 1 nM cm, p = 0.8, ka1 = 104 M–1 s–1, kd1 = 0.001 s–1, ka2 = 8×104 M–1 s–1, kd2 = 0.04 s–1
































Equations 22 can also be employed in the case of two different analytes,
although the last relationship for calculating the sensor response must be
modified to account for the different masses of the analytes.
Multivalent receptor binding is a case when a single receptor molecule
can bind more than one molecule of analyte. Multivalent binding capacity is
a frequent feature of many biomolecular systems, for instance antibodies. An-
other example is the formation of triplexes by oligonucleotides. If a purine
oligonucleotide is fixed at the sensor surface as a receptor, a complementary
oligonucleotide can bind to it and to create a duplex. In special cases, an-
other oligonucleotide molecule may bind to the duplex and form a triplex.
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This situation involves two successive reactions, each occurring at a unique








γ1 = [AR] γ2 = [ARA]
∂γ2
∂t












β – γ1 – γ2
)






Here the standard sensor response is assumed to be the case when all recep-
tors are bound in 1 : 1 complexes (duplexes). That is why the relative response
can exceed 1, as is seen in Fig. 5.
Fig. 5 Kinetics and sensorgram according to the model of consecutive two binding
reactions in case of bivalent receptor (Eq. 23). Parameters: α0 = 1.5 µM, β = 1 nM cm,
ka1 = 6×104 M–1 s–1, kd1 = 0.003 s–1, ka2 = 104 M–1 s–1, kd2 = 0.012 s–1
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Binding of a multivalent analyte occurs when a single analyte molecule
can simultaneously occupy more than one receptor molecule. This case does
not mirror the previous one, because the resulting analyte/receptor interac-
tion strongly depends on the receptor distribution on the sensor surface. For
sufficiently sparse receptor spacing, only a single binding mode is available
despite the number of analyte binding sites – once the analyte is caught by
a receptor, it is isolated from other distant receptors. Increasing the receptor
density increases the probability of forming a receptor pattern that allows an
analyte to bind multiple receptors. In [12] the authors introduced the con-
cept of dividing the active sensor layer into spheres with a radius equal to the
functional distance between the two binding sites of the analyte. Using Pois-
son statistics they estimated the portion p of those receptors (RC) that were at
least by two inside one sphere. Remaining receptors (RS) were expected to be
single within a sphere. The kinetic model considered simple 1 : 1 binding on




ARS A + RC
ka
kd




Assuming the same rate constants for both binding sites on the analyte, the
following set of equations is obtained:




β β2 = [RC] = pβ




























γ1 + γ2 + 2γ3
)
/β .
Note that a factor of 2 appears in the kinetic equations to account for the dou-
bled probability because of two binding sites on the analyte. In the equation
for ∂γ3
∂t , the fraction
β2–γ2–2γ3
β2
is the probability that there is a free receptor in-
side the sphere where the ARC complex occurs. The second fraction, 1VspNA ,
where Vsp is the sphere volume and NA is Avogadro’s number, represents the
concentration of the available analyte – one molecule in the Vsp sphere. It
has been demonstrated in [12] that this model fits experimental data substan-
tially better than a solvent kinetic model of multiple binding, which does not
respect the fixed positions of the receptors.
At the end of this section it is worth mentioning that besides SPR stud-
ies where the analyte binding to the receptor is the only running interaction,
competitive SPR biosensor experiments with two concurrent interactions,
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i.e., analyte-immobilized receptor and analyte-another ligand in solution, can
also be performed. Proper kinetic models for competitive SPR studies should
be developed based on the appropriate kinetic equations for the particular
interactions, using an approach analogous to the aforementioned cases.
2.3
Thermodynamic Context of Equilibrium and Kinetic Constants
The equilibrium association constant K is directly related to the change of the
molar Gibbs energy attributed to complex formation ∆G 0:





where R is the universal gas constant, T is the absolute temperature, and C 0
is a standard concentration – as a rule its value is taken as 1 M. The basic
temperature dependence of ∆G is given by the van’t Hoff equation:
∆G = ∆H – T∆S , (28)
where ∆H and ∆S are the changes of enthalpy and of entropy. If they are both




versus 1/T (van’t Hoff plot)
should be linear. The ∆H and ∆S values can be determined directly from the
graph; more precise is a least square fit of Eqs. 27 and 28.
The simple van’t Hoff equation (Eq. 28) is not completely correct if the
complex formation results in a change of the specific heat capacity ∆Cp,
in which case neither ∆H nor ∆S are exactly independent of temperature.















where T0 is a reference temperature. To obtain reliable values of ∆HTo, ∆STo,
and ∆Cp (T0 is defined, usually T0 = 298.15 K, i.e., 25 ◦C), precise data over
a wider range of temperatures are necessary for the fit. Estimation of any of
the thermodynamic parameters from another experiment is very helpful.
The temperature dependence of ka and kd is usually characterized by
means of activation energy (Eacta and E
act
d ) according to the Arrhenius equa-
tion:




where P is a constant known as the pre-exponential factor. The activation en-
ergy is assumed to be a measure of the amount of thermal energy required for
binding or dissociation. Because Eacta and E
act
d can be considered as activation
enthalpies, the reaction enthalpy can be calculated from the relationship:
∆H = Eacta – E
act
d . (31)
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An unusually high Eact value indicates that binding and/or dissociation re-
quires the surmounting of high potential energy barriers, suggesting that
conformational rearrangements are required.
When possible, the kinetic rate constants determined using SPR sensors
have been compared to those obtained in bulk solution using other methods.
Good agreement was obtained only in some cases. For instance, it has been
reported [14] that when a study of the interactions between small inhibitor
molecules and immobilized proteins was carefully designed, performed, and
analyzed, very good agreement with the bulk data was achieved.







where ϕ is a steric interaction factor, ε is an electrostatic interaction factor, r is
an interaction radius. DA and DR are translation diffusion coefficients of the
analyte and the receptor molecule.
Let us consider the term of the translation diffusion. The diffusion coeffi-
cient D expresses the ability of a molecule to change its position in solution
due to chaotic translation motion. Basic evaluation of the diffusion coefficient





where kB is the Boltzmann constant, T is the absolute temperature, η is the
viscosity of the fluid and a is the radius of the sphere approximating the
molecule size. Therefore, the diffusion coefficient decreases strongly with
increasing size of the molecule. In contrast to the case of both interaction
partners in solution, the translation diffusion of the receptor is limited when
it is immobilized at the sensor surface. The value inside the parentheses in
Eq. 32 may then be reduced and approximated as close to the DA term alone.
The final effect of immobilization on the translation diffusion term would de-
pend on the ratio between DA and DR. If the receptor is a large molecule like
protein and the analyte is a small molecule like the inhibitors used in the
experiments reported in [14], then DA ≈ (DA + DR) and the association and
dissociation rate constants may be very close for both the SPR biosensor and
for reactions in the bulk. On the other hand, a small receptor interacting with
a large analyte may be characterized by rate constants significantly different
from those measured in the bulk.
To conclude this section we summarize that, in general, the kinetic rate
constants obtained from SPR sensors may not agree with those obtained in
solution. The SPR technique seems to be better suited to performing compar-
ative studies of molecules according their affinity and other interaction char-
acteristics. However, improvements in the precision of SPR measurements
and of their theoretical description may soon lead to new approaches for ex-
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tracting fundamental information about biomolecular interactions using SPR
sensors with receptors with varying degrees of restricted mobility.
3
Mass Transport Effects
In SPR biosensors, the rate of biomolecular interactions at the surface depends
on the free analyte transport toward (association stage) or away from (disso-
ciation stage) the active zone. The stepwise free analyte concentration changes
discussed above are only an idealization, because the free analyte transport is
always limited. The influence of analyte transport on the reactions at the sen-
sor surface is given by comparing the transport throughput to the kinetic rates.
Slow analyte transport causes a decrease in its concentration when it is con-
sumed during the association phase and an increase when it is produced during
the dissociation phase. As a result, both reactions are slowed down.
This effect is illustrated in Fig. 6 where the kinetics of a simple pseudo
first-order reaction are calculated assuming that analyte transport is propor-
Fig. 6 Free analyte concentrations in the active layer and sensorgrams for the pseudo first-
order reaction and two-compartment model of the analyte transport. Parameters: α0 =
1.5 µM, β = 1 nM cm. Left ka = 0.03 M–1 s–1, kd = 0.003 s–1; right no binding of analyte to
receptor. Rate constant of the analyte diffusion flux (Eq. 32) kM/hlayer = 3×10–5 s–1 cm–1
(dashed line), 3×10–6 s–1 cm–1 (dash-and-dot), and 10–6 s–1 cm–1 (solid). Dotted line no
limitations of the analyte transport
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tional to the concentration difference between the bulk analyte solution and
the active sensor layer (two-compartment model, discussed in greater detail
later). In addition to the effect on analyte binding kinetics, the figure also
clearly illustrates that the reaction between the receptor and analyte influ-
ences, i.e., significantly reduces the free analyte concentration. If the reaction
does not occur (right-hand figures), the free analyte concentration reaches its
equilibrium value more rapidly.
3.1
Analyte Transport in a Flow Cell
The flow cell shape is typically rectangular with its length l (dimension
along the flow) and width w (dimension perpendicular to the flow and par-
allel to the sensor surface) in the range 10–0–10–2 cm, and a substantially
lower height h (dimension perpendicular to the sensor surface) measuring





where ρ and η are the density and viscosity of the fluid, and Φ is the flow rate
(volume of fluid passing through the cell per unit time interval). The flow is
expected to be laminar (without turbulence) if Re < 2100 [15]. For water at
20 ◦C, Re = (Φ/h) · 0.998 mm2 s–1. Considering typical flow cell dimensions
and flow rates, the Reynolds number does not exceed several hundreds. The
distance between the active sensor surface and both the inlet and outlet is as
a rule far enough that the laminar flow profile is fully developed in the ac-
tive sensor region [16]. The velocity profile is therefore considered as constant
over the sensor active zone.
Let us introduce spatial coordinates in the flow-cell interior: x in direction
of the length, y in direction of the height, and z in direction of the width. The
magnitude of the velocity (its direction is uniformly parallel to the x-axis)
depends mainly on y. The velocity profile is parabolic, with the maximum
velocity vmax at the mid-point of the cell height and zero velocity at the cell
walls. In contrast, the velocity dependence on z is negligible (except for the
regions very close to the cell walls, which are sufficiently far from the active
region) [17]. The total fluid flux through the flow cell can thus be obtained
by integrating over the y coordinate from zero to h. This provides a relation







Similarly to the flow velocity, other parameters characterizing analyte trans-
port are also constant in the z-direction. This allows us to reduce the trans-
port problem to two spatial dimensions described by the coordinates x and y.
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The actual analyte concentration, which is of course no longer constant, is





dependence of the analyte concentration is given by the continuity equation.
If no transport mechanism other than the laminar flow is considered, a par-



























To model the effect of an analyte injection, the equation has to be solved for
an initial condition of zero analyte concentration inside the flow cell at t = 0





= α0. Results are shown in Fig. 7. It can be seen that for
the central part of the vertical profile the injected analyte concentration α0 is
achieved relatively rapidly (depending on the flow rate), but the analyte con-
centrations remains zero in close proximity of the cell walls. This is a direct
consequence of laminar flow – analyte transport to the active surface layer by
laminar flow alone is very ineffective.
The other transport mechanism, i.e., translational diffusion of the analyte,
becomes therefore highly important in the vicinity of the active sensor layer.
Translational diffusion is a mechanism that leads to concentration unifor-
mity in non-mixed solutions. It is described by the first Fick’s law that states
proportionality between the rate of diffusion and the concentration gradient.
Fig. 7 Analyte concentration in a flow cell at 10 mm distance from the injection en-
trance reached 3 s (dotted line), 6 s (dashed), and 15 s (solid) after beginning of the
injection as a consequence of pure laminar flow (diffusion not considered). Flow rates
were 10 µL min–1 (left), 30 µL min–1 (middle), and 90 µL min–1 (right). Cell dimensions:
20 mm (length) × 2.7 mm (width) × 0.05 mm (height)
Molecular Interactions in SPR Sensors 17
Fig. 8 Analyte concentration in a flow cell at 10 mm distance from the injection en-
trance reached 3 s (dotted line), 6 s (dashed), and 15 s (solid) after beginning of the
injection as a consequence of laminar flow and diffusion. Flow rates were 10 µL min–1
(left), 30 µL min–1 (middle), and 90 µL min–1 (right), diffusion coefficient 10–6 cm2 s–1.
Cell dimensions: 20 mm (length) × 2.7 mm (width) × 0.05 mm (height)
The proportionality constant D is called the diffusion coefficient and quan-
tifies the chaotic translation motion of the molecules in solution. Its basic
evaluation is given by the Stokes formula (Eq. 33). The diffusion coefficient
decreases as the size of the molecule increases. For typical biomolecules in
aqueous medium, D is usually between 10–7 cm2 s–1 and 10–6 cm2 s–1. Tem-
perature dependence of the diffusion coefficient follows T/η, where T is
absolute temperature and η viscosity of the solvent, unless the temperature
change does not alter the molecular shape.
If the translation diffusion is taken into account, the equation of the ana-

































The effect of diffusion on the analyte distribution is shown in Fig. 8, where
Eq. 37 was solved using the same boundary conditions that were applied to
Eq. 35 to generate Fig. 7. Note the significant increase in analyte concentra-
tion near the cell walls, thanks to diffusion.
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3.2
Full Model of Mass Transport
A rigorous approach to modeling the reaction kinetics at the sensor surface,
including the mass transport effects, requires solving the fundamental par-
Fig. 9 Results of the full model of the analyte transport coupled to pseudo first-order re-
action kinetics. The model fitted to experimental sensorgram of DNA 23-mer binding to
its immobilized complementary DNA chain. The experimental sensorgram (upper graph,
black solid line with the association and dissociation periods indicated by vertical dashed
lines) is very well fitted by the theoretical course of the relative sensor response (gray long
dashes). The graphs below show the free analyte concentration in the close vicinity of the
active sensor layer as it is distributed 6, 50, 100, 150, and 200 s after the injection (on
the left, from the bottom up) and 0, 0.5, 1.12, 2.4, and 3.75 s after stopping the injection
(on the right, from the top down). The times corresponding to particular concentration
profiles are indicated in the upper graph by same graphical symbols. In the case of the
dissociation phase they can be resolved only after expansion of the time axis (insert).
Parameters: α0 = 10–7 M, β = 1.84×10–9 M cm, Φ = 70 mL min–1, D = 2.5×10–6 cm2 s–1,
ka = 5.6×105 M–1 s–1, kd = 2.5×10–6 s–1. The model was applied to the central part of the
flow cell (xy coordinates corresponding to the active zone of the sensor) with dimensions
of 2.5 mm×2.7 mm×0.04 mm
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tial differential (Eq. 37, PDE) coupled with the relevant kinetic equations.
The coupling is twofold. First, we have to apply the actual analyte concentra-
tion at the given point on the sensor surface. As this value varies along the
x-coordinate, the concentration of analyte/receptor complexes can no longer
be considered as only time dependent – it must be described as a function
of t and x: γ = γ (x, t). The kinetic equations need to be modified accordingly;




= kaα(x, 0, t) [β – γ (x, t)] – kdγ (x, t) . (38)
Secondly, we have to introduce the consumption or production of the free
analyte due to the interaction with receptors to the PDE. It is usually per-









For more complex reaction kinetics the right side of the equation must com-
prise all kinds of complexes (the formation of which requires consumption
of the analyte) multiplied by respective stoichiometric factors. Analogously to




is introduced for the flow-cell wall opposite to the sensor surface.
Equation Eq. 37 can be solved only numerically. Most often a finite element
method with various grids in the xy region of the flow cell is employed [18],
but other approaches have also been tested [19]. An illustration of the full
model results is given in Fig. 9.
The enormously time-consuming nature of full model calculations pre-
vents this approach from being used for complete fits of experimental data.
As a rule, it is employed to verify simpler models and/or to confirm the
reasonability of rate constants by comparison with experimental data. To en-
able more convenient and routine analysis of measured sensorgrams, simpler
models of mass transport effects have been derived.
3.3
Simplified Models of Mass Transport
The first simplification of Eq. 37 is based on the assumption that the ana-
lyte transport in the x direction is mainly conductive, i.e., it is controlled by
the flow in the cell. The relation between conductive transport and diffusion
in y direction is often characterized by the Peclét number, which reflects the
ratio of the ideal time required for an analyte molecule to diffuse from the cell
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middle (y = h/2) to the cell wall, to the minimal time required for that same





If the Peclét number is high compared to 1 (Pe  1), Eq. 37 can be simpli-
fied by omitting the diffusion term in the x direction and by linearizing the
flow velocity dependence on y, because we can limit calculations of the ana-






















For a pseudo first-order analyte-to-receptor reaction this equation coupled
with the reaction kinetics Eq. 38 via Eq. 39 can be solved so that an equation
for only γ (x, t) is obtained:
∂γ (x, t)
∂t

















Equation 43, which is much easier to solve than the full model, can be fur-
ther simplified in order to eliminate the integral term. This approximation
can be applied when the dependence of ∂γ (x,t)
∂t on x is rather weak and can be
assumed to be linear. This linearization allows the integral term to be evalu-
ated explicitly. The result can be written formally in a form analogous to the
original kinetic equation (Eq. 12):
dγ (x, t)
dt
= kefa (x, t)α0 [β – γ (x, t)] – k
ef
d (x, t)γ (x, t) , (44)




1 + ka [β – γ (x, t)]/kM(x)
kefd =
kd








Thanks to the previously applied assumption that γ (x, t) is linearly dependent
on x, it is also possible to integrate it over the active sensor region. As a re-
sult, we obtain equations analogous to Eq. 44, where γ (x, t) is replaced by the
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average concentration of complexes 〈γ 〉 (t):
d 〈γ 〉 (t)
dt
= kefa (t)α0 [β – 〈γ 〉 (t)] – kefd (t) 〈γ 〉 (t)
kefa =
ka











Equations 46 have been directly derived from the full model in [19]. On the
other hand, they are almost identical with the relations obtained from the
so-called two-compartment model (the only difference is that the numerical
coefficient kM is a little bit lower). The two-compartment model was first de-
veloped for sensors with receptors placed on small spheres [23]. In [24–26] it
was adapted for the SPR flow cell and in [18] it was approved and verified by
comparison of numerical results with those obtained from the full model. The
two-compartment model approximates the analyte distribution in the vicin-
ity of the receptors by considering two distinct regions. The first is a thin layer
around the active receptor zone of effective thickness hlayer, and the second
is the remaining volume with the analyte concentration equal to the injected
one, i.e., α0. While the analyte concentration in the bulk is constant (within
a given compartment), analyte transport to the inner compartment is con-
trolled by diffusion. The actual analyte concentration at the sensor surface
is then given by the difference between the diffusion flow and the consump-
tion/production of the analyte via interaction with receptors. For the simple























For a quasi-steady-state approximation where dαdt is set to zero in Eq. 47,
equations analogous to Eq. 46 are obtained from Eqs. 12 and 47.
The kM value can be considered as a measure of the mass transport. Its ef-
fect on the SPR response can be evaluated by the maximal difference of the
denominator in Eq. 46 from unity [16]. It is equal to the ratio of the reaction
velocity to the diffusion flux of the analyte at the beginning of the association
stage:
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For small Damköhler numbers (Da  1) the mass transport is much faster
than the surface reaction itself and therefore the mass transport effect may
be ignored. On the other hand, if the Damköhler number is high (Da  1)
the sensorgram profile is completely controlled by the diffusion mass transfer
and is it not possible to determine rate constants of the surface reaction.
All of the transport models presented so far assume that the diffusion mo-
bility of the analyte in the active sensor zone is the same as in the bulk. In case
of the sensors using a thick skeleton to fix the receptors, such as a dextran ma-
trix, solgel, or MIPs, it might be useful to take into account varying analyte
diffusion mobility inside the active sensor layer. Detail analysis and proposed
models can be found in [28].
4
Summary
A constant and homogeneous concentration of free analyte represents the
ideal condition for modeling molecular interactions at the surface of an SPR
biosensor. In the most frequent case where an analyte binds to an immo-
bilized receptor with 1 : 1 stoichiometry, the interaction follows the pseudo
first-order kinetic model. Adequate interaction models can be built up to
describe more complex molecular interactions; some of them have been pre-
sented and explained above.
The effect of mass transport on molecular binding in the SPR sensor active
layer can be evaluated by means of the Damköhler number (Eq. 50). Except
for cases of a very low Damköhler number, mass transport has to be regarded
in theoretical models by means of the aforementioned equations.
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